CINXE.COM

<!DOCTYPE html><html lang="en"><head><meta charSet="utf-8"/><meta name="viewport" content="width=device-width"/><script src="https://cmp.osano.com/6olh2SicG0V81Mlk/49948ac0-3014-48ce-a11e-afc811dc7037/osano.js"></script><title>Center for Biosimilars®</title><meta name="description" content=""/><meta property="og:url" content="https://www.centerforbiosimilars.com "/><meta property="og:title" content="Center for Biosimilars®"/><meta property="og:image" content=""/><meta property="og:site_name" content="Center for Biosimilars"/><meta property="og:description" content=""/><meta name="twitter:card" content="summary"/><meta name="twitter:title" content="Center for Biosimilars®"/><meta name="twitter:image" content=""/><meta name="twitter:site" content="@@BiosimCenter"/><meta name="twitter:description" content=""/><meta name="robots" content="max-image-preview:large"/><meta name="robots" content="max-video-preview:-1"/><link rel="preconnect dns-prefetch" href="https://cmp.osano.com"/><link rel="preconnect dns-prefetch" href="https://res.lassomarketing.io"/><link rel="preconnect dns-prefetch" href="https://www.lightboxcdn.com"/><link rel="preconnect dns-prefetch" href="https://pub.doubleverify.com"/><link rel="preconnect dns-prefetch" href="https://cdn.doubleverify.com"/><link rel="preconnect dns-prefetch" href="https://cdn.segment.com"/><link rel="preconnect dns-prefetch" href="https://securepubads.g.doubleclick.net"/><link rel="preconnect dns-prefetch" href="https://pagead2.googlesyndication.com"/><link rel="preconnect dns-prefetch" href="https://cdn.sanity.io"/><link rel="preconnect dns-prefetch" href="https://www.google-analytics.com"/><link rel="preconnect dns-prefetch" href="https://www.googletagmanager.com"/><link rel="preconnect dns-prefetch" href="https://player.vimeo.com"/><link rel="preconnect dns-prefetch" href="https://youtube.com"/><link rel="preconnect dns-prefetch" href="https://connect.facebook.net"/><link rel="preconnect dns-prefetch" href="https://www.facebook.com"/><link rel="preconnect dns-prefetch" href="https://static.ads-twitter.com"/><link rel="preconnect dns-prefetch" href="https://ad.doubleclick.net"/><link rel="preload" href="https://securepubads.g.doubleclick.net/tag/js/gpt.js"/><link rel="preload" href="https://pub.doubleverify.com/signals/pub.js#ctx=20083417&cmp=DV464021"/><link rel="icon" href="/favicon.ico"/><script async="" src="https://securepubads.g.doubleclick.net/tag/js/gpt.js"></script><script src="https://pub.doubleverify.com/signals/pub.js#ctx=20083417&cmp=DV464021"></script><meta name="keywords" content="biosimilars,biosimilar,interchangeability,interchangeable biosimilars,interchangeable biosimilar,biosimilar resources,bio-betters,biobetters,biologics,biologic drugs,biosimilar savings,biosimilar development,biosimilars in the clinical setting,biologic medications,biosimilar drugs,biosimilar medications,oncology biosimilars,rheumatology biosimilars,ophthalmology biosimilars,biosimilar insulin,biosimilar insulins"/><script src="https://one.centerforbiosimilars.com/tagmanager/scripts/one.js"></script><script>window.dataLayer = window.dataLayer || []; window.dataLayer.push({ event: "page_dimensions", pageTitle: "Center for Biosimilars®", dimension9: "home", dimension11: "", dimension12: "", dimension13: "", dimension14: "", dimension15: "home", dimension18: "", dimension19: "", dimension20: "", });</script><script type="module"> (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start': new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0], j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src= 'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f); })(window,document,'script','dataLayer','GTM-P2DHQJ7'); </script><script type="module"> var ALGOLIA_INSIGHTS_SRC = "https://cdn.jsdelivr.net/npm/search-insights@2.4.0"; !function(e,a,t,n,s,i,c){e.AlgoliaAnalyticsObject=s,e[s]=e[s]||function(){ (e[s].queue=e[s].queue||[]).push(arguments)},i=a.createElement(t),c=a.getElementsByTagName(t)[0], i.async=1,i.src=n,c.parentNode.insertBefore(i,c) }(window,document,"script",ALGOLIA_INSIGHTS_SRC,"aa");</script><link rel="canonical" href="https://www.centerforbiosimilars.com"/><script type="application/ld+json">{"@context":"https://schema.org","@type":"Organization","logo":"https://www.centerforbiosimilars.com/Biosimilars_ajmc_logo.png","url":"https://www.centerforbiosimilars.com","contactPoint":{"@type":"ContactPoint","availableLanguage":["English"]},"sameAs":["https://www.facebook.com/centerforbiosimilars/","https://twitter.com/biosimcenter","https://www.linkedin.com/company/thecenterforbiosimilars","/rss"]}</script><link rel="preload" as="image" imagesrcset="/_next/image?url=%2FBioSim_white.png&w=256&q=75 1x, /_next/image?url=%2FBioSim_white.png&w=384&q=75 2x"/><meta name="next-head-count" content="13"/><script async="" type="text/javascript" src="https://www.lightboxcdn.com/static/lightbox_mjh.js"></script><script defer="" src="https://res.lassomarketing.io/scripts/lasso-imp-id-min.js" type="text/javascript"></script> <script defer="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js"></script> <script type="module"> !function(){var analytics=window.analytics=window.analytics||[];if(!analytics.initialize)if(analytics.invoked)window.console&&console.error&&console.error("Segment snippet included twice.");else{analytics.invoked=!0;analytics.methods=["trackSubmit","trackClick","trackLink","trackForm","pageview","identify","reset","group","track","ready","alias","debug","page","once","off","on","addSourceMiddleware","addIntegrationMiddleware","setAnonymousId","addDestinationMiddleware"];analytics.factory=function(e){return function(){var t=Array.prototype.slice.call(arguments);t.unshift(e);analytics.push(t);return analytics}};for(var e=0;e<analytics.methods.length;e++){var key=analytics.methods[e];analytics[key]=analytics.factory(key)}analytics.load=function(key,e){var t=document.createElement("script");t.type="text/javascript";t.async=!0;t.src="https://cdn.segment.com/analytics.js/v1/" + key + "/analytics.min.js";var n=document.getElementsByTagName("script")[0];n.parentNode.insertBefore(t,n);analytics._loadOptions=e};analytics.SNIPPET_VERSION="4.13.1"; window.LassoImpressionID = lassoImpID(); analytics.load("BBbKMoOjmhsxPnbd2nO6osz3zq67DzuN"); analytics.page({ 'LassoImpressionID': window.LassoImpressionID }); }}(); </script> <link rel="preload" href="/_next/static/css/86a01d5a3c136fc5.css" as="style"/><link rel="stylesheet" href="/_next/static/css/86a01d5a3c136fc5.css" data-n-g=""/><link rel="preload" href="/_next/static/css/d62dfbdb12bb5fcd.css" as="style"/><link rel="stylesheet" href="/_next/static/css/d62dfbdb12bb5fcd.css" data-n-p=""/><noscript data-n-css=""></noscript><script defer="" nomodule="" src="/_next/static/chunks/polyfills-c67a75d1b6f99dc8.js"></script><script src="/_next/static/chunks/webpack-7ae19a9295132ab1.js" defer=""></script><script src="/_next/static/chunks/framework-45ce3d09104a2cae.js" defer=""></script><script src="/_next/static/chunks/main-c1ce322a402d266c.js" defer=""></script><script src="/_next/static/chunks/pages/_app-2e54c3b07442f0f5.js" defer=""></script><script src="/_next/static/chunks/69bd6bf3-c7219ac9ecb38ac9.js" defer=""></script><script src="/_next/static/chunks/f36c6662-e730e1316f9aa347.js" defer=""></script><script src="/_next/static/chunks/8eec4907-3e083fdcb8f62d72.js" defer=""></script><script src="/_next/static/chunks/065a3ddb-42216585c327b2a5.js" defer=""></script><script src="/_next/static/chunks/9814d858-cb162ab048445baf.js" defer=""></script><script src="/_next/static/chunks/72585f70-0d4479e14d41a365.js" defer=""></script><script src="/_next/static/chunks/59b4e022-12a1c6f09c31aa87.js" defer=""></script><script src="/_next/static/chunks/9762-2ef0479d694e43a1.js" defer=""></script><script src="/_next/static/chunks/1426-83dba18574fca30d.js" defer=""></script><script src="/_next/static/chunks/4179-91956f2d2c4bf724.js" defer=""></script><script src="/_next/static/chunks/8598-87eedee31545cdc7.js" defer=""></script><script src="/_next/static/chunks/9455-6f83e09602a9a2d5.js" defer=""></script><script src="/_next/static/chunks/3431-b745fb60e49bd8dc.js" defer=""></script><script src="/_next/static/chunks/8318-496702465b201726.js" defer=""></script><script src="/_next/static/chunks/528-412a4c551cf3b636.js" defer=""></script><script src="/_next/static/chunks/pages/index-30f9703e5c384bca.js" defer=""></script><script src="/_next/static/cCw4k4UN0a-RdhqtGj97I/_buildManifest.js" defer=""></script><script src="/_next/static/cCw4k4UN0a-RdhqtGj97I/_ssgManifest.js" defer=""></script><style id="__jsx-1661e6713d4eb9b5">.leaderboardAdWrapper.jsx-1661e6713d4eb9b5{min-height:90px;background:#fff}.leaderboardAdWrapper.jsx-1661e6713d4eb9b5 .AD728x90.jsx-1661e6713d4eb9b5{}@media screen and (min-width:768px){.leader-fixed.jsx-1661e6713d4eb9b5{position:fixed;margin-top:1rem;z-index:999999}}.leaderboardAdWrapper.jsx-1661e6713d4eb9b5 .AD728x90.jsx-1661e6713d4eb9b5 div[id*="google_ads_iframe"].jsx-1661e6713d4eb9b5:empty{height:0px!important}@media screen and (max-width:668px){.leaderboardAdWrapper.jsx-1661e6713d4eb9b5{min-height:0px;position:fixed;background:white;left:0;right:0;top:55px;padding-top:.5rem;padding-bottom:.25rem;z-index:9999}}</style><style id="__jsx-19ede9f0a5a45918">.jsx-19ede9f0a5a45918::-webkit-scrollbar{display:none}</style><style id="__jsx-276744038">.button.jsx-276744038{height:0px;position:relative;z-index:999;bottom:176px;left:50%;-webkit-transform:translateX(-50%);-moz-transform:translateX(-50%);-ms-transform:translateX(-50%);-o-transform:translateX(-50%);transform:translateX(-50%)}.button.jsx-276744038::before{content:"AJMC Supplement";display:block;position:relative;width:-webkit-fit-content;width:-moz-fit-content;width:fit-content;padding:7.5px 10px;font-weight:bold;-webkit-border-radius:5px;-moz-border-radius:5px;border-radius:5px;z-index:99999999;background-color:var(--primary);color:white;bottom:69px;left:50%;-webkit-transform:translateX(-50%);-moz-transform:translateX(-50%);-ms-transform:translateX(-50%);-o-transform:translateX(-50%);transform:translateX(-50%);font-size:.75rem;text-align:center;line-height:1.15;max-width:200px}.pill.jsx-276744038{height:0px}.pill.jsx-276744038::before{display:block;content:"On-Demand";height:22px;width:-webkit-fit-content;width:-moz-fit-content;width:fit-content;background:var(--secondary);color:var(--primary);font-size:10px;font-weight:bold;padding:.25rem .5rem;text-align:center;-webkit-border-top-right-radius:15px;-moz-border-radius-topright:15px;border-top-right-radius:15px;-webkit-border-bottom-left-radius:15px;-moz-border-radius-bottomleft:15px;border-bottom-left-radius:15px;position:relative;float:right;bottom:413px;z-index:99}.bottomDiv.jsx-276744038{width:100%;display:block;position:relative;top:-10px;height:300px;z-index:99;background:#fff;text-align:center;font-size:.875rem;-webkit-text-decoration-line:none;-moz-text-decoration-line:none;text-decoration-line:none}.bottomDiv.jsx-276744038::before{content:" ";display:block;width:100%;height:280px;border-top:8px solid var(--primary);left:-54px!important;-webkit-transform:rotate(7.5deg)!important;-moz-transform:rotate(7.5deg)!important;-ms-transform:rotate(7.5deg)!important;-o-transform:rotate(7.5deg)!important;transform:rotate(7.5deg)!important;position:absolute!important;background:white;z-index:1;top:-7px}.bottomDiv.jsx-276744038::after{content:" ";display:block;width:100%;height:280px;border-top:8px solid var(--primary);left:20px!important;top:-2px;background:white;-webkit-transform:rotate(-7.5deg)!important;-moz-transform:rotate(-7.5deg)!important;-ms-transform:rotate(-7.5deg)!important;-o-transform:rotate(-7.5deg)!important;transform:rotate(-7.5deg)!important;position:absolute!important;z-index:1}.border-div.jsx-276744038{content:" ";display:block;width:100%;height:280px;left:-50px!important;-webkit-transform:rotate(7.5deg)!important;-moz-transform:rotate(7.5deg)!important;-ms-transform:rotate(7.5deg)!important;-o-transform:rotate(7.5deg)!important;transform:rotate(7.5deg)!important;position:relative;background:white;z-index:99;top:-116px}.content-button.jsx-276744038{position:relative;border:1px solid var(--primary);min-width:40px;width:-webkit-fit-content;width:-moz-fit-content;width:fit-content;padding:5px 10px;font-weight:bold;-webkit-border-radius:5px;-moz-border-radius:5px;border-radius:5px;font-size:.75rem;z-index:9999;background:var(--primary);color:white;top:150px;left:70px}.content-wrap.jsx-276744038{position:absolute;width:100%;height:-webkit-fit-content;height:-moz-fit-content;height:fit-content;z-index:99;top:45%;display:-webkit-box;display:-webkit-flex;display:-moz-box;display:-ms-flexbox;display:flex;-webkit-box-orient:vertical;-webkit-box-direction:normal;-webkit-flex-direction:column;-moz-box-orient:vertical;-moz-box-direction:normal;-ms-flex-direction:column;flex-direction:column}#viewMore01165eb6b-e5ea-405c-a68b-f614a03b306e.jsx-276744038:hover{background:var(--secondary)}.view-more-wrap01165eb6b-e5ea-405c-a68b-f614a03b306e.jsx-276744038{width:100%;height:10%;display:-webkit-box;display:-webkit-flex;display:-moz-box;display:-ms-flexbox;display:flex;background:var(--primary);-webkit-box-pack:justify;-webkit-justify-content:space-between;-moz-box-pack:justify;-ms-flex-pack:justify;justify-content:space-between;-webkit-box-align:center;-webkit-align-items:center;-moz-box-align:center;-ms-flex-align:center;align-items:center;position:absolute;top:90%;z-index:999;background:-webkit-linear-gradient(left,var(--primary)50%,var(--secondary)50%);background:-moz-linear-gradient(left,var(--primary)50%,var(--secondary)50%);background:-o-linear-gradient(left,var(--primary)50%,var(--secondary)50%);background:linear-gradient(to right,var(--primary)50%,var(--secondary)50%);-webkit-background-size:200%100%;-moz-background-size:200%100%;-o-background-size:200%100%;background-size:200%100%;background-position:left bottom;-webkit-transition:all 150ms ease;-moz-transition:all 150ms ease;-o-transition:all 150ms ease;transition:all 150ms ease}.view#more-wrap01165eb6b-e5ea-405c-a68b-f614a03b306e.jsx-276744038:hover{background-position:right bottom}.view-more-wrap-wipe.jsx-276744038{background-position:right bottom}.text-white.jsx-276744038{color:var(--primary)}</style><style id="__jsx-726976786">.button.jsx-726976786{height:0px;position:relative;z-index:999;bottom:176px;left:50%;-webkit-transform:translateX(-50%);-moz-transform:translateX(-50%);-ms-transform:translateX(-50%);-o-transform:translateX(-50%);transform:translateX(-50%)}.button.jsx-726976786::before{content:"Live Event";display:block;position:relative;width:-webkit-fit-content;width:-moz-fit-content;width:fit-content;padding:7.5px 10px;font-weight:bold;-webkit-border-radius:5px;-moz-border-radius:5px;border-radius:5px;z-index:99999999;background-color:var(--primary);color:white;bottom:69px;left:50%;-webkit-transform:translateX(-50%);-moz-transform:translateX(-50%);-ms-transform:translateX(-50%);-o-transform:translateX(-50%);transform:translateX(-50%);font-size:.75rem;text-align:center;line-height:1.15;max-width:200px}.pill.jsx-726976786{height:0px}.pill.jsx-726976786::before{display:block;content:"Live";height:22px;width:-webkit-fit-content;width:-moz-fit-content;width:fit-content;background:var(--secondary);color:var(--primary);font-size:10px;font-weight:bold;padding:.25rem .5rem;text-align:center;-webkit-border-top-right-radius:15px;-moz-border-radius-topright:15px;border-top-right-radius:15px;-webkit-border-bottom-left-radius:15px;-moz-border-radius-bottomleft:15px;border-bottom-left-radius:15px;position:relative;float:right;bottom:413px;z-index:99}.bottomDiv.jsx-726976786{width:100%;display:block;position:relative;top:-10px;height:300px;z-index:99;background:#fff;text-align:center;font-size:.875rem;-webkit-text-decoration-line:none;-moz-text-decoration-line:none;text-decoration-line:none}.bottomDiv.jsx-726976786::before{content:" ";display:block;width:100%;height:280px;border-top:8px solid var(--primary);left:-54px!important;-webkit-transform:rotate(7.5deg)!important;-moz-transform:rotate(7.5deg)!important;-ms-transform:rotate(7.5deg)!important;-o-transform:rotate(7.5deg)!important;transform:rotate(7.5deg)!important;position:absolute!important;background:white;z-index:1;top:-7px}.bottomDiv.jsx-726976786::after{content:" ";display:block;width:100%;height:280px;border-top:8px solid var(--primary);left:20px!important;top:-2px;background:white;-webkit-transform:rotate(-7.5deg)!important;-moz-transform:rotate(-7.5deg)!important;-ms-transform:rotate(-7.5deg)!important;-o-transform:rotate(-7.5deg)!important;transform:rotate(-7.5deg)!important;position:absolute!important;z-index:1}.border-div.jsx-726976786{content:" ";display:block;width:100%;height:280px;left:-50px!important;-webkit-transform:rotate(7.5deg)!important;-moz-transform:rotate(7.5deg)!important;-ms-transform:rotate(7.5deg)!important;-o-transform:rotate(7.5deg)!important;transform:rotate(7.5deg)!important;position:relative;background:white;z-index:99;top:-116px}.content-button.jsx-726976786{position:relative;border:1px solid var(--primary);min-width:40px;width:-webkit-fit-content;width:-moz-fit-content;width:fit-content;padding:5px 10px;font-weight:bold;-webkit-border-radius:5px;-moz-border-radius:5px;border-radius:5px;font-size:.75rem;z-index:9999;background:var(--primary);color:white;top:150px;left:70px}.content-wrap.jsx-726976786{position:absolute;width:100%;height:-webkit-fit-content;height:-moz-fit-content;height:fit-content;z-index:99;top:45%;display:-webkit-box;display:-webkit-flex;display:-moz-box;display:-ms-flexbox;display:flex;-webkit-box-orient:vertical;-webkit-box-direction:normal;-webkit-flex-direction:column;-moz-box-orient:vertical;-moz-box-direction:normal;-ms-flex-direction:column;flex-direction:column}#viewMore1d6c81f31-e9ec-4815-833b-818bf5602646.jsx-726976786:hover{background:var(--secondary)}.view-more-wrap1d6c81f31-e9ec-4815-833b-818bf5602646.jsx-726976786{width:100%;height:10%;display:-webkit-box;display:-webkit-flex;display:-moz-box;display:-ms-flexbox;display:flex;background:var(--primary);-webkit-box-pack:justify;-webkit-justify-content:space-between;-moz-box-pack:justify;-ms-flex-pack:justify;justify-content:space-between;-webkit-box-align:center;-webkit-align-items:center;-moz-box-align:center;-ms-flex-align:center;align-items:center;position:absolute;top:90%;z-index:999;background:-webkit-linear-gradient(left,var(--primary)50%,var(--secondary)50%);background:-moz-linear-gradient(left,var(--primary)50%,var(--secondary)50%);background:-o-linear-gradient(left,var(--primary)50%,var(--secondary)50%);background:linear-gradient(to right,var(--primary)50%,var(--secondary)50%);-webkit-background-size:200%100%;-moz-background-size:200%100%;-o-background-size:200%100%;background-size:200%100%;background-position:left bottom;-webkit-transition:all 150ms ease;-moz-transition:all 150ms ease;-o-transition:all 150ms ease;transition:all 150ms ease}.view#more-wrap1d6c81f31-e9ec-4815-833b-818bf5602646.jsx-726976786:hover{background-position:right bottom}.view-more-wrap-wipe.jsx-726976786{background-position:right bottom}.text-white.jsx-726976786{color:var(--primary)}</style><style id="__jsx-4247410062">.button.jsx-4247410062{height:0px;position:relative;z-index:999;bottom:176px;left:50%;-webkit-transform:translateX(-50%);-moz-transform:translateX(-50%);-ms-transform:translateX(-50%);-o-transform:translateX(-50%);transform:translateX(-50%)}.button.jsx-4247410062::before{content:"On-Demand Virtual Symposium";display:block;position:relative;width:-webkit-fit-content;width:-moz-fit-content;width:fit-content;padding:7.5px 10px;font-weight:bold;-webkit-border-radius:5px;-moz-border-radius:5px;border-radius:5px;z-index:99999999;background-color:var(--primary);color:white;bottom:69px;left:50%;-webkit-transform:translateX(-50%);-moz-transform:translateX(-50%);-ms-transform:translateX(-50%);-o-transform:translateX(-50%);transform:translateX(-50%);font-size:.75rem;text-align:center;line-height:1.15;max-width:200px}.pill.jsx-4247410062{height:0px}.pill.jsx-4247410062::before{display:block;content:"On-Demand";height:22px;width:-webkit-fit-content;width:-moz-fit-content;width:fit-content;background:var(--secondary);color:var(--primary);font-size:10px;font-weight:bold;padding:.25rem .5rem;text-align:center;-webkit-border-top-right-radius:15px;-moz-border-radius-topright:15px;border-top-right-radius:15px;-webkit-border-bottom-left-radius:15px;-moz-border-radius-bottomleft:15px;border-bottom-left-radius:15px;position:relative;float:right;bottom:413px;z-index:99}.bottomDiv.jsx-4247410062{width:100%;display:block;position:relative;top:-10px;height:300px;z-index:99;background:#fff;text-align:center;font-size:.875rem;-webkit-text-decoration-line:none;-moz-text-decoration-line:none;text-decoration-line:none}.bottomDiv.jsx-4247410062::before{content:" ";display:block;width:100%;height:280px;border-top:8px solid var(--primary);left:-54px!important;-webkit-transform:rotate(7.5deg)!important;-moz-transform:rotate(7.5deg)!important;-ms-transform:rotate(7.5deg)!important;-o-transform:rotate(7.5deg)!important;transform:rotate(7.5deg)!important;position:absolute!important;background:white;z-index:1;top:-7px}.bottomDiv.jsx-4247410062::after{content:" ";display:block;width:100%;height:280px;border-top:8px solid var(--primary);left:20px!important;top:-2px;background:white;-webkit-transform:rotate(-7.5deg)!important;-moz-transform:rotate(-7.5deg)!important;-ms-transform:rotate(-7.5deg)!important;-o-transform:rotate(-7.5deg)!important;transform:rotate(-7.5deg)!important;position:absolute!important;z-index:1}.border-div.jsx-4247410062{content:" ";display:block;width:100%;height:280px;left:-50px!important;-webkit-transform:rotate(7.5deg)!important;-moz-transform:rotate(7.5deg)!important;-ms-transform:rotate(7.5deg)!important;-o-transform:rotate(7.5deg)!important;transform:rotate(7.5deg)!important;position:relative;background:white;z-index:99;top:-116px}.content-button.jsx-4247410062{position:relative;border:1px solid var(--primary);min-width:40px;width:-webkit-fit-content;width:-moz-fit-content;width:fit-content;padding:5px 10px;font-weight:bold;-webkit-border-radius:5px;-moz-border-radius:5px;border-radius:5px;font-size:.75rem;z-index:9999;background:var(--primary);color:white;top:150px;left:70px}.content-wrap.jsx-4247410062{position:absolute;width:100%;height:-webkit-fit-content;height:-moz-fit-content;height:fit-content;z-index:99;top:45%;display:-webkit-box;display:-webkit-flex;display:-moz-box;display:-ms-flexbox;display:flex;-webkit-box-orient:vertical;-webkit-box-direction:normal;-webkit-flex-direction:column;-moz-box-orient:vertical;-moz-box-direction:normal;-ms-flex-direction:column;flex-direction:column}#viewMore200a8213b-95a7-4fc6-9391-1307b6b90ab1.jsx-4247410062:hover{background:var(--secondary)}.view-more-wrap200a8213b-95a7-4fc6-9391-1307b6b90ab1.jsx-4247410062{width:100%;height:10%;display:-webkit-box;display:-webkit-flex;display:-moz-box;display:-ms-flexbox;display:flex;background:var(--primary);-webkit-box-pack:justify;-webkit-justify-content:space-between;-moz-box-pack:justify;-ms-flex-pack:justify;justify-content:space-between;-webkit-box-align:center;-webkit-align-items:center;-moz-box-align:center;-ms-flex-align:center;align-items:center;position:absolute;top:90%;z-index:999;background:-webkit-linear-gradient(left,var(--primary)50%,var(--secondary)50%);background:-moz-linear-gradient(left,var(--primary)50%,var(--secondary)50%);background:-o-linear-gradient(left,var(--primary)50%,var(--secondary)50%);background:linear-gradient(to right,var(--primary)50%,var(--secondary)50%);-webkit-background-size:200%100%;-moz-background-size:200%100%;-o-background-size:200%100%;background-size:200%100%;background-position:left bottom;-webkit-transition:all 150ms ease;-moz-transition:all 150ms ease;-o-transition:all 150ms ease;transition:all 150ms ease}.view#more-wrap200a8213b-95a7-4fc6-9391-1307b6b90ab1.jsx-4247410062:hover{background-position:right bottom}.view-more-wrap-wipe.jsx-4247410062{background-position:right bottom}.text-white.jsx-4247410062{color:var(--primary)}</style><style id="__jsx-985042568">.button.jsx-985042568{height:0px;position:relative;z-index:999;bottom:176px;left:50%;-webkit-transform:translateX(-50%);-moz-transform:translateX(-50%);-ms-transform:translateX(-50%);-o-transform:translateX(-50%);transform:translateX(-50%)}.button.jsx-985042568::before{content:"On-Demand Virtual Symposium";display:block;position:relative;width:-webkit-fit-content;width:-moz-fit-content;width:fit-content;padding:7.5px 10px;font-weight:bold;-webkit-border-radius:5px;-moz-border-radius:5px;border-radius:5px;z-index:99999999;background-color:var(--primary);color:white;bottom:69px;left:50%;-webkit-transform:translateX(-50%);-moz-transform:translateX(-50%);-ms-transform:translateX(-50%);-o-transform:translateX(-50%);transform:translateX(-50%);font-size:.75rem;text-align:center;line-height:1.15;max-width:200px}.pill.jsx-985042568{height:0px}.pill.jsx-985042568::before{display:block;content:"On-Demand";height:22px;width:-webkit-fit-content;width:-moz-fit-content;width:fit-content;background:var(--secondary);color:var(--primary);font-size:10px;font-weight:bold;padding:.25rem .5rem;text-align:center;-webkit-border-top-right-radius:15px;-moz-border-radius-topright:15px;border-top-right-radius:15px;-webkit-border-bottom-left-radius:15px;-moz-border-radius-bottomleft:15px;border-bottom-left-radius:15px;position:relative;float:right;bottom:413px;z-index:99}.bottomDiv.jsx-985042568{width:100%;display:block;position:relative;top:-10px;height:300px;z-index:99;background:#fff;text-align:center;font-size:.875rem;-webkit-text-decoration-line:none;-moz-text-decoration-line:none;text-decoration-line:none}.bottomDiv.jsx-985042568::before{content:" ";display:block;width:100%;height:280px;border-top:8px solid var(--primary);left:-54px!important;-webkit-transform:rotate(7.5deg)!important;-moz-transform:rotate(7.5deg)!important;-ms-transform:rotate(7.5deg)!important;-o-transform:rotate(7.5deg)!important;transform:rotate(7.5deg)!important;position:absolute!important;background:white;z-index:1;top:-7px}.bottomDiv.jsx-985042568::after{content:" ";display:block;width:100%;height:280px;border-top:8px solid var(--primary);left:20px!important;top:-2px;background:white;-webkit-transform:rotate(-7.5deg)!important;-moz-transform:rotate(-7.5deg)!important;-ms-transform:rotate(-7.5deg)!important;-o-transform:rotate(-7.5deg)!important;transform:rotate(-7.5deg)!important;position:absolute!important;z-index:1}.border-div.jsx-985042568{content:" ";display:block;width:100%;height:280px;left:-50px!important;-webkit-transform:rotate(7.5deg)!important;-moz-transform:rotate(7.5deg)!important;-ms-transform:rotate(7.5deg)!important;-o-transform:rotate(7.5deg)!important;transform:rotate(7.5deg)!important;position:relative;background:white;z-index:99;top:-116px}.content-button.jsx-985042568{position:relative;border:1px solid var(--primary);min-width:40px;width:-webkit-fit-content;width:-moz-fit-content;width:fit-content;padding:5px 10px;font-weight:bold;-webkit-border-radius:5px;-moz-border-radius:5px;border-radius:5px;font-size:.75rem;z-index:9999;background:var(--primary);color:white;top:150px;left:70px}.content-wrap.jsx-985042568{position:absolute;width:100%;height:-webkit-fit-content;height:-moz-fit-content;height:fit-content;z-index:99;top:45%;display:-webkit-box;display:-webkit-flex;display:-moz-box;display:-ms-flexbox;display:flex;-webkit-box-orient:vertical;-webkit-box-direction:normal;-webkit-flex-direction:column;-moz-box-orient:vertical;-moz-box-direction:normal;-ms-flex-direction:column;flex-direction:column}#viewMore35f2f9f0c-ffe1-4536-a7f0-60e033a46312.jsx-985042568:hover{background:var(--secondary)}.view-more-wrap35f2f9f0c-ffe1-4536-a7f0-60e033a46312.jsx-985042568{width:100%;height:10%;display:-webkit-box;display:-webkit-flex;display:-moz-box;display:-ms-flexbox;display:flex;background:var(--primary);-webkit-box-pack:justify;-webkit-justify-content:space-between;-moz-box-pack:justify;-ms-flex-pack:justify;justify-content:space-between;-webkit-box-align:center;-webkit-align-items:center;-moz-box-align:center;-ms-flex-align:center;align-items:center;position:absolute;top:90%;z-index:999;background:-webkit-linear-gradient(left,var(--primary)50%,var(--secondary)50%);background:-moz-linear-gradient(left,var(--primary)50%,var(--secondary)50%);background:-o-linear-gradient(left,var(--primary)50%,var(--secondary)50%);background:linear-gradient(to right,var(--primary)50%,var(--secondary)50%);-webkit-background-size:200%100%;-moz-background-size:200%100%;-o-background-size:200%100%;background-size:200%100%;background-position:left bottom;-webkit-transition:all 150ms ease;-moz-transition:all 150ms ease;-o-transition:all 150ms ease;transition:all 150ms ease}.view#more-wrap35f2f9f0c-ffe1-4536-a7f0-60e033a46312.jsx-985042568:hover{background-position:right bottom}.view-more-wrap-wipe.jsx-985042568{background-position:right bottom}.text-white.jsx-985042568{color:var(--primary)}</style><style id="__jsx-2548275183">.button.jsx-2548275183{height:0px;position:relative;z-index:999;bottom:176px;left:50%;-webkit-transform:translateX(-50%);-moz-transform:translateX(-50%);-ms-transform:translateX(-50%);-o-transform:translateX(-50%);transform:translateX(-50%)}.button.jsx-2548275183::before{content:"On-Demand Virtual Symposium";display:block;position:relative;width:-webkit-fit-content;width:-moz-fit-content;width:fit-content;padding:7.5px 10px;font-weight:bold;-webkit-border-radius:5px;-moz-border-radius:5px;border-radius:5px;z-index:99999999;background-color:var(--primary);color:white;bottom:69px;left:50%;-webkit-transform:translateX(-50%);-moz-transform:translateX(-50%);-ms-transform:translateX(-50%);-o-transform:translateX(-50%);transform:translateX(-50%);font-size:.75rem;text-align:center;line-height:1.15;max-width:200px}.pill.jsx-2548275183{height:0px}.pill.jsx-2548275183::before{display:block;content:"On-Demand";height:22px;width:-webkit-fit-content;width:-moz-fit-content;width:fit-content;background:var(--secondary);color:var(--primary);font-size:10px;font-weight:bold;padding:.25rem .5rem;text-align:center;-webkit-border-top-right-radius:15px;-moz-border-radius-topright:15px;border-top-right-radius:15px;-webkit-border-bottom-left-radius:15px;-moz-border-radius-bottomleft:15px;border-bottom-left-radius:15px;position:relative;float:right;bottom:413px;z-index:99}.bottomDiv.jsx-2548275183{width:100%;display:block;position:relative;top:-10px;height:300px;z-index:99;background:#fff;text-align:center;font-size:.875rem;-webkit-text-decoration-line:none;-moz-text-decoration-line:none;text-decoration-line:none}.bottomDiv.jsx-2548275183::before{content:" ";display:block;width:100%;height:280px;border-top:8px solid var(--primary);left:-54px!important;-webkit-transform:rotate(7.5deg)!important;-moz-transform:rotate(7.5deg)!important;-ms-transform:rotate(7.5deg)!important;-o-transform:rotate(7.5deg)!important;transform:rotate(7.5deg)!important;position:absolute!important;background:white;z-index:1;top:-7px}.bottomDiv.jsx-2548275183::after{content:" ";display:block;width:100%;height:280px;border-top:8px solid var(--primary);left:20px!important;top:-2px;background:white;-webkit-transform:rotate(-7.5deg)!important;-moz-transform:rotate(-7.5deg)!important;-ms-transform:rotate(-7.5deg)!important;-o-transform:rotate(-7.5deg)!important;transform:rotate(-7.5deg)!important;position:absolute!important;z-index:1}.border-div.jsx-2548275183{content:" ";display:block;width:100%;height:280px;left:-50px!important;-webkit-transform:rotate(7.5deg)!important;-moz-transform:rotate(7.5deg)!important;-ms-transform:rotate(7.5deg)!important;-o-transform:rotate(7.5deg)!important;transform:rotate(7.5deg)!important;position:relative;background:white;z-index:99;top:-116px}.content-button.jsx-2548275183{position:relative;border:1px solid var(--primary);min-width:40px;width:-webkit-fit-content;width:-moz-fit-content;width:fit-content;padding:5px 10px;font-weight:bold;-webkit-border-radius:5px;-moz-border-radius:5px;border-radius:5px;font-size:.75rem;z-index:9999;background:var(--primary);color:white;top:150px;left:70px}.content-wrap.jsx-2548275183{position:absolute;width:100%;height:-webkit-fit-content;height:-moz-fit-content;height:fit-content;z-index:99;top:45%;display:-webkit-box;display:-webkit-flex;display:-moz-box;display:-ms-flexbox;display:flex;-webkit-box-orient:vertical;-webkit-box-direction:normal;-webkit-flex-direction:column;-moz-box-orient:vertical;-moz-box-direction:normal;-ms-flex-direction:column;flex-direction:column}#viewMore4b3692513-63e3-4143-be46-fedbcb8387a5.jsx-2548275183:hover{background:var(--secondary)}.view-more-wrap4b3692513-63e3-4143-be46-fedbcb8387a5.jsx-2548275183{width:100%;height:10%;display:-webkit-box;display:-webkit-flex;display:-moz-box;display:-ms-flexbox;display:flex;background:var(--primary);-webkit-box-pack:justify;-webkit-justify-content:space-between;-moz-box-pack:justify;-ms-flex-pack:justify;justify-content:space-between;-webkit-box-align:center;-webkit-align-items:center;-moz-box-align:center;-ms-flex-align:center;align-items:center;position:absolute;top:90%;z-index:999;background:-webkit-linear-gradient(left,var(--primary)50%,var(--secondary)50%);background:-moz-linear-gradient(left,var(--primary)50%,var(--secondary)50%);background:-o-linear-gradient(left,var(--primary)50%,var(--secondary)50%);background:linear-gradient(to right,var(--primary)50%,var(--secondary)50%);-webkit-background-size:200%100%;-moz-background-size:200%100%;-o-background-size:200%100%;background-size:200%100%;background-position:left bottom;-webkit-transition:all 150ms ease;-moz-transition:all 150ms ease;-o-transition:all 150ms ease;transition:all 150ms ease}.view#more-wrap4b3692513-63e3-4143-be46-fedbcb8387a5.jsx-2548275183:hover{background-position:right bottom}.view-more-wrap-wipe.jsx-2548275183{background-position:right bottom}.text-white.jsx-2548275183{color:var(--primary)}</style><style id="__jsx-3728211798">.button.jsx-3728211798{height:0px;position:relative;z-index:999;bottom:176px;left:50%;-webkit-transform:translateX(-50%);-moz-transform:translateX(-50%);-ms-transform:translateX(-50%);-o-transform:translateX(-50%);transform:translateX(-50%)}.button.jsx-3728211798::before{content:"On-Demand Virtual Symposium";display:block;position:relative;width:-webkit-fit-content;width:-moz-fit-content;width:fit-content;padding:7.5px 10px;font-weight:bold;-webkit-border-radius:5px;-moz-border-radius:5px;border-radius:5px;z-index:99999999;background-color:var(--primary);color:white;bottom:69px;left:50%;-webkit-transform:translateX(-50%);-moz-transform:translateX(-50%);-ms-transform:translateX(-50%);-o-transform:translateX(-50%);transform:translateX(-50%);font-size:.75rem;text-align:center;line-height:1.15;max-width:200px}.pill.jsx-3728211798{height:0px}.pill.jsx-3728211798::before{display:block;content:"On-Demand";height:22px;width:-webkit-fit-content;width:-moz-fit-content;width:fit-content;background:var(--secondary);color:var(--primary);font-size:10px;font-weight:bold;padding:.25rem .5rem;text-align:center;-webkit-border-top-right-radius:15px;-moz-border-radius-topright:15px;border-top-right-radius:15px;-webkit-border-bottom-left-radius:15px;-moz-border-radius-bottomleft:15px;border-bottom-left-radius:15px;position:relative;float:right;bottom:413px;z-index:99}.bottomDiv.jsx-3728211798{width:100%;display:block;position:relative;top:-10px;height:300px;z-index:99;background:#fff;text-align:center;font-size:.875rem;-webkit-text-decoration-line:none;-moz-text-decoration-line:none;text-decoration-line:none}.bottomDiv.jsx-3728211798::before{content:" ";display:block;width:100%;height:280px;border-top:8px solid var(--primary);left:-54px!important;-webkit-transform:rotate(7.5deg)!important;-moz-transform:rotate(7.5deg)!important;-ms-transform:rotate(7.5deg)!important;-o-transform:rotate(7.5deg)!important;transform:rotate(7.5deg)!important;position:absolute!important;background:white;z-index:1;top:-7px}.bottomDiv.jsx-3728211798::after{content:" ";display:block;width:100%;height:280px;border-top:8px solid var(--primary);left:20px!important;top:-2px;background:white;-webkit-transform:rotate(-7.5deg)!important;-moz-transform:rotate(-7.5deg)!important;-ms-transform:rotate(-7.5deg)!important;-o-transform:rotate(-7.5deg)!important;transform:rotate(-7.5deg)!important;position:absolute!important;z-index:1}.border-div.jsx-3728211798{content:" ";display:block;width:100%;height:280px;left:-50px!important;-webkit-transform:rotate(7.5deg)!important;-moz-transform:rotate(7.5deg)!important;-ms-transform:rotate(7.5deg)!important;-o-transform:rotate(7.5deg)!important;transform:rotate(7.5deg)!important;position:relative;background:white;z-index:99;top:-116px}.content-button.jsx-3728211798{position:relative;border:1px solid var(--primary);min-width:40px;width:-webkit-fit-content;width:-moz-fit-content;width:fit-content;padding:5px 10px;font-weight:bold;-webkit-border-radius:5px;-moz-border-radius:5px;border-radius:5px;font-size:.75rem;z-index:9999;background:var(--primary);color:white;top:150px;left:70px}.content-wrap.jsx-3728211798{position:absolute;width:100%;height:-webkit-fit-content;height:-moz-fit-content;height:fit-content;z-index:99;top:45%;display:-webkit-box;display:-webkit-flex;display:-moz-box;display:-ms-flexbox;display:flex;-webkit-box-orient:vertical;-webkit-box-direction:normal;-webkit-flex-direction:column;-moz-box-orient:vertical;-moz-box-direction:normal;-ms-flex-direction:column;flex-direction:column}#viewMore51de83d65-461b-4a03-bfc2-3c44b1f983c9.jsx-3728211798:hover{background:var(--secondary)}.view-more-wrap51de83d65-461b-4a03-bfc2-3c44b1f983c9.jsx-3728211798{width:100%;height:10%;display:-webkit-box;display:-webkit-flex;display:-moz-box;display:-ms-flexbox;display:flex;background:var(--primary);-webkit-box-pack:justify;-webkit-justify-content:space-between;-moz-box-pack:justify;-ms-flex-pack:justify;justify-content:space-between;-webkit-box-align:center;-webkit-align-items:center;-moz-box-align:center;-ms-flex-align:center;align-items:center;position:absolute;top:90%;z-index:999;background:-webkit-linear-gradient(left,var(--primary)50%,var(--secondary)50%);background:-moz-linear-gradient(left,var(--primary)50%,var(--secondary)50%);background:-o-linear-gradient(left,var(--primary)50%,var(--secondary)50%);background:linear-gradient(to right,var(--primary)50%,var(--secondary)50%);-webkit-background-size:200%100%;-moz-background-size:200%100%;-o-background-size:200%100%;background-size:200%100%;background-position:left bottom;-webkit-transition:all 150ms ease;-moz-transition:all 150ms ease;-o-transition:all 150ms ease;transition:all 150ms ease}.view#more-wrap51de83d65-461b-4a03-bfc2-3c44b1f983c9.jsx-3728211798:hover{background-position:right bottom}.view-more-wrap-wipe.jsx-3728211798{background-position:right bottom}.text-white.jsx-3728211798{color:var(--primary)}</style><style id="__jsx-2374338299">.button.jsx-2374338299{height:0px;position:relative;z-index:999;bottom:176px;left:50%;-webkit-transform:translateX(-50%);-moz-transform:translateX(-50%);-ms-transform:translateX(-50%);-o-transform:translateX(-50%);transform:translateX(-50%)}.button.jsx-2374338299::before{content:"On-Demand Virtual Symposium";display:block;position:relative;width:-webkit-fit-content;width:-moz-fit-content;width:fit-content;padding:7.5px 10px;font-weight:bold;-webkit-border-radius:5px;-moz-border-radius:5px;border-radius:5px;z-index:99999999;background-color:var(--primary);color:white;bottom:69px;left:50%;-webkit-transform:translateX(-50%);-moz-transform:translateX(-50%);-ms-transform:translateX(-50%);-o-transform:translateX(-50%);transform:translateX(-50%);font-size:.75rem;text-align:center;line-height:1.15;max-width:200px}.pill.jsx-2374338299{height:0px}.pill.jsx-2374338299::before{display:block;content:"On-Demand";height:22px;width:-webkit-fit-content;width:-moz-fit-content;width:fit-content;background:var(--secondary);color:var(--primary);font-size:10px;font-weight:bold;padding:.25rem .5rem;text-align:center;-webkit-border-top-right-radius:15px;-moz-border-radius-topright:15px;border-top-right-radius:15px;-webkit-border-bottom-left-radius:15px;-moz-border-radius-bottomleft:15px;border-bottom-left-radius:15px;position:relative;float:right;bottom:413px;z-index:99}.bottomDiv.jsx-2374338299{width:100%;display:block;position:relative;top:-10px;height:300px;z-index:99;background:#fff;text-align:center;font-size:.875rem;-webkit-text-decoration-line:none;-moz-text-decoration-line:none;text-decoration-line:none}.bottomDiv.jsx-2374338299::before{content:" ";display:block;width:100%;height:280px;border-top:8px solid var(--primary);left:-54px!important;-webkit-transform:rotate(7.5deg)!important;-moz-transform:rotate(7.5deg)!important;-ms-transform:rotate(7.5deg)!important;-o-transform:rotate(7.5deg)!important;transform:rotate(7.5deg)!important;position:absolute!important;background:white;z-index:1;top:-7px}.bottomDiv.jsx-2374338299::after{content:" ";display:block;width:100%;height:280px;border-top:8px solid var(--primary);left:20px!important;top:-2px;background:white;-webkit-transform:rotate(-7.5deg)!important;-moz-transform:rotate(-7.5deg)!important;-ms-transform:rotate(-7.5deg)!important;-o-transform:rotate(-7.5deg)!important;transform:rotate(-7.5deg)!important;position:absolute!important;z-index:1}.border-div.jsx-2374338299{content:" ";display:block;width:100%;height:280px;left:-50px!important;-webkit-transform:rotate(7.5deg)!important;-moz-transform:rotate(7.5deg)!important;-ms-transform:rotate(7.5deg)!important;-o-transform:rotate(7.5deg)!important;transform:rotate(7.5deg)!important;position:relative;background:white;z-index:99;top:-116px}.content-button.jsx-2374338299{position:relative;border:1px solid var(--primary);min-width:40px;width:-webkit-fit-content;width:-moz-fit-content;width:fit-content;padding:5px 10px;font-weight:bold;-webkit-border-radius:5px;-moz-border-radius:5px;border-radius:5px;font-size:.75rem;z-index:9999;background:var(--primary);color:white;top:150px;left:70px}.content-wrap.jsx-2374338299{position:absolute;width:100%;height:-webkit-fit-content;height:-moz-fit-content;height:fit-content;z-index:99;top:45%;display:-webkit-box;display:-webkit-flex;display:-moz-box;display:-ms-flexbox;display:flex;-webkit-box-orient:vertical;-webkit-box-direction:normal;-webkit-flex-direction:column;-moz-box-orient:vertical;-moz-box-direction:normal;-ms-flex-direction:column;flex-direction:column}#viewMore6fe815760-37e8-45aa-9a66-be0aae5f9319.jsx-2374338299:hover{background:var(--secondary)}.view-more-wrap6fe815760-37e8-45aa-9a66-be0aae5f9319.jsx-2374338299{width:100%;height:10%;display:-webkit-box;display:-webkit-flex;display:-moz-box;display:-ms-flexbox;display:flex;background:var(--primary);-webkit-box-pack:justify;-webkit-justify-content:space-between;-moz-box-pack:justify;-ms-flex-pack:justify;justify-content:space-between;-webkit-box-align:center;-webkit-align-items:center;-moz-box-align:center;-ms-flex-align:center;align-items:center;position:absolute;top:90%;z-index:999;background:-webkit-linear-gradient(left,var(--primary)50%,var(--secondary)50%);background:-moz-linear-gradient(left,var(--primary)50%,var(--secondary)50%);background:-o-linear-gradient(left,var(--primary)50%,var(--secondary)50%);background:linear-gradient(to right,var(--primary)50%,var(--secondary)50%);-webkit-background-size:200%100%;-moz-background-size:200%100%;-o-background-size:200%100%;background-size:200%100%;background-position:left bottom;-webkit-transition:all 150ms ease;-moz-transition:all 150ms ease;-o-transition:all 150ms ease;transition:all 150ms ease}.view#more-wrap6fe815760-37e8-45aa-9a66-be0aae5f9319.jsx-2374338299:hover{background-position:right bottom}.view-more-wrap-wipe.jsx-2374338299{background-position:right bottom}.text-white.jsx-2374338299{color:var(--primary)}</style><style id="__jsx-651135293">.button.jsx-651135293{height:0px;position:relative;z-index:999;bottom:176px;left:50%;-webkit-transform:translateX(-50%);-moz-transform:translateX(-50%);-ms-transform:translateX(-50%);-o-transform:translateX(-50%);transform:translateX(-50%)}.button.jsx-651135293::before{content:"On-Demand Virtual Symposium";display:block;position:relative;width:-webkit-fit-content;width:-moz-fit-content;width:fit-content;padding:7.5px 10px;font-weight:bold;-webkit-border-radius:5px;-moz-border-radius:5px;border-radius:5px;z-index:99999999;background-color:var(--primary);color:white;bottom:69px;left:50%;-webkit-transform:translateX(-50%);-moz-transform:translateX(-50%);-ms-transform:translateX(-50%);-o-transform:translateX(-50%);transform:translateX(-50%);font-size:.75rem;text-align:center;line-height:1.15;max-width:200px}.pill.jsx-651135293{height:0px}.pill.jsx-651135293::before{display:block;content:"On-Demand";height:22px;width:-webkit-fit-content;width:-moz-fit-content;width:fit-content;background:var(--secondary);color:var(--primary);font-size:10px;font-weight:bold;padding:.25rem .5rem;text-align:center;-webkit-border-top-right-radius:15px;-moz-border-radius-topright:15px;border-top-right-radius:15px;-webkit-border-bottom-left-radius:15px;-moz-border-radius-bottomleft:15px;border-bottom-left-radius:15px;position:relative;float:right;bottom:413px;z-index:99}.bottomDiv.jsx-651135293{width:100%;display:block;position:relative;top:-10px;height:300px;z-index:99;background:#fff;text-align:center;font-size:.875rem;-webkit-text-decoration-line:none;-moz-text-decoration-line:none;text-decoration-line:none}.bottomDiv.jsx-651135293::before{content:" ";display:block;width:100%;height:280px;border-top:8px solid var(--primary);left:-54px!important;-webkit-transform:rotate(7.5deg)!important;-moz-transform:rotate(7.5deg)!important;-ms-transform:rotate(7.5deg)!important;-o-transform:rotate(7.5deg)!important;transform:rotate(7.5deg)!important;position:absolute!important;background:white;z-index:1;top:-7px}.bottomDiv.jsx-651135293::after{content:" ";display:block;width:100%;height:280px;border-top:8px solid var(--primary);left:20px!important;top:-2px;background:white;-webkit-transform:rotate(-7.5deg)!important;-moz-transform:rotate(-7.5deg)!important;-ms-transform:rotate(-7.5deg)!important;-o-transform:rotate(-7.5deg)!important;transform:rotate(-7.5deg)!important;position:absolute!important;z-index:1}.border-div.jsx-651135293{content:" ";display:block;width:100%;height:280px;left:-50px!important;-webkit-transform:rotate(7.5deg)!important;-moz-transform:rotate(7.5deg)!important;-ms-transform:rotate(7.5deg)!important;-o-transform:rotate(7.5deg)!important;transform:rotate(7.5deg)!important;position:relative;background:white;z-index:99;top:-116px}.content-button.jsx-651135293{position:relative;border:1px solid var(--primary);min-width:40px;width:-webkit-fit-content;width:-moz-fit-content;width:fit-content;padding:5px 10px;font-weight:bold;-webkit-border-radius:5px;-moz-border-radius:5px;border-radius:5px;font-size:.75rem;z-index:9999;background:var(--primary);color:white;top:150px;left:70px}.content-wrap.jsx-651135293{position:absolute;width:100%;height:-webkit-fit-content;height:-moz-fit-content;height:fit-content;z-index:99;top:45%;display:-webkit-box;display:-webkit-flex;display:-moz-box;display:-ms-flexbox;display:flex;-webkit-box-orient:vertical;-webkit-box-direction:normal;-webkit-flex-direction:column;-moz-box-orient:vertical;-moz-box-direction:normal;-ms-flex-direction:column;flex-direction:column}#viewMore77cbe0326-0e0d-4b64-8868-95c41183767c.jsx-651135293:hover{background:var(--secondary)}.view-more-wrap77cbe0326-0e0d-4b64-8868-95c41183767c.jsx-651135293{width:100%;height:10%;display:-webkit-box;display:-webkit-flex;display:-moz-box;display:-ms-flexbox;display:flex;background:var(--primary);-webkit-box-pack:justify;-webkit-justify-content:space-between;-moz-box-pack:justify;-ms-flex-pack:justify;justify-content:space-between;-webkit-box-align:center;-webkit-align-items:center;-moz-box-align:center;-ms-flex-align:center;align-items:center;position:absolute;top:90%;z-index:999;background:-webkit-linear-gradient(left,var(--primary)50%,var(--secondary)50%);background:-moz-linear-gradient(left,var(--primary)50%,var(--secondary)50%);background:-o-linear-gradient(left,var(--primary)50%,var(--secondary)50%);background:linear-gradient(to right,var(--primary)50%,var(--secondary)50%);-webkit-background-size:200%100%;-moz-background-size:200%100%;-o-background-size:200%100%;background-size:200%100%;background-position:left bottom;-webkit-transition:all 150ms ease;-moz-transition:all 150ms ease;-o-transition:all 150ms ease;transition:all 150ms ease}.view#more-wrap77cbe0326-0e0d-4b64-8868-95c41183767c.jsx-651135293:hover{background-position:right bottom}.view-more-wrap-wipe.jsx-651135293{background-position:right bottom}.text-white.jsx-651135293{color:var(--primary)}</style></head><body><div id="__next" data-reactroot=""><nav class="NavBrands_navBrands___hLgZ"><div class="container"><ul><li><div><a target="_blank" rel="noreferrer" href="https://www.ajmc.com/"><div class="NavBrands_brandLogo__Llsyx"><img src="/AJMC_25Lockup_white.png" alt="Center for Biosimilars" class="NavBrands_logo__5hwvf"/><img src="/AJMC_25Lockup.png" alt="Center for Biosimilars" class="NavBrands_logoColor__MJVD3"/></div></a></div></li><li><a target="_blank" rel="noreferrer" href="https://www.centerforbiosimilars.com/"><div class="NavBrands_currentBrandLogo__ueYYe"><img src="/Biosimilars_logo.png" alt="Center for Biosimilars" class="NavBrands_logo__5hwvf"/></div></a></li></ul></div></nav><div class="-mb-6"><div id="frame-nav" class="sticky top-0 left-0 bg-main-nav-bg text-main-nav-text z-[9948010]"><div class="container px-4 mx-auto flex justify-between items-center h-[65px] pl-4 pr-4" id="frame-mob-nav"><div class="block lg:hidden"><svg stroke="currentColor" fill="currentColor" stroke-width="0" viewBox="0 0 20 20" aria-hidden="true" class="text-3xl" height="1em" width="1em" xmlns="http://www.w3.org/2000/svg"><path fill-rule="evenodd" d="M3 5a1 1 0 011-1h12a1 1 0 110 2H4a1 1 0 01-1-1zM3 10a1 1 0 011-1h12a1 1 0 110 2H4a1 1 0 01-1-1zM3 15a1 1 0 011-1h12a1 1 0 110 2H4a1 1 0 01-1-1z" clip-rule="evenodd"></path></svg></div><div class="flex-auto hidden w-auto text-sm text-left lg:flex"><div class="relative flex items-center cursor-pointer lg:px-2"><div class="whitespace-nowrap flex items-center">News<svg stroke="currentColor" fill="currentColor" stroke-width="0" viewBox="0 0 24 24" height="1em" width="1em" xmlns="http://www.w3.org/2000/svg"><path d="m11.998 17 7-8h-14z"></path></svg></div><div id="div_sub_menu_dropdown_desktop_0" class="absolute bg-main-nav-item-bg text-main-nav-item-text z-[9999999999] border hidden max-h-[1000px]" style="top:30px;left:0;min-width:180px"><a target="_self" href="/news"><div style="white-space:nowrap" class="w-full px-4 py-2 hover:bg-main-nav-item-hover-bg hover:text-main-nav-item-hover-text">All News</div></a><a target="_self" href="/approvals-launches"><div style="white-space:nowrap" class="w-full px-4 py-2 hover:bg-main-nav-item-hover-bg hover:text-main-nav-item-hover-text">Product Approvals and Launches</div></a></div></div><div class="relative flex items-center cursor-pointer lg:px-2"><div class="whitespace-nowrap flex items-center">Media<svg stroke="currentColor" fill="currentColor" stroke-width="0" viewBox="0 0 24 24" height="1em" width="1em" xmlns="http://www.w3.org/2000/svg"><path d="m11.998 17 7-8h-14z"></path></svg></div><div id="div_sub_menu_dropdown_desktop_1" class="absolute bg-main-nav-item-bg text-main-nav-item-text z-[9999999999] border hidden max-h-[1000px]" style="top:30px;left:0;min-width:180px"><a target="_self" href="/videos"><div style="white-space:nowrap" class="w-full px-4 py-2 hover:bg-main-nav-item-hover-bg hover:text-main-nav-item-hover-text">All Videos</div></a><a target="_self" href="/insights"><div style="white-space:nowrap" class="w-full px-4 py-2 hover:bg-main-nav-item-hover-bg hover:text-main-nav-item-hover-text">Insights</div></a><a target="_self" href="/interviews"><div style="white-space:nowrap" class="w-full px-4 py-2 hover:bg-main-nav-item-hover-bg hover:text-main-nav-item-hover-text">Interviews</div></a><a target="_self" href="/peer-exchange"><div style="white-space:nowrap" class="w-full px-4 py-2 hover:bg-main-nav-item-hover-bg hover:text-main-nav-item-hover-text">Peer Exchange</div></a><a target="_self" href="/podcasts"><div style="white-space:nowrap" class="w-full px-4 py-2 hover:bg-main-nav-item-hover-bg hover:text-main-nav-item-hover-text">Podcasts</div></a><a target="_self" href="/stakeholder-summit"><div style="white-space:nowrap" class="w-full px-4 py-2 hover:bg-main-nav-item-hover-bg hover:text-main-nav-item-hover-text">Stakeholder Summit</div></a></div></div><div class="relative flex items-center cursor-pointer lg:px-2"><div class="whitespace-nowrap flex items-center">Compendia<svg stroke="currentColor" fill="currentColor" stroke-width="0" viewBox="0 0 24 24" height="1em" width="1em" xmlns="http://www.w3.org/2000/svg"><path d="m11.998 17 7-8h-14z"></path></svg></div><div id="div_sub_menu_dropdown_desktop_2" class="absolute bg-main-nav-item-bg text-main-nav-item-text z-[9999999999] border hidden max-h-[1000px]" style="top:30px;left:0;min-width:180px"><a target="_self" href="/clinical/bone-health"><div style="white-space:nowrap" class="w-full px-4 py-2 hover:bg-main-nav-item-hover-bg hover:text-main-nav-item-hover-text">Bone Health</div></a><a target="_self" href="/clinical/dermatology"><div style="white-space:nowrap" class="w-full px-4 py-2 hover:bg-main-nav-item-hover-bg hover:text-main-nav-item-hover-text">Dermatology</div></a><a target="_self" href="/clinical/diabetes"><div style="white-space:nowrap" class="w-full px-4 py-2 hover:bg-main-nav-item-hover-bg hover:text-main-nav-item-hover-text">Diabetes</div></a><a target="_self" href="/clinical/gastroenterology"><div style="white-space:nowrap" class="w-full px-4 py-2 hover:bg-main-nav-item-hover-bg hover:text-main-nav-item-hover-text">Gastroenterology</div></a><a target="_self" href="/clinical/hematology"><div style="white-space:nowrap" class="w-full px-4 py-2 hover:bg-main-nav-item-hover-bg hover:text-main-nav-item-hover-text">Hematology</div></a><a target="_self" href="/clinical/immunology"><div style="white-space:nowrap" class="w-full px-4 py-2 hover:bg-main-nav-item-hover-bg hover:text-main-nav-item-hover-text">Immunology</div></a><a target="_self" href="/clinical/neurology"><div style="white-space:nowrap" class="w-full px-4 py-2 hover:bg-main-nav-item-hover-bg hover:text-main-nav-item-hover-text">Neurology</div></a><a target="_self" href="/clinical/oncology"><div style="white-space:nowrap" class="w-full px-4 py-2 hover:bg-main-nav-item-hover-bg hover:text-main-nav-item-hover-text">Oncology</div></a><a target="_self" href="/clinical/ophthalmology"><div style="white-space:nowrap" class="w-full px-4 py-2 hover:bg-main-nav-item-hover-bg hover:text-main-nav-item-hover-text">Ophthalmology</div></a><a target="_self" href="/clinical/rare-disease"><div style="white-space:nowrap" class="w-full px-4 py-2 hover:bg-main-nav-item-hover-bg hover:text-main-nav-item-hover-text">Rare Disease</div></a><a target="_self" href="/clinical/respiratory"><div style="white-space:nowrap" class="w-full px-4 py-2 hover:bg-main-nav-item-hover-bg hover:text-main-nav-item-hover-text">Respiratory</div></a><a target="_self" href="/clinical/rheumatology"><div style="white-space:nowrap" class="w-full px-4 py-2 hover:bg-main-nav-item-hover-bg hover:text-main-nav-item-hover-text">Rheumatology</div></a></div></div><div class="relative flex items-center cursor-pointer lg:px-2"><div class="whitespace-nowrap flex items-center">Conferences<svg stroke="currentColor" fill="currentColor" stroke-width="0" viewBox="0 0 24 24" height="1em" width="1em" xmlns="http://www.w3.org/2000/svg"><path d="m11.998 17 7-8h-14z"></path></svg></div><div id="div_sub_menu_dropdown_desktop_3" class="absolute bg-main-nav-item-bg text-main-nav-item-text z-[9999999999] border hidden max-h-[1000px]" style="top:30px;left:0;min-width:180px"><a target="_self" href="/latest-conference"><div style="white-space:nowrap" class="w-full px-4 py-2 hover:bg-main-nav-item-hover-bg hover:text-main-nav-item-hover-text">Conference Coverage</div></a><a target="_self" href="/conference"><div style="white-space:nowrap" class="w-full px-4 py-2 hover:bg-main-nav-item-hover-bg hover:text-main-nav-item-hover-text">Conference Listing</div></a></div></div><div class="relative flex items-center cursor-pointer lg:px-2"><a target="_self" class="whitespace-nowrap flex items-center" href="/continuing-education">CME/CE</a></div><div class="relative flex items-center cursor-pointer lg:px-2"><div class="whitespace-nowrap flex items-center">Resources<svg stroke="currentColor" fill="currentColor" stroke-width="0" viewBox="0 0 24 24" height="1em" width="1em" xmlns="http://www.w3.org/2000/svg"><path d="m11.998 17 7-8h-14z"></path></svg></div><div id="div_sub_menu_dropdown_desktop_5" class="absolute bg-main-nav-item-bg text-main-nav-item-text z-[9999999999] border hidden max-h-[1000px]" style="top:30px;left:0;min-width:180px"><a target="_self" href="/authors"><div style="white-space:nowrap" class="w-full px-4 py-2 hover:bg-main-nav-item-hover-bg hover:text-main-nav-item-hover-text">Authors</div></a><a target="_self" href="/resources"><div style="white-space:nowrap" class="w-full px-4 py-2 hover:bg-main-nav-item-hover-bg hover:text-main-nav-item-hover-text">Biosimilar Resources</div></a><a target="_self" href="/interactive-tools"><div style="white-space:nowrap" class="w-full px-4 py-2 hover:bg-main-nav-item-hover-bg hover:text-main-nav-item-hover-text">Interactive Tools</div></a><a target="_self" href="/sap-partners"><div style="white-space:nowrap" class="w-full px-4 py-2 hover:bg-main-nav-item-hover-bg hover:text-main-nav-item-hover-text">Partners</div></a><a target="_self" href="/polls"><div style="white-space:nowrap" class="w-full px-4 py-2 hover:bg-main-nav-item-hover-bg hover:text-main-nav-item-hover-text">Polls and Quizzes</div></a><a target="_self" href="/sponsored"><div style="white-space:nowrap" class="w-full px-4 py-2 hover:bg-main-nav-item-hover-bg hover:text-main-nav-item-hover-text">Sponsored</div></a><a target="_self" href="/when-choice-arrives-competition-consequences"><div style="white-space:nowrap" class="w-full px-4 py-2 hover:bg-main-nav-item-hover-bg hover:text-main-nav-item-hover-text">WHEN CHOICE ARRIVES: Competition & Consequences</div></a></div></div><div class="relative flex items-center cursor-pointer lg:px-2"><a target="_self" class="whitespace-nowrap flex items-center" href="https://one.centerforbiosimilars.com/subscribe">Subscribe</a></div><div class="relative flex items-center cursor-pointer lg:px-2"><a target="_self" class="whitespace-nowrap flex items-center" href="/biosimilar-approvals">BIOSIMILAR APPROVALS</a></div></div><div class="flex flex-wrap items-center flex-none md:relative md:flex-nowrap"><svg stroke="currentColor" fill="currentColor" stroke-width="0" viewBox="0 0 512 512" class="hidden md:block text-2xl cursor-pointer mr-[0.125rem] mt-[0.125rem] focus:border focus:border-primary" height="1em" width="1em" xmlns="http://www.w3.org/2000/svg"><path d="M505 442.7L405.3 343c-4.5-4.5-10.6-7-17-7H372c27.6-35.3 44-79.7 44-128C416 93.1 322.9 0 208 0S0 93.1 0 208s93.1 208 208 208c48.3 0 92.7-16.4 128-44v16.3c0 6.4 2.5 12.5 7 17l99.7 99.7c9.4 9.4 24.6 9.4 33.9 0l28.3-28.3c9.4-9.4 9.4-24.6.1-34zM208 336c-70.7 0-128-57.2-128-128 0-70.7 57.2-128 128-128 70.7 0 128 57.2 128 128 0 70.7-57.2 128-128 128z"></path></svg><svg stroke="currentColor" fill="currentColor" stroke-width="0" viewBox="0 0 512 512" class="block md:hidden text-2xl cursor-pointer mr-[0.125rem] mt-[0.125rem] focus:border focus:border-primary" height="1em" width="1em" xmlns="http://www.w3.org/2000/svg"><path d="M505 442.7L405.3 343c-4.5-4.5-10.6-7-17-7H372c27.6-35.3 44-79.7 44-128C416 93.1 322.9 0 208 0S0 93.1 0 208s93.1 208 208 208c48.3 0 92.7-16.4 128-44v16.3c0 6.4 2.5 12.5 7 17l99.7 99.7c9.4 9.4 24.6 9.4 33.9 0l28.3-28.3c9.4-9.4 9.4-24.6.1-34zM208 336c-70.7 0-128-57.2-128-128 0-70.7 57.2-128 128-128 70.7 0 128 57.2 128 128 0 70.7-57.2 128-128 128z"></path></svg><a rel="noreferrer noopener" class="hidden pr-1 lg:block" target="_blank" href="https://www.facebook.com/centerforbiosimilars/"><p> <svg id='Capa_1' enableBackground='new 0 0 512 512' height='25px' viewBox='0 0 512 512' width='25px' xmlns='http://www.w3.org/2000/svg'> <path d='m512 256c0-141.4-114.6-256-256-256s-256 114.6-256 256 114.6 256 256 256c1.5 0 3 0 4.5-.1v-199.2h-55v-64.1h55v-47.2c0-54.7 33.4-84.5 82.2-84.5 23.4 0 43.5 1.7 49.3 2.5v57.2h-33.6c-26.5 0-31.7 12.6-31.7 31.1v40.8h63.5l-8.3 64.1h-55.2v189.5c107-30.7 185.3-129.2 185.3-246.1z' /> </svg> </p></a><a rel="noreferrer noopener" class="hidden pr-1 lg:block" target="_blank" href="https://twitter.com/biosimcenter"><p> <svg xmlns='http://www.w3.org/2000/svg' version='1.1' width='25' height='25' viewBox='1.41 1.41 252.9 252.9'> <g transform='translate(1.4065934065934016 1.4065934065934016) scale(2.81 2.81)'> <polygon points='24.89,23.01 57.79,66.99 65.24,66.99 32.34,23.01 ' transform=' matrix(1 0 0 1 0 0) ' /> <path d='M 45 0 L 45 0 C 20.147 0 0 20.147 0 45 v 0 c 0 24.853 20.147 45 45 45 h 0 c 24.853 0 45 -20.147 45 -45 v 0 C 90 20.147 69.853 0 45 0 z M 56.032 70.504 L 41.054 50.477 L 22.516 70.504 h -4.765 L 38.925 47.63 L 17.884 19.496 h 16.217 L 47.895 37.94 l 17.072 -18.444 h 4.765 L 50.024 40.788 l 22.225 29.716 H 56.032 z' transform=' matrix(1 0 0 1 0 0) ' strokeLinecap='round' /> </g> </svg> </p></a><a rel="noreferrer noopener" class="hidden pr-1 lg:block" target="_blank" href="https://www.linkedin.com/company/thecenterforbiosimilars"><p> <svg height='25px' viewBox='0 0 512 512' width='25px' xmlns='http://www.w3.org/2000/svg'> <path d='m256 0c-141.363281 0-256 114.636719-256 256s114.636719 256 256 256 256-114.636719 256-256-114.636719-256-256-256zm-74.390625 387h-62.347656v-187.574219h62.347656zm-31.171875-213.1875h-.40625c-20.921875 0-34.453125-14.402344-34.453125-32.402344 0-18.40625 13.945313-32.410156 35.273437-32.410156 21.328126 0 34.453126 14.003906 34.859376 32.410156 0 18-13.53125 32.402344-35.273438 32.402344zm255.984375 213.1875h-62.339844v-100.347656c0-25.21875-9.027343-42.417969-31.585937-42.417969-17.222656 0-27.480469 11.601563-31.988282 22.800781-1.648437 4.007813-2.050781 9.609375-2.050781 15.214844v104.75h-62.34375s.816407-169.976562 0-187.574219h62.34375v26.558594c8.285157-12.78125 23.109375-30.960937 56.1875-30.960937 41.019531 0 71.777344 26.808593 71.777344 84.421874zm0 0' /> </svg> </p></a><a rel="noreferrer noopener" class="hidden pr-1 lg:block" target="_blank" href="/rss"><p><svg width='25px' height='25px' viewBox="0 0 512 512" width="512pt" xmlns="http://www.w3.org/2000/svg"> <path d="m437.019531 74.980469c-48.351562-48.351563-112.640625-74.980469-181.019531-74.980469s-132.667969 26.628906-181.019531 74.980469c-48.351563 48.351562-74.980469 112.640625-74.980469 181.019531s26.628906 132.667969 74.980469 181.019531c48.351562 48.351563 112.640625 74.980469 181.019531 74.980469s132.667969-26.628906 181.019531-74.980469c48.351563-48.351562 74.980469-112.640625 74.980469-181.019531s-26.628906-132.667969-74.980469-181.019531zm-267.757812 292.957031c-13.730469 0-24.90625-11.171875-24.90625-24.90625s11.175781-24.90625 24.90625-24.90625c13.734375 0 24.90625 11.171875 24.90625 24.90625s-11.171875 24.90625-24.90625 24.90625zm80.277343 4.925781c-8.28125 0-15-6.714843-15-15 0-44.171875-35.9375-80.109375-80.109374-80.109375-8.285157 0-15-6.71875-15-15 0-8.285156 6.714843-15 15-15 60.714843 0 110.109374 49.394532 110.109374 110.109375 0 8.285157-6.714843 15-15 15zm67.09375 0c-8.285156 0-15-6.714843-15-15 0-81.167969-66.035156-147.203125-147.203124-147.203125-8.285157 0-15-6.714844-15-15s6.714843-15 15-15c97.710937 0 177.203124 79.492188 177.203124 177.203125 0 8.285157-6.714843 15-15 15zm66.292969 0c-8.28125 0-15-6.714843-15-15 0-117.722656-95.773437-213.496093-213.496093-213.496093-8.285157 0-15-6.714844-15-15 0-8.285157 6.714843-15 15-15 65.039062 0 126.1875 25.328124 172.179687 71.316406 45.988281 45.992187 71.316406 107.140625 71.316406 172.179687 0 8.285157-6.714843 15-15 15zm0 0"/> </svg></p></a><div id="div_search_box" class="hidden flex-none md:absolute top-[50px] w-full md:w-[400px] md:left-[-400px] z-50 bg-search-box-bg p-2 rounded-xl"><form method="GET" action="/search" class="flex items-center justify-between w-full"><input type="text" name="searchTerm" placeholder="SEARCH" class="bg-white p-1 rounded-md border-0 w-[80%] text-black" required=""/><input type="submit" value="SEARCH" class="ml-2 cursor-pointer bg-search-box-button-bg text-search-box-button-text hover:bg-search-box-button-hover-bg hover:text-search-box-button-hover-text ronded rounded-md p-1 font-bold w-[20%]"/></form></div></div></div><div id="div_search_box_mobile" class="hidden flex-none md:absolute top-[50px] md:w-[400px] md:left-[-400px] z-50 bg-search-box-bg p-2 rounded-xl"><form method="GET" action="/search" class="flex items-center justify-between w-full"><input type="text" name="searchTerm" placeholder="SEARCH" class="bg-white p-1 rounded-md border-0 w-[80%] text-black" required=""/><input type="submit" value="SEARCH" class="ml-2 bg-search-box-button-bg text-search-box-button-text ronded rounded-md p-1 font-bold w-[20%]"/></form></div><div class="hidden fixed w-full top-0 modal h-[100vh] overflow-y-scroll z-[9999] max-h-screen" id="div_mobile_main_menu_0"><div class="bg-primary h-full w-[80%] "><div class="pb-10 container text-white max-h-screen overflow-auto pt-4"><div class="flex items-center py-4 px-2 relative "><div class="text-3xl w-[18%] xs:ml-8 text-left"><svg stroke="currentColor" fill="currentColor" stroke-width="0" viewBox="0 0 512 512" height="1em" width="1em" xmlns="http://www.w3.org/2000/svg"><path d="M289.94 256l95-95A24 24 0 00351 127l-95 95-95-95a24 24 0 00-34 34l95 95-95 95a24 24 0 1034 34l95-95 95 95a24 24 0 0034-34z"></path></svg></div><div class="mx-auto w-[70%] text-center pt-2 absolute top-1/2 left-1/2 -translate-x-1/2 -translate-y-1/2"><span style="box-sizing:border-box;display:inline-block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:relative;max-width:100%"><span style="box-sizing:border-box;display:block;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;max-width:100%"><img style="display:block;max-width:100%;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0" alt="" aria-hidden="true" src="data:image/svg+xml,%3csvg%20xmlns=%27http://www.w3.org/2000/svg%27%20version=%271.1%27%20width=%27180%27%20height=%2745%27/%3e"/></span><img alt="logo" srcSet="/_next/image?url=%2FBioSim_white.png&w=256&q=75 1x, /_next/image?url=%2FBioSim_white.png&w=384&q=75 2x" src="/_next/image?url=%2FBioSim_white.png&w=384&q=75" decoding="async" data-nimg="intrinsic" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/></span></div></div><div class="border-b border-[rgba(0,0,0,.20)] mx-2 pb-2"></div><div class="relative border-b border-[rgba(0,0,0,.20)] mx-2 py-2"><div class="flex items-center justify-between p-2"><div class="flex items-center w-full justify-between">Business Practice<svg stroke="currentColor" fill="currentColor" stroke-width="0" viewBox="0 0 24 24" height="1em" width="1em" xmlns="http://www.w3.org/2000/svg"><path d="m11.998 17 7-8h-14z"></path></svg></div></div><div class="hidden bg-nav-secondary -mx-2 " id="div_sub_menu_dropdown_mobile_0"><a class="block w-full pt-2 pb-2 pl-6 pr-6 hover:bg-secondary text-sm border-b border-[rgba(0,0,0,0.1)]" href="/business-practice/business">Business</a><a class="block w-full pt-2 pb-2 pl-6 pr-6 hover:bg-secondary text-sm border-b border-[rgba(0,0,0,0.1)]" href="/business-practice/development">Development</a><a class="block w-full pt-2 pb-2 pl-6 pr-6 hover:bg-secondary text-sm border-b border-[rgba(0,0,0,0.1)]" href="/business-practice/legal">Legal</a><a class="block w-full pt-2 pb-2 pl-6 pr-6 hover:bg-secondary text-sm border-b border-[rgba(0,0,0,0.1)]" href="/business-practice/policy">Policy</a><a class="block w-full pt-2 pb-2 pl-6 pr-6 hover:bg-secondary text-sm border-b border-[rgba(0,0,0,0.1)]" href="/business-practice/practice">Practice</a><a class="block w-full pt-2 pb-2 pl-6 pr-6 hover:bg-secondary text-sm border-b border-[rgba(0,0,0,0.1)]" href="/business-practice/regulatory">Regulatory</a></div></div><div class="relative py-2 border-b border-[rgba(0,0,0,.20)] mx-2"><button aria-controls="div_main_menu_dropdown_mobile_0" class="flex items-center p-2 w-full "><span class="flex items-center w-full justify-between">News<svg stroke="currentColor" fill="currentColor" stroke-width="0" viewBox="0 0 24 24" height="1em" width="1em" xmlns="http://www.w3.org/2000/svg"><path d="m11.998 17 7-8h-14z"></path></svg></span></button><div class="hidden bg-nav-secondary -mx-2" id="div_main_menu_dropdown_mobile_0"><a href="/news"><div class=" pt-2 pb-2 pl-6 pr-6 hover:bg-secondary text-sm border-b border-[rgba(0,0,0,.20)]">All News</div></a><a href="/approvals-launches"><div class=" pt-2 pb-2 pl-6 pr-6 hover:bg-secondary text-sm border-b border-[rgba(0,0,0,.20)]">Product Approvals and Launches</div></a></div></div><div class="relative py-2 border-b border-[rgba(0,0,0,.20)] mx-2"><button aria-controls="div_main_menu_dropdown_mobile_1" class="flex items-center p-2 w-full "><span class="flex items-center w-full justify-between">Media<svg stroke="currentColor" fill="currentColor" stroke-width="0" viewBox="0 0 24 24" height="1em" width="1em" xmlns="http://www.w3.org/2000/svg"><path d="m11.998 17 7-8h-14z"></path></svg></span></button><div class="hidden bg-nav-secondary -mx-2" id="div_main_menu_dropdown_mobile_1"><a href="/videos"><div class=" pt-2 pb-2 pl-6 pr-6 hover:bg-secondary text-sm border-b border-[rgba(0,0,0,.20)]">All Videos</div></a><a href="/insights"><div class=" pt-2 pb-2 pl-6 pr-6 hover:bg-secondary text-sm border-b border-[rgba(0,0,0,.20)]">Insights</div></a><a href="/interviews"><div class=" pt-2 pb-2 pl-6 pr-6 hover:bg-secondary text-sm border-b border-[rgba(0,0,0,.20)]">Interviews</div></a><a href="/peer-exchange"><div class=" pt-2 pb-2 pl-6 pr-6 hover:bg-secondary text-sm border-b border-[rgba(0,0,0,.20)]">Peer Exchange</div></a><a href="/podcasts"><div class=" pt-2 pb-2 pl-6 pr-6 hover:bg-secondary text-sm border-b border-[rgba(0,0,0,.20)]">Podcasts</div></a><a href="/stakeholder-summit"><div class=" pt-2 pb-2 pl-6 pr-6 hover:bg-secondary text-sm border-b border-[rgba(0,0,0,.20)]">Stakeholder Summit</div></a></div></div><div class="relative py-2 border-b border-[rgba(0,0,0,.20)] mx-2"><button aria-controls="div_main_menu_dropdown_mobile_2" class="flex items-center p-2 w-full "><span class="flex items-center w-full justify-between">Compendia<svg stroke="currentColor" fill="currentColor" stroke-width="0" viewBox="0 0 24 24" height="1em" width="1em" xmlns="http://www.w3.org/2000/svg"><path d="m11.998 17 7-8h-14z"></path></svg></span></button><div class="hidden bg-nav-secondary -mx-2" id="div_main_menu_dropdown_mobile_2"><a href="/clinical/bone-health"><div class=" pt-2 pb-2 pl-6 pr-6 hover:bg-secondary text-sm border-b border-[rgba(0,0,0,.20)]">Bone Health</div></a><a href="/clinical/dermatology"><div class=" pt-2 pb-2 pl-6 pr-6 hover:bg-secondary text-sm border-b border-[rgba(0,0,0,.20)]">Dermatology</div></a><a href="/clinical/diabetes"><div class=" pt-2 pb-2 pl-6 pr-6 hover:bg-secondary text-sm border-b border-[rgba(0,0,0,.20)]">Diabetes</div></a><a href="/clinical/gastroenterology"><div class=" pt-2 pb-2 pl-6 pr-6 hover:bg-secondary text-sm border-b border-[rgba(0,0,0,.20)]">Gastroenterology</div></a><a href="/clinical/hematology"><div class=" pt-2 pb-2 pl-6 pr-6 hover:bg-secondary text-sm border-b border-[rgba(0,0,0,.20)]">Hematology</div></a><a href="/clinical/immunology"><div class=" pt-2 pb-2 pl-6 pr-6 hover:bg-secondary text-sm border-b border-[rgba(0,0,0,.20)]">Immunology</div></a><a href="/clinical/neurology"><div class=" pt-2 pb-2 pl-6 pr-6 hover:bg-secondary text-sm border-b border-[rgba(0,0,0,.20)]">Neurology</div></a><a href="/clinical/oncology"><div class=" pt-2 pb-2 pl-6 pr-6 hover:bg-secondary text-sm border-b border-[rgba(0,0,0,.20)]">Oncology</div></a><a href="/clinical/ophthalmology"><div class=" pt-2 pb-2 pl-6 pr-6 hover:bg-secondary text-sm border-b border-[rgba(0,0,0,.20)]">Ophthalmology</div></a><a href="/clinical/rare-disease"><div class=" pt-2 pb-2 pl-6 pr-6 hover:bg-secondary text-sm border-b border-[rgba(0,0,0,.20)]">Rare Disease</div></a><a href="/clinical/respiratory"><div class=" pt-2 pb-2 pl-6 pr-6 hover:bg-secondary text-sm border-b border-[rgba(0,0,0,.20)]">Respiratory</div></a><a href="/clinical/rheumatology"><div class=" pt-2 pb-2 pl-6 pr-6 hover:bg-secondary text-sm border-b border-[rgba(0,0,0,.20)]">Rheumatology</div></a></div></div><div class="relative py-2 border-b border-[rgba(0,0,0,.20)] mx-2"><button aria-controls="div_main_menu_dropdown_mobile_3" class="flex items-center p-2 w-full "><span class="flex items-center w-full justify-between">Conferences<svg stroke="currentColor" fill="currentColor" stroke-width="0" viewBox="0 0 24 24" height="1em" width="1em" xmlns="http://www.w3.org/2000/svg"><path d="m11.998 17 7-8h-14z"></path></svg></span></button><div class="hidden bg-nav-secondary -mx-2" id="div_main_menu_dropdown_mobile_3"><a href="/latest-conference"><div class=" pt-2 pb-2 pl-6 pr-6 hover:bg-secondary text-sm border-b border-[rgba(0,0,0,.20)]">Conference Coverage</div></a><a href="/conference"><div class=" pt-2 pb-2 pl-6 pr-6 hover:bg-secondary text-sm border-b border-[rgba(0,0,0,.20)]">Conference Listing</div></a></div></div><div class="relative py-2 border-b border-[rgba(0,0,0,.1)] mx-2"><div class="flex items-center p-2 " href="/continuing-education"><span class="flex items-center w-full justify-between">CME/CE</span></div></div><div class="relative py-2 border-b border-[rgba(0,0,0,.20)] mx-2"><button aria-controls="div_main_menu_dropdown_mobile_5" class="flex items-center p-2 w-full "><span class="flex items-center w-full justify-between">Resources<svg stroke="currentColor" fill="currentColor" stroke-width="0" viewBox="0 0 24 24" height="1em" width="1em" xmlns="http://www.w3.org/2000/svg"><path d="m11.998 17 7-8h-14z"></path></svg></span></button><div class="hidden bg-nav-secondary -mx-2" id="div_main_menu_dropdown_mobile_5"><a href="/authors"><div class=" pt-2 pb-2 pl-6 pr-6 hover:bg-secondary text-sm border-b border-[rgba(0,0,0,.20)]">Authors</div></a><a href="/resources"><div class=" pt-2 pb-2 pl-6 pr-6 hover:bg-secondary text-sm border-b border-[rgba(0,0,0,.20)]">Biosimilar Resources</div></a><a href="/interactive-tools"><div class=" pt-2 pb-2 pl-6 pr-6 hover:bg-secondary text-sm border-b border-[rgba(0,0,0,.20)]">Interactive Tools</div></a><a href="/sap-partners"><div class=" pt-2 pb-2 pl-6 pr-6 hover:bg-secondary text-sm border-b border-[rgba(0,0,0,.20)]">Partners</div></a><a href="/polls"><div class=" pt-2 pb-2 pl-6 pr-6 hover:bg-secondary text-sm border-b border-[rgba(0,0,0,.20)]">Polls and Quizzes</div></a><a href="/sponsored"><div class=" pt-2 pb-2 pl-6 pr-6 hover:bg-secondary text-sm border-b border-[rgba(0,0,0,.20)]">Sponsored</div></a><a href="/when-choice-arrives-competition-consequences"><div class=" pt-2 pb-2 pl-6 pr-6 hover:bg-secondary text-sm border-b border-[rgba(0,0,0,.20)]">WHEN CHOICE ARRIVES: Competition & Consequences</div></a></div></div><div class="relative py-2 border-b border-[rgba(0,0,0,.1)] mx-2"><div class="flex items-center p-2 " href="https://one.centerforbiosimilars.com/subscribe"><span class="flex items-center w-full justify-between">Subscribe</span></div></div><div class="relative py-2 border-b border-[rgba(0,0,0,.1)] mx-2"><div class="flex items-center p-2 " href="/biosimilar-approvals"><span class="flex items-center w-full justify-between">BIOSIMILAR APPROVALS</span></div></div></div></div></div><div class="w-full h-[2px] bg-main-nav-border-bg"></div></div><div class="flex sm:hidden flex-row min-w-screen justify-center items-center bg-gray-200 z-[99] px-2 border-b-1 shadow-md mt-[70px] -mb-12"><div class="flex-none p-2 "><button class="flex flex-row items-center justify-between px-2 py-1 focus:outline-none text-gray-700"><span class="mr-1 text-gray-800 text-bold">Choose a Specialty</span><svg id="arrow-up" class="w-4 h-4 text-gray-800 mt-[2px]" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 20 20"><path fill="black" fill-rule="evenodd" d="M14.707 12.707a1 1 0 01-1.414 0L10 9.414l-3.293 3.293a1 1 0 01-1.414-1.414l4-4a1 1 0 011.414 0l4 4a1 1 0 010 1.414z" clip-rule="evenodd"></path></svg></button><div id="options" class="max-h-0 overflow-hidden transition-all z-[99] absolute w-screen left-0 right-0 mt-2 bg-white rounded-lg shadow-xl"><ul class="px-2 pt-1"><li class="border-b mb-0 p-2" href="/clinical/bone-health">Bone Health</li><li class="border-b mb-0 p-2" href="/clinical/immunology">Immunology</li><li class="border-b mb-0 p-2" href="/clinical/hematology">Hematology</li><li class="border-b mb-0 p-2" href="/clinical/respiratory">Respiratory</li><li class="border-b mb-0 p-2" href="/clinical/dermatology">Dermatology</li><li class="border-b mb-0 p-2" href="/clinical/diabetes">Diabetes</li><li class="border-b mb-0 p-2" href="/clinical/gastroenterology">Gastroenterology</li><li class="border-b mb-0 p-2" href="/clinical/neurology">Neurology</li><li class="border-b mb-0 p-2" href="/clinical/oncology">Oncology</li><li class="border-b mb-0 p-2" href="/clinical/ophthalmology">Ophthalmology</li><li class="border-b mb-0 p-2" href="/clinical/rare-disease">Rare Disease</li><li class="border-b mb-0 p-2" href="/clinical/rheumatology">Rheumatology</li></ul></div></div></div><div class="container top-ad-div px-4 mx-auto pl-2 pr-2 sm:h-[98px] sm:w-[728px]"><div id="leaderboardWrapper" class="jsx-1661e6713d4eb9b5 leaderboardAdWrapper mx-auto mt-1 flex min-h-0 md:min-h-[90px] justify-center items-center flex-col relative z-[99999] "><div class="jsx-1661e6713d4eb9b5 bg-white md:-translate-x-4"><div class="jsx-1661e6713d4eb9b5 text-[8px] text-center text-gray-600 hidden relative">Advertisement</div><div id="div-gpt-ad-top" class="jsx-1661e6713d4eb9b5 AD728x90 mx-auto text-center x"></div></div></div></div><div class="relative mb-8 hidden md:block"><div class="bg-white py-4 mt-4"><div class="mx-auto md:max-w-4xl lg:max-w-5xl xl:max-w-7xl "><div style="border-bottom:3px solid #ddd" class="flex border-b-6 pb-2 px-1 -mx-2"><div class=" isolate z-[10000] " data-headlessui-state=""><button class="inline-flex items-center gap-x-1 text-md leading-6 text-gray-700 pr-4 mr-4 px-2 focus:outline-none outline-none " type="button" aria-expanded="false" data-headlessui-state="">Business Practice<svg xmlns="http://www.w3.org/2000/svg" width="12" height="12" fill="currentColor" class="bi bi-chevron-down mt-1" stroke-width="0" stroke="#000" viewBox="0 0 16 16"><path fill-rule="evenodd" d="M1.646 4.646a.5.5 0 0 1 .708 0L8 10.293l5.646-5.647a.5.5 0 0 1 .708.708l-6 6a.5.5 0 0 1-.708 0l-6-6a.5.5 0 0 1 0-.708z"></path></svg></button><noscript><div><a href="/business-practice/business" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Business</a><a href="/business-practice/development" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Development</a><a href="/business-practice/legal" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Legal</a><a href="/business-practice/policy" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Policy</a><a href="/business-practice/practice" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Practice</a><a href="/business-practice/regulatory" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Regulatory</a></div></noscript></div></div></div></div></div><div id="" class="customPageFullWidthClass container mx-auto flex m-1 min-h-[57vh] px-4"><div class="customPageFullWidthClass flex-auto w-[calc(100%-300px)] pr-0 md:pr-6 mt-16 sm:mt-0"><div class="m-2"><h2 class="text-3xl">Latest News</h2><div class="w-full border-b border-secondary"></div><div class="grid gap-2 md:gap-4 grid-cols-1 md:grid-cols-2"><div class="col-span-2 relative py-4"><div><div><div class="text-[8px] text-center text-gray-500 hidden"> </div><div id="div-gpt-ad-infeed-top"></div></div></div></div><div class="flex mt-4 col-span-2"><a class="flex-none w-[32%] mr-[.75rem] mt-4 sm:w-60 md:mt-3" href="/view/biosimilars-help-alvotech-revenues-soar-over-400-year-over-year"><div class=""><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:relative"><span style="box-sizing:border-box;display:block;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;padding-top:56.08333333333333%"></span><img alt="biosimilars and revenue | Image credit: เด็กชาย นุ่มนิ่ม - stock.adobe.com" title="biosimilars and revenue | Image credit: เด็กชาย นุ่มนิ่ม - stock.adobe.com" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="responsive" class="shrink-0" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/><noscript><img alt="biosimilars and revenue | Image credit: เด็กชาย นุ่มนิ่ม - stock.adobe.com" title="biosimilars and revenue | Image credit: เด็กชาย นุ่มนิ่ม - stock.adobe.com" sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F229ca2e182044b95580c7d9dbf79fd1cb5ad2235-1200x673.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=640&q=75 640w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F229ca2e182044b95580c7d9dbf79fd1cb5ad2235-1200x673.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=750&q=75 750w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F229ca2e182044b95580c7d9dbf79fd1cb5ad2235-1200x673.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=828&q=75 828w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F229ca2e182044b95580c7d9dbf79fd1cb5ad2235-1200x673.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=1080&q=75 1080w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F229ca2e182044b95580c7d9dbf79fd1cb5ad2235-1200x673.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=1200&q=75 1200w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F229ca2e182044b95580c7d9dbf79fd1cb5ad2235-1200x673.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=1920&q=75 1920w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F229ca2e182044b95580c7d9dbf79fd1cb5ad2235-1200x673.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=2048&q=75 2048w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F229ca2e182044b95580c7d9dbf79fd1cb5ad2235-1200x673.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75 3840w" src="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F229ca2e182044b95580c7d9dbf79fd1cb5ad2235-1200x673.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75" decoding="async" data-nimg="responsive" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" class="shrink-0" loading="lazy"/></noscript></span></div></a><div class="flex-auto py-2 border-t-2 border-t-gray-100"><div><a class="font-bold" href="/view/biosimilars-help-alvotech-revenues-soar-over-400-year-over-year">Biosimilars Help Alvotech Revenues Soar Over 400% Year Over Year</a></div><div class="pb-2"><div><span class="text-md "><span class="mr-1 italic">By </span><a class="mr-1 text-sky-800 hover:text-primary" href="/authors/skylar-jeremias">Skylar Jeremias</a></span></div></div><a href="/view/biosimilars-help-alvotech-revenues-soar-over-400-year-over-year"><span class="text-sm text-gray-500">March 31st 2025</span></a></div></div><div class="flex mt-4 col-span-2 md:col-span-1"><a class="flex-none w-[32%] mr-[1rem] md:w-32 mt-4" href="/view/pbm-evolution-towards-value-based-care-shifts-to-transparent-pharmacy-pricing"><div class=""><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:relative"><span style="box-sizing:border-box;display:block;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;padding-top:53.333333333333336%"></span><img alt="Josh Canavan, PharmD, head of pharmacy at RazorMetrics and Chris O'Dell, senior vice president of market solutions at Turquoise Health." title="Josh Canavan, PharmD, head of pharmacy at RazorMetrics and Chris O'Dell, senior vice president of market solutions at Turquoise Health." src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="responsive" class="shrink-0" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/><noscript><img alt="Josh Canavan, PharmD, head of pharmacy at RazorMetrics and Chris O'Dell, senior vice president of market solutions at Turquoise Health." title="Josh Canavan, PharmD, head of pharmacy at RazorMetrics and Chris O'Dell, senior vice president of market solutions at Turquoise Health." sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Ff7ea168fd491fe55481fad0fd2ca7544df68ea0a-3750x2000.png%3Ffit%3Dcrop%26auto%3Dformat&w=640&q=75 640w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Ff7ea168fd491fe55481fad0fd2ca7544df68ea0a-3750x2000.png%3Ffit%3Dcrop%26auto%3Dformat&w=750&q=75 750w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Ff7ea168fd491fe55481fad0fd2ca7544df68ea0a-3750x2000.png%3Ffit%3Dcrop%26auto%3Dformat&w=828&q=75 828w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Ff7ea168fd491fe55481fad0fd2ca7544df68ea0a-3750x2000.png%3Ffit%3Dcrop%26auto%3Dformat&w=1080&q=75 1080w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Ff7ea168fd491fe55481fad0fd2ca7544df68ea0a-3750x2000.png%3Ffit%3Dcrop%26auto%3Dformat&w=1200&q=75 1200w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Ff7ea168fd491fe55481fad0fd2ca7544df68ea0a-3750x2000.png%3Ffit%3Dcrop%26auto%3Dformat&w=1920&q=75 1920w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Ff7ea168fd491fe55481fad0fd2ca7544df68ea0a-3750x2000.png%3Ffit%3Dcrop%26auto%3Dformat&w=2048&q=75 2048w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Ff7ea168fd491fe55481fad0fd2ca7544df68ea0a-3750x2000.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75 3840w" src="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Ff7ea168fd491fe55481fad0fd2ca7544df68ea0a-3750x2000.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75" decoding="async" data-nimg="responsive" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" class="shrink-0" loading="lazy"/></noscript></span></div></a><div class="flex-auto py-2 border-t-2 border-t-gray-100"><div><a class="font-bold" href="/view/pbm-evolution-towards-value-based-care-shifts-to-transparent-pharmacy-pricing">PBM Evolution Toward Value-Based Care Shifts to Transparent Pharmacy Pricing</a></div><div class="pb-2"><div><span class="text-md "><span class="mr-1 italic">By </span><a class="mr-1 text-sky-800 hover:text-primary" href="/authors/cameron-santoro">Cameron Santoro</a></span></div></div><a href="/view/pbm-evolution-towards-value-based-care-shifts-to-transparent-pharmacy-pricing"><span class="text-sm text-gray-500">March 30th 2025</span></a></div></div><div class="flex mt-4 col-span-2 md:col-span-1"><a class="flex-none w-[32%] mr-[1rem] md:w-32 mt-4" href="/view/fda-approves-another-pair-of-denosumab-biosimilars-conexxence-and-bomyntra"><div class=""><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:relative"><span style="box-sizing:border-box;display:block;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;padding-top:62.9110418830045%"></span><img alt="FDA Approved. | Image Credit: gguy - stock.adobe.com " title="FDA Approved. | Image Credit: gguy - stock.adobe.com " src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="responsive" class="shrink-0" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/><noscript><img alt="FDA Approved. | Image Credit: gguy - stock.adobe.com " title="FDA Approved. | Image Credit: gguy - stock.adobe.com " sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Ff61e00527e75d813a50dddfd0067d4c76d20d322-5778x3635.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=640&q=75 640w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Ff61e00527e75d813a50dddfd0067d4c76d20d322-5778x3635.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=750&q=75 750w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Ff61e00527e75d813a50dddfd0067d4c76d20d322-5778x3635.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=828&q=75 828w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Ff61e00527e75d813a50dddfd0067d4c76d20d322-5778x3635.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=1080&q=75 1080w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Ff61e00527e75d813a50dddfd0067d4c76d20d322-5778x3635.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=1200&q=75 1200w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Ff61e00527e75d813a50dddfd0067d4c76d20d322-5778x3635.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=1920&q=75 1920w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Ff61e00527e75d813a50dddfd0067d4c76d20d322-5778x3635.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=2048&q=75 2048w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Ff61e00527e75d813a50dddfd0067d4c76d20d322-5778x3635.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75 3840w" src="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Ff61e00527e75d813a50dddfd0067d4c76d20d322-5778x3635.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75" decoding="async" data-nimg="responsive" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" class="shrink-0" loading="lazy"/></noscript></span></div></a><div class="flex-auto py-2 border-t-2 border-t-gray-100"><div><a class="font-bold" href="/view/fda-approves-another-pair-of-denosumab-biosimilars-conexxence-and-bomyntra">FDA Approves Another Pair of Denosumab Biosimilars, Conexxence and Bomyntra </a></div><div class="pb-2"><div><span class="text-md "><span class="mr-1 italic">By </span><a class="mr-1 text-sky-800 hover:text-primary" href="/authors/cameron-santoro">Cameron Santoro</a></span></div></div><a href="/view/fda-approves-another-pair-of-denosumab-biosimilars-conexxence-and-bomyntra"><span class="text-sm text-gray-500">March 27th 2025</span></a></div></div><div class="flex mt-4 col-span-2 md:col-span-1"><a class="flex-none w-[32%] mr-[1rem] md:w-32 mt-4" href="/view/as-biosimilar-substitutions-become-more-common-education-and-patient-counseling-are-paramount"><div class=""><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:relative"><span style="box-sizing:border-box;display:block;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;padding-top:56.2374245472837%"></span><img alt="doctor talking to patient about biosimilars | Image credit: sebra - stock.adobe.com" title="doctor talking to patient about biosimilars | Image credit: sebra - stock.adobe.com" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="responsive" class="shrink-0" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/><noscript><img alt="doctor talking to patient about biosimilars | Image credit: sebra - stock.adobe.com" title="doctor talking to patient about biosimilars | Image credit: sebra - stock.adobe.com" sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F33ee25000ca99f7104221be3e70804bff1aed07d-7952x4472.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=640&q=75 640w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F33ee25000ca99f7104221be3e70804bff1aed07d-7952x4472.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=750&q=75 750w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F33ee25000ca99f7104221be3e70804bff1aed07d-7952x4472.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=828&q=75 828w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F33ee25000ca99f7104221be3e70804bff1aed07d-7952x4472.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=1080&q=75 1080w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F33ee25000ca99f7104221be3e70804bff1aed07d-7952x4472.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=1200&q=75 1200w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F33ee25000ca99f7104221be3e70804bff1aed07d-7952x4472.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=1920&q=75 1920w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F33ee25000ca99f7104221be3e70804bff1aed07d-7952x4472.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=2048&q=75 2048w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F33ee25000ca99f7104221be3e70804bff1aed07d-7952x4472.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75 3840w" src="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F33ee25000ca99f7104221be3e70804bff1aed07d-7952x4472.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75" decoding="async" data-nimg="responsive" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" class="shrink-0" loading="lazy"/></noscript></span></div></a><div class="flex-auto py-2 border-t-2 border-t-gray-100"><div><a class="font-bold" href="/view/as-biosimilar-substitutions-become-more-common-education-and-patient-counseling-are-paramount">As Biosimilar Substitutions Become More Common, Education and Patient Counseling Are Paramount</a></div><div class="pb-2"><div><span class="text-md "><span class="mr-1 italic">By </span><a class="mr-1 text-sky-800 hover:text-primary" href="/authors/luke-halpern">Luke Halpern</a></span></div></div><a href="/view/as-biosimilar-substitutions-become-more-common-education-and-patient-counseling-are-paramount"><span class="text-sm text-gray-500">March 27th 2025</span></a></div></div><div class="flex mt-4 col-span-2 md:col-span-1"><a class="flex-none w-[32%] mr-[1rem] md:w-32 mt-4" href="/view/adalimumab-biosimilars-show-similar-outcomes-in-psoriasis-after-nonmedical-switch"><div class=""><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:relative"><span style="box-sizing:border-box;display:block;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;padding-top:66.66666666666666%"></span><img alt="psoraisis | Image credit: pimentos - stock.adobe.com" title="psoraisis | Image credit: pimentos - stock.adobe.com" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="responsive" class="shrink-0" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/><noscript><img alt="psoraisis | Image credit: pimentos - stock.adobe.com" title="psoraisis | Image credit: pimentos - stock.adobe.com" sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F1d9e52f022f5262620c6e572b854f87e40781b95-8256x5504.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=640&q=75 640w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F1d9e52f022f5262620c6e572b854f87e40781b95-8256x5504.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=750&q=75 750w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F1d9e52f022f5262620c6e572b854f87e40781b95-8256x5504.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=828&q=75 828w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F1d9e52f022f5262620c6e572b854f87e40781b95-8256x5504.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=1080&q=75 1080w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F1d9e52f022f5262620c6e572b854f87e40781b95-8256x5504.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=1200&q=75 1200w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F1d9e52f022f5262620c6e572b854f87e40781b95-8256x5504.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=1920&q=75 1920w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F1d9e52f022f5262620c6e572b854f87e40781b95-8256x5504.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=2048&q=75 2048w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F1d9e52f022f5262620c6e572b854f87e40781b95-8256x5504.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75 3840w" src="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F1d9e52f022f5262620c6e572b854f87e40781b95-8256x5504.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75" decoding="async" data-nimg="responsive" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" class="shrink-0" loading="lazy"/></noscript></span></div></a><div class="flex-auto py-2 border-t-2 border-t-gray-100"><div><a class="font-bold" href="/view/adalimumab-biosimilars-show-similar-outcomes-in-psoriasis-after-nonmedical-switch">Adalimumab Biosimilars Show Similar Outcomes in Psoriasis After Nonmedical Switch</a></div><div class="pb-2"><div><span class="text-md "><span class="mr-1 italic">By </span><a class="mr-1 text-sky-800 hover:text-primary" href="/authors/skylar-jeremias">Skylar Jeremias</a></span></div></div><a href="/view/adalimumab-biosimilars-show-similar-outcomes-in-psoriasis-after-nonmedical-switch"><span class="text-sm text-gray-500">March 26th 2025</span></a></div></div></div></div><div class="jsx-19ede9f0a5a45918 py-4 relative px-0"><div class="jsx-19ede9f0a5a45918 "><div class="flex justify-between items-center py-1 space-x-4 border-0 select-none sm:border-b border-secondary"><div class="text-3xl text-primary ">Latest Videos</div></div></div><div style="scroll-snap-type:none" class="jsx-19ede9f0a5a45918 flex items-start overflow-x-auto space-x-4 py-4 relative mx-auto w-[calc(100%-64px)]"><a id="" class="w-[200px] h-fit space-y-3 flex-none select-none no-underline" style="scroll-snap-align:center;text-decoration:none" href="/view/the-top-5-biosimilar-articles-for-the-week-of-march-24"><div class="w-full shadow-md shadow-gray-800 overflow-hidden relative bg-white aspect-video"><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="" title="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:contain"/><noscript><img alt="" title="" sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F055847b24eb25c4de818dc3f9b17dbcc30f51ca5-1920x1080.png%2FScreenshot%25202025-03-25%2520at%252010.25.37%2520AM%2520(2).png%3Ffit%3Dcrop%26auto%3Dformat&w=640&q=30 640w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F055847b24eb25c4de818dc3f9b17dbcc30f51ca5-1920x1080.png%2FScreenshot%25202025-03-25%2520at%252010.25.37%2520AM%2520(2).png%3Ffit%3Dcrop%26auto%3Dformat&w=750&q=30 750w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F055847b24eb25c4de818dc3f9b17dbcc30f51ca5-1920x1080.png%2FScreenshot%25202025-03-25%2520at%252010.25.37%2520AM%2520(2).png%3Ffit%3Dcrop%26auto%3Dformat&w=828&q=30 828w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F055847b24eb25c4de818dc3f9b17dbcc30f51ca5-1920x1080.png%2FScreenshot%25202025-03-25%2520at%252010.25.37%2520AM%2520(2).png%3Ffit%3Dcrop%26auto%3Dformat&w=1080&q=30 1080w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F055847b24eb25c4de818dc3f9b17dbcc30f51ca5-1920x1080.png%2FScreenshot%25202025-03-25%2520at%252010.25.37%2520AM%2520(2).png%3Ffit%3Dcrop%26auto%3Dformat&w=1200&q=30 1200w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F055847b24eb25c4de818dc3f9b17dbcc30f51ca5-1920x1080.png%2FScreenshot%25202025-03-25%2520at%252010.25.37%2520AM%2520(2).png%3Ffit%3Dcrop%26auto%3Dformat&w=1920&q=30 1920w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F055847b24eb25c4de818dc3f9b17dbcc30f51ca5-1920x1080.png%2FScreenshot%25202025-03-25%2520at%252010.25.37%2520AM%2520(2).png%3Ffit%3Dcrop%26auto%3Dformat&w=2048&q=30 2048w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F055847b24eb25c4de818dc3f9b17dbcc30f51ca5-1920x1080.png%2FScreenshot%25202025-03-25%2520at%252010.25.37%2520AM%2520(2).png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=30 3840w" src="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F055847b24eb25c4de818dc3f9b17dbcc30f51ca5-1920x1080.png%2FScreenshot%25202025-03-25%2520at%252010.25.37%2520AM%2520(2).png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=30" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:contain" loading="lazy"/></noscript></span></div><div class="w-full flex-wrap text-center text-sm mt-4 font-light no-underline text-gray-700"></div></a><a id="" class="w-[200px] h-fit space-y-3 flex-none select-none no-underline" style="scroll-snap-align:center;text-decoration:none" href="/view/the-top-5-biosimilar-articles-for-the-week-of-march-17"><div class="w-full shadow-md shadow-gray-800 overflow-hidden relative bg-white aspect-video"><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="" title="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:contain"/><noscript><img alt="" title="" sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F41b285c34f4e67bd6f606b2d117671b82f0197dd-1920x1080.png%2FScreenshot%25202025-03-19%2520at%252011.23.54%2520AM%2520(2).png%3Ffit%3Dcrop%26auto%3Dformat&w=640&q=30 640w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F41b285c34f4e67bd6f606b2d117671b82f0197dd-1920x1080.png%2FScreenshot%25202025-03-19%2520at%252011.23.54%2520AM%2520(2).png%3Ffit%3Dcrop%26auto%3Dformat&w=750&q=30 750w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F41b285c34f4e67bd6f606b2d117671b82f0197dd-1920x1080.png%2FScreenshot%25202025-03-19%2520at%252011.23.54%2520AM%2520(2).png%3Ffit%3Dcrop%26auto%3Dformat&w=828&q=30 828w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F41b285c34f4e67bd6f606b2d117671b82f0197dd-1920x1080.png%2FScreenshot%25202025-03-19%2520at%252011.23.54%2520AM%2520(2).png%3Ffit%3Dcrop%26auto%3Dformat&w=1080&q=30 1080w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F41b285c34f4e67bd6f606b2d117671b82f0197dd-1920x1080.png%2FScreenshot%25202025-03-19%2520at%252011.23.54%2520AM%2520(2).png%3Ffit%3Dcrop%26auto%3Dformat&w=1200&q=30 1200w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F41b285c34f4e67bd6f606b2d117671b82f0197dd-1920x1080.png%2FScreenshot%25202025-03-19%2520at%252011.23.54%2520AM%2520(2).png%3Ffit%3Dcrop%26auto%3Dformat&w=1920&q=30 1920w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F41b285c34f4e67bd6f606b2d117671b82f0197dd-1920x1080.png%2FScreenshot%25202025-03-19%2520at%252011.23.54%2520AM%2520(2).png%3Ffit%3Dcrop%26auto%3Dformat&w=2048&q=30 2048w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F41b285c34f4e67bd6f606b2d117671b82f0197dd-1920x1080.png%2FScreenshot%25202025-03-19%2520at%252011.23.54%2520AM%2520(2).png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=30 3840w" src="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F41b285c34f4e67bd6f606b2d117671b82f0197dd-1920x1080.png%2FScreenshot%25202025-03-19%2520at%252011.23.54%2520AM%2520(2).png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=30" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:contain" loading="lazy"/></noscript></span></div><div class="w-full flex-wrap text-center text-sm mt-4 font-light no-underline text-gray-700"></div></a><a id="" class="w-[200px] h-fit space-y-3 flex-none select-none no-underline" style="scroll-snap-align:center;text-decoration:none" href="/view/the-top-5-biosimilar-articles-for-the-week-of-march-10"><div class="w-full shadow-md shadow-gray-800 overflow-hidden relative bg-white aspect-video"><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="" title="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:contain"/><noscript><img alt="" title="" sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F8783648e307c0d134df1e6baa07d3329aafc5364-1920x1080.png%2FTop5Thumbnail.CFB.3.10.25.png%3Ffit%3Dcrop%26auto%3Dformat&w=640&q=30 640w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F8783648e307c0d134df1e6baa07d3329aafc5364-1920x1080.png%2FTop5Thumbnail.CFB.3.10.25.png%3Ffit%3Dcrop%26auto%3Dformat&w=750&q=30 750w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F8783648e307c0d134df1e6baa07d3329aafc5364-1920x1080.png%2FTop5Thumbnail.CFB.3.10.25.png%3Ffit%3Dcrop%26auto%3Dformat&w=828&q=30 828w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F8783648e307c0d134df1e6baa07d3329aafc5364-1920x1080.png%2FTop5Thumbnail.CFB.3.10.25.png%3Ffit%3Dcrop%26auto%3Dformat&w=1080&q=30 1080w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F8783648e307c0d134df1e6baa07d3329aafc5364-1920x1080.png%2FTop5Thumbnail.CFB.3.10.25.png%3Ffit%3Dcrop%26auto%3Dformat&w=1200&q=30 1200w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F8783648e307c0d134df1e6baa07d3329aafc5364-1920x1080.png%2FTop5Thumbnail.CFB.3.10.25.png%3Ffit%3Dcrop%26auto%3Dformat&w=1920&q=30 1920w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F8783648e307c0d134df1e6baa07d3329aafc5364-1920x1080.png%2FTop5Thumbnail.CFB.3.10.25.png%3Ffit%3Dcrop%26auto%3Dformat&w=2048&q=30 2048w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F8783648e307c0d134df1e6baa07d3329aafc5364-1920x1080.png%2FTop5Thumbnail.CFB.3.10.25.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=30 3840w" src="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F8783648e307c0d134df1e6baa07d3329aafc5364-1920x1080.png%2FTop5Thumbnail.CFB.3.10.25.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=30" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:contain" loading="lazy"/></noscript></span></div><div class="w-full flex-wrap text-center text-sm mt-4 font-light no-underline text-gray-700"></div></a><a id="" class="w-[200px] h-fit space-y-3 flex-none select-none no-underline" style="scroll-snap-align:center;text-decoration:none" href="/view/the-top-5-biosimilar-articles-for-the-week-of-march-3"><div class="w-full shadow-md shadow-gray-800 overflow-hidden relative bg-white aspect-video"><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="" title="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:contain"/><noscript><img alt="" title="" sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F42296a12b4d4aa3c7d4fa1bf1ab79e35d18c334f-1920x1080.png%2FScreenshot%25202025-03-05%2520at%25203.37.32%2520PM%2520(2).png%3Ffit%3Dcrop%26auto%3Dformat&w=640&q=30 640w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F42296a12b4d4aa3c7d4fa1bf1ab79e35d18c334f-1920x1080.png%2FScreenshot%25202025-03-05%2520at%25203.37.32%2520PM%2520(2).png%3Ffit%3Dcrop%26auto%3Dformat&w=750&q=30 750w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F42296a12b4d4aa3c7d4fa1bf1ab79e35d18c334f-1920x1080.png%2FScreenshot%25202025-03-05%2520at%25203.37.32%2520PM%2520(2).png%3Ffit%3Dcrop%26auto%3Dformat&w=828&q=30 828w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F42296a12b4d4aa3c7d4fa1bf1ab79e35d18c334f-1920x1080.png%2FScreenshot%25202025-03-05%2520at%25203.37.32%2520PM%2520(2).png%3Ffit%3Dcrop%26auto%3Dformat&w=1080&q=30 1080w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F42296a12b4d4aa3c7d4fa1bf1ab79e35d18c334f-1920x1080.png%2FScreenshot%25202025-03-05%2520at%25203.37.32%2520PM%2520(2).png%3Ffit%3Dcrop%26auto%3Dformat&w=1200&q=30 1200w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F42296a12b4d4aa3c7d4fa1bf1ab79e35d18c334f-1920x1080.png%2FScreenshot%25202025-03-05%2520at%25203.37.32%2520PM%2520(2).png%3Ffit%3Dcrop%26auto%3Dformat&w=1920&q=30 1920w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F42296a12b4d4aa3c7d4fa1bf1ab79e35d18c334f-1920x1080.png%2FScreenshot%25202025-03-05%2520at%25203.37.32%2520PM%2520(2).png%3Ffit%3Dcrop%26auto%3Dformat&w=2048&q=30 2048w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F42296a12b4d4aa3c7d4fa1bf1ab79e35d18c334f-1920x1080.png%2FScreenshot%25202025-03-05%2520at%25203.37.32%2520PM%2520(2).png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=30 3840w" src="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F42296a12b4d4aa3c7d4fa1bf1ab79e35d18c334f-1920x1080.png%2FScreenshot%25202025-03-05%2520at%25203.37.32%2520PM%2520(2).png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=30" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:contain" loading="lazy"/></noscript></span></div><div class="w-full flex-wrap text-center text-sm mt-4 font-light no-underline text-gray-700"></div></a><a id="" class="w-[200px] h-fit space-y-3 flex-none select-none no-underline" style="scroll-snap-align:center;text-decoration:none" href="/view/the-top-5-biosimilar-articles-for-the-week-of-february-24"><div class="w-full shadow-md shadow-gray-800 overflow-hidden relative bg-white aspect-video"><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="" title="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:contain"/><noscript><img alt="" title="" sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F3dffe2d24a371a6e0c2be9b98b25f403ce463eed-1920x1080.png%2FScreenshot%25202025-02-26%2520at%252010.46.36%2520AM%2520(2).png%3Ffit%3Dcrop%26auto%3Dformat&w=640&q=30 640w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F3dffe2d24a371a6e0c2be9b98b25f403ce463eed-1920x1080.png%2FScreenshot%25202025-02-26%2520at%252010.46.36%2520AM%2520(2).png%3Ffit%3Dcrop%26auto%3Dformat&w=750&q=30 750w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F3dffe2d24a371a6e0c2be9b98b25f403ce463eed-1920x1080.png%2FScreenshot%25202025-02-26%2520at%252010.46.36%2520AM%2520(2).png%3Ffit%3Dcrop%26auto%3Dformat&w=828&q=30 828w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F3dffe2d24a371a6e0c2be9b98b25f403ce463eed-1920x1080.png%2FScreenshot%25202025-02-26%2520at%252010.46.36%2520AM%2520(2).png%3Ffit%3Dcrop%26auto%3Dformat&w=1080&q=30 1080w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F3dffe2d24a371a6e0c2be9b98b25f403ce463eed-1920x1080.png%2FScreenshot%25202025-02-26%2520at%252010.46.36%2520AM%2520(2).png%3Ffit%3Dcrop%26auto%3Dformat&w=1200&q=30 1200w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F3dffe2d24a371a6e0c2be9b98b25f403ce463eed-1920x1080.png%2FScreenshot%25202025-02-26%2520at%252010.46.36%2520AM%2520(2).png%3Ffit%3Dcrop%26auto%3Dformat&w=1920&q=30 1920w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F3dffe2d24a371a6e0c2be9b98b25f403ce463eed-1920x1080.png%2FScreenshot%25202025-02-26%2520at%252010.46.36%2520AM%2520(2).png%3Ffit%3Dcrop%26auto%3Dformat&w=2048&q=30 2048w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F3dffe2d24a371a6e0c2be9b98b25f403ce463eed-1920x1080.png%2FScreenshot%25202025-02-26%2520at%252010.46.36%2520AM%2520(2).png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=30 3840w" src="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F3dffe2d24a371a6e0c2be9b98b25f403ce463eed-1920x1080.png%2FScreenshot%25202025-02-26%2520at%252010.46.36%2520AM%2520(2).png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=30" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:contain" loading="lazy"/></noscript></span></div><div class="w-full flex-wrap text-center text-sm mt-4 font-light no-underline text-gray-700"></div></a><a id="" class="w-[200px] h-fit space-y-3 flex-none select-none no-underline" style="scroll-snap-align:center;text-decoration:none" href="/view/the-top-5-biosimilar-articles-for-the-week-of-february-17"><div class="w-full shadow-md shadow-gray-800 overflow-hidden relative bg-white aspect-video"><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="" title="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:contain"/><noscript><img alt="" title="" sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F85f6bcb086fc8247455699a21e476787dc8af0fb-1920x1080.png%2FTop5.CFB.Thumbnail.2.17.25.png%3Ffit%3Dcrop%26auto%3Dformat&w=640&q=30 640w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F85f6bcb086fc8247455699a21e476787dc8af0fb-1920x1080.png%2FTop5.CFB.Thumbnail.2.17.25.png%3Ffit%3Dcrop%26auto%3Dformat&w=750&q=30 750w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F85f6bcb086fc8247455699a21e476787dc8af0fb-1920x1080.png%2FTop5.CFB.Thumbnail.2.17.25.png%3Ffit%3Dcrop%26auto%3Dformat&w=828&q=30 828w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F85f6bcb086fc8247455699a21e476787dc8af0fb-1920x1080.png%2FTop5.CFB.Thumbnail.2.17.25.png%3Ffit%3Dcrop%26auto%3Dformat&w=1080&q=30 1080w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F85f6bcb086fc8247455699a21e476787dc8af0fb-1920x1080.png%2FTop5.CFB.Thumbnail.2.17.25.png%3Ffit%3Dcrop%26auto%3Dformat&w=1200&q=30 1200w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F85f6bcb086fc8247455699a21e476787dc8af0fb-1920x1080.png%2FTop5.CFB.Thumbnail.2.17.25.png%3Ffit%3Dcrop%26auto%3Dformat&w=1920&q=30 1920w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F85f6bcb086fc8247455699a21e476787dc8af0fb-1920x1080.png%2FTop5.CFB.Thumbnail.2.17.25.png%3Ffit%3Dcrop%26auto%3Dformat&w=2048&q=30 2048w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F85f6bcb086fc8247455699a21e476787dc8af0fb-1920x1080.png%2FTop5.CFB.Thumbnail.2.17.25.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=30 3840w" src="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F85f6bcb086fc8247455699a21e476787dc8af0fb-1920x1080.png%2FTop5.CFB.Thumbnail.2.17.25.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=30" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:contain" loading="lazy"/></noscript></span></div><div class="w-full flex-wrap text-center text-sm mt-4 font-light no-underline text-gray-700"></div></a><a id="" class="w-[200px] h-fit space-y-3 flex-none select-none no-underline" style="scroll-snap-align:center;text-decoration:none" href="/view/enhancing-biosimilar-adoption-in-value-based-oncology-care"><div class="w-full shadow-md shadow-gray-800 overflow-hidden relative bg-white aspect-video"><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="" title="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:contain"/><noscript><img alt="" title="" sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fccb6a378936d1c19bc0462ee818a856f4625b8a3-1200x675.png%2FTravis%2520Brewer%2520image.png%3Ffit%3Dcrop%26auto%3Dformat&w=640&q=30 640w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fccb6a378936d1c19bc0462ee818a856f4625b8a3-1200x675.png%2FTravis%2520Brewer%2520image.png%3Ffit%3Dcrop%26auto%3Dformat&w=750&q=30 750w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fccb6a378936d1c19bc0462ee818a856f4625b8a3-1200x675.png%2FTravis%2520Brewer%2520image.png%3Ffit%3Dcrop%26auto%3Dformat&w=828&q=30 828w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fccb6a378936d1c19bc0462ee818a856f4625b8a3-1200x675.png%2FTravis%2520Brewer%2520image.png%3Ffit%3Dcrop%26auto%3Dformat&w=1080&q=30 1080w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fccb6a378936d1c19bc0462ee818a856f4625b8a3-1200x675.png%2FTravis%2520Brewer%2520image.png%3Ffit%3Dcrop%26auto%3Dformat&w=1200&q=30 1200w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fccb6a378936d1c19bc0462ee818a856f4625b8a3-1200x675.png%2FTravis%2520Brewer%2520image.png%3Ffit%3Dcrop%26auto%3Dformat&w=1920&q=30 1920w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fccb6a378936d1c19bc0462ee818a856f4625b8a3-1200x675.png%2FTravis%2520Brewer%2520image.png%3Ffit%3Dcrop%26auto%3Dformat&w=2048&q=30 2048w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fccb6a378936d1c19bc0462ee818a856f4625b8a3-1200x675.png%2FTravis%2520Brewer%2520image.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=30 3840w" src="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fccb6a378936d1c19bc0462ee818a856f4625b8a3-1200x675.png%2FTravis%2520Brewer%2520image.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=30" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:contain" loading="lazy"/></noscript></span></div><div class="w-full flex-wrap text-center text-sm mt-4 font-light no-underline text-gray-700"></div></a><a id="" class="w-[200px] h-fit space-y-3 flex-none select-none no-underline" style="scroll-snap-align:center;text-decoration:none" href="/view/the-top-5-biosimilar-articles-for-the-week-of-february-10"><div class="w-full shadow-md shadow-gray-800 overflow-hidden relative bg-white aspect-video"><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="" title="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:contain"/><noscript><img alt="" title="" sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F136b92b91e67227bbb6f45deca0cdab825a19fbe-1920x1080.png%2FTop5.thumbnail.2.10.png%3Ffit%3Dcrop%26auto%3Dformat&w=640&q=30 640w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F136b92b91e67227bbb6f45deca0cdab825a19fbe-1920x1080.png%2FTop5.thumbnail.2.10.png%3Ffit%3Dcrop%26auto%3Dformat&w=750&q=30 750w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F136b92b91e67227bbb6f45deca0cdab825a19fbe-1920x1080.png%2FTop5.thumbnail.2.10.png%3Ffit%3Dcrop%26auto%3Dformat&w=828&q=30 828w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F136b92b91e67227bbb6f45deca0cdab825a19fbe-1920x1080.png%2FTop5.thumbnail.2.10.png%3Ffit%3Dcrop%26auto%3Dformat&w=1080&q=30 1080w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F136b92b91e67227bbb6f45deca0cdab825a19fbe-1920x1080.png%2FTop5.thumbnail.2.10.png%3Ffit%3Dcrop%26auto%3Dformat&w=1200&q=30 1200w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F136b92b91e67227bbb6f45deca0cdab825a19fbe-1920x1080.png%2FTop5.thumbnail.2.10.png%3Ffit%3Dcrop%26auto%3Dformat&w=1920&q=30 1920w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F136b92b91e67227bbb6f45deca0cdab825a19fbe-1920x1080.png%2FTop5.thumbnail.2.10.png%3Ffit%3Dcrop%26auto%3Dformat&w=2048&q=30 2048w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F136b92b91e67227bbb6f45deca0cdab825a19fbe-1920x1080.png%2FTop5.thumbnail.2.10.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=30 3840w" src="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F136b92b91e67227bbb6f45deca0cdab825a19fbe-1920x1080.png%2FTop5.thumbnail.2.10.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=30" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:contain" loading="lazy"/></noscript></span></div><div class="w-full flex-wrap text-center text-sm mt-4 font-light no-underline text-gray-700"></div></a><a id="" class="w-[200px] h-fit space-y-3 flex-none select-none no-underline" style="scroll-snap-align:center;text-decoration:none" href="/view/the-top-5-biosimilar-articles-for-the-week-of-february-3"><div class="w-full shadow-md shadow-gray-800 overflow-hidden relative bg-white aspect-video"><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="" title="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:contain"/><noscript><img alt="" title="" sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F2d31e4d09ebfc598fdcb71676676a0ff3843bb0c-1920x1080.png%2FTop5Thumbnail.2.3.25.png%3Ffit%3Dcrop%26auto%3Dformat&w=640&q=30 640w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F2d31e4d09ebfc598fdcb71676676a0ff3843bb0c-1920x1080.png%2FTop5Thumbnail.2.3.25.png%3Ffit%3Dcrop%26auto%3Dformat&w=750&q=30 750w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F2d31e4d09ebfc598fdcb71676676a0ff3843bb0c-1920x1080.png%2FTop5Thumbnail.2.3.25.png%3Ffit%3Dcrop%26auto%3Dformat&w=828&q=30 828w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F2d31e4d09ebfc598fdcb71676676a0ff3843bb0c-1920x1080.png%2FTop5Thumbnail.2.3.25.png%3Ffit%3Dcrop%26auto%3Dformat&w=1080&q=30 1080w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F2d31e4d09ebfc598fdcb71676676a0ff3843bb0c-1920x1080.png%2FTop5Thumbnail.2.3.25.png%3Ffit%3Dcrop%26auto%3Dformat&w=1200&q=30 1200w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F2d31e4d09ebfc598fdcb71676676a0ff3843bb0c-1920x1080.png%2FTop5Thumbnail.2.3.25.png%3Ffit%3Dcrop%26auto%3Dformat&w=1920&q=30 1920w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F2d31e4d09ebfc598fdcb71676676a0ff3843bb0c-1920x1080.png%2FTop5Thumbnail.2.3.25.png%3Ffit%3Dcrop%26auto%3Dformat&w=2048&q=30 2048w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F2d31e4d09ebfc598fdcb71676676a0ff3843bb0c-1920x1080.png%2FTop5Thumbnail.2.3.25.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=30 3840w" src="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F2d31e4d09ebfc598fdcb71676676a0ff3843bb0c-1920x1080.png%2FTop5Thumbnail.2.3.25.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=30" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:contain" loading="lazy"/></noscript></span></div><div class="w-full flex-wrap text-center text-sm mt-4 font-light no-underline text-gray-700"></div></a><a id="" class="w-[200px] h-fit space-y-3 flex-none select-none no-underline" style="scroll-snap-align:center;text-decoration:none" href="/view/understanding-biosimilars-through-education-and-pbm-formulary-perspective"><div class="w-full shadow-md shadow-gray-800 overflow-hidden relative bg-white aspect-video"><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="" title="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:contain"/><noscript><img alt="" title="" sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F89d5757303480ab1520c8dcb016f7f5b2f3e65e9-1920x1080.png%2FJosh%2520Canavan%252C%2520PharmD%2520thumbnail.png%3Ffit%3Dcrop%26auto%3Dformat&w=640&q=30 640w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F89d5757303480ab1520c8dcb016f7f5b2f3e65e9-1920x1080.png%2FJosh%2520Canavan%252C%2520PharmD%2520thumbnail.png%3Ffit%3Dcrop%26auto%3Dformat&w=750&q=30 750w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F89d5757303480ab1520c8dcb016f7f5b2f3e65e9-1920x1080.png%2FJosh%2520Canavan%252C%2520PharmD%2520thumbnail.png%3Ffit%3Dcrop%26auto%3Dformat&w=828&q=30 828w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F89d5757303480ab1520c8dcb016f7f5b2f3e65e9-1920x1080.png%2FJosh%2520Canavan%252C%2520PharmD%2520thumbnail.png%3Ffit%3Dcrop%26auto%3Dformat&w=1080&q=30 1080w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F89d5757303480ab1520c8dcb016f7f5b2f3e65e9-1920x1080.png%2FJosh%2520Canavan%252C%2520PharmD%2520thumbnail.png%3Ffit%3Dcrop%26auto%3Dformat&w=1200&q=30 1200w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F89d5757303480ab1520c8dcb016f7f5b2f3e65e9-1920x1080.png%2FJosh%2520Canavan%252C%2520PharmD%2520thumbnail.png%3Ffit%3Dcrop%26auto%3Dformat&w=1920&q=30 1920w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F89d5757303480ab1520c8dcb016f7f5b2f3e65e9-1920x1080.png%2FJosh%2520Canavan%252C%2520PharmD%2520thumbnail.png%3Ffit%3Dcrop%26auto%3Dformat&w=2048&q=30 2048w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F89d5757303480ab1520c8dcb016f7f5b2f3e65e9-1920x1080.png%2FJosh%2520Canavan%252C%2520PharmD%2520thumbnail.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=30 3840w" src="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F89d5757303480ab1520c8dcb016f7f5b2f3e65e9-1920x1080.png%2FJosh%2520Canavan%252C%2520PharmD%2520thumbnail.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=30" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:contain" loading="lazy"/></noscript></span></div><div class="w-full flex-wrap text-center text-sm mt-4 font-light no-underline text-gray-700"></div></a><a id="" class="w-[200px] h-fit space-y-3 flex-none select-none no-underline" style="scroll-snap-align:center;text-decoration:none" href="/view/the-top-5-biosimilar-articles-for-the-week-of-january-27"><div class="w-full shadow-md shadow-gray-800 overflow-hidden relative bg-white aspect-video"><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="" title="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:contain"/><noscript><img alt="" title="" sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fee18f4823a3ef2d8baf89a83bc96dc574ba6d501-1920x1080.png%2FCFBThumbnail.1.27.2025.png%3Ffit%3Dcrop%26auto%3Dformat&w=640&q=30 640w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fee18f4823a3ef2d8baf89a83bc96dc574ba6d501-1920x1080.png%2FCFBThumbnail.1.27.2025.png%3Ffit%3Dcrop%26auto%3Dformat&w=750&q=30 750w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fee18f4823a3ef2d8baf89a83bc96dc574ba6d501-1920x1080.png%2FCFBThumbnail.1.27.2025.png%3Ffit%3Dcrop%26auto%3Dformat&w=828&q=30 828w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fee18f4823a3ef2d8baf89a83bc96dc574ba6d501-1920x1080.png%2FCFBThumbnail.1.27.2025.png%3Ffit%3Dcrop%26auto%3Dformat&w=1080&q=30 1080w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fee18f4823a3ef2d8baf89a83bc96dc574ba6d501-1920x1080.png%2FCFBThumbnail.1.27.2025.png%3Ffit%3Dcrop%26auto%3Dformat&w=1200&q=30 1200w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fee18f4823a3ef2d8baf89a83bc96dc574ba6d501-1920x1080.png%2FCFBThumbnail.1.27.2025.png%3Ffit%3Dcrop%26auto%3Dformat&w=1920&q=30 1920w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fee18f4823a3ef2d8baf89a83bc96dc574ba6d501-1920x1080.png%2FCFBThumbnail.1.27.2025.png%3Ffit%3Dcrop%26auto%3Dformat&w=2048&q=30 2048w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fee18f4823a3ef2d8baf89a83bc96dc574ba6d501-1920x1080.png%2FCFBThumbnail.1.27.2025.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=30 3840w" src="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fee18f4823a3ef2d8baf89a83bc96dc574ba6d501-1920x1080.png%2FCFBThumbnail.1.27.2025.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=30" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:contain" loading="lazy"/></noscript></span></div><div class="w-full flex-wrap text-center text-sm mt-4 font-light no-underline text-gray-700"></div></a><a id="" class="w-[200px] h-fit space-y-3 flex-none select-none no-underline" style="scroll-snap-align:center;text-decoration:none" href="/view/the-top-5-biosimilar-articles-for-the-week-of-january-20"><div class="w-full shadow-md shadow-gray-800 overflow-hidden relative bg-white aspect-video"><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="" title="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:contain"/><noscript><img alt="" title="" sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fadb638b8b5e074f0f12f8e59627c4eedd020b664-1920x1080.png%2FCFBThumbnail.1.20.25.png%3Ffit%3Dcrop%26auto%3Dformat&w=640&q=30 640w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fadb638b8b5e074f0f12f8e59627c4eedd020b664-1920x1080.png%2FCFBThumbnail.1.20.25.png%3Ffit%3Dcrop%26auto%3Dformat&w=750&q=30 750w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fadb638b8b5e074f0f12f8e59627c4eedd020b664-1920x1080.png%2FCFBThumbnail.1.20.25.png%3Ffit%3Dcrop%26auto%3Dformat&w=828&q=30 828w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fadb638b8b5e074f0f12f8e59627c4eedd020b664-1920x1080.png%2FCFBThumbnail.1.20.25.png%3Ffit%3Dcrop%26auto%3Dformat&w=1080&q=30 1080w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fadb638b8b5e074f0f12f8e59627c4eedd020b664-1920x1080.png%2FCFBThumbnail.1.20.25.png%3Ffit%3Dcrop%26auto%3Dformat&w=1200&q=30 1200w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fadb638b8b5e074f0f12f8e59627c4eedd020b664-1920x1080.png%2FCFBThumbnail.1.20.25.png%3Ffit%3Dcrop%26auto%3Dformat&w=1920&q=30 1920w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fadb638b8b5e074f0f12f8e59627c4eedd020b664-1920x1080.png%2FCFBThumbnail.1.20.25.png%3Ffit%3Dcrop%26auto%3Dformat&w=2048&q=30 2048w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fadb638b8b5e074f0f12f8e59627c4eedd020b664-1920x1080.png%2FCFBThumbnail.1.20.25.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=30 3840w" src="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fadb638b8b5e074f0f12f8e59627c4eedd020b664-1920x1080.png%2FCFBThumbnail.1.20.25.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=30" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:contain" loading="lazy"/></noscript></span></div><div class="w-full flex-wrap text-center text-sm mt-4 font-light no-underline text-gray-700"></div></a><a id="" class="w-[200px] h-fit space-y-3 flex-none select-none no-underline" style="scroll-snap-align:center;text-decoration:none" href="/view/the-top-5-biosimilar-articles-for-the-week-of-january-13"><div class="w-full shadow-md shadow-gray-800 overflow-hidden relative bg-white aspect-video"><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="" title="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:contain"/><noscript><img alt="" title="" sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F42f86f28b62922cd2c41aac5b8e3d95202d0a99f-1920x1080.png%2FCFBThumbnail.1.13.25.png%3Ffit%3Dcrop%26auto%3Dformat&w=640&q=30 640w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F42f86f28b62922cd2c41aac5b8e3d95202d0a99f-1920x1080.png%2FCFBThumbnail.1.13.25.png%3Ffit%3Dcrop%26auto%3Dformat&w=750&q=30 750w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F42f86f28b62922cd2c41aac5b8e3d95202d0a99f-1920x1080.png%2FCFBThumbnail.1.13.25.png%3Ffit%3Dcrop%26auto%3Dformat&w=828&q=30 828w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F42f86f28b62922cd2c41aac5b8e3d95202d0a99f-1920x1080.png%2FCFBThumbnail.1.13.25.png%3Ffit%3Dcrop%26auto%3Dformat&w=1080&q=30 1080w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F42f86f28b62922cd2c41aac5b8e3d95202d0a99f-1920x1080.png%2FCFBThumbnail.1.13.25.png%3Ffit%3Dcrop%26auto%3Dformat&w=1200&q=30 1200w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F42f86f28b62922cd2c41aac5b8e3d95202d0a99f-1920x1080.png%2FCFBThumbnail.1.13.25.png%3Ffit%3Dcrop%26auto%3Dformat&w=1920&q=30 1920w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F42f86f28b62922cd2c41aac5b8e3d95202d0a99f-1920x1080.png%2FCFBThumbnail.1.13.25.png%3Ffit%3Dcrop%26auto%3Dformat&w=2048&q=30 2048w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F42f86f28b62922cd2c41aac5b8e3d95202d0a99f-1920x1080.png%2FCFBThumbnail.1.13.25.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=30 3840w" src="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F42f86f28b62922cd2c41aac5b8e3d95202d0a99f-1920x1080.png%2FCFBThumbnail.1.13.25.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=30" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:contain" loading="lazy"/></noscript></span></div><div class="w-full flex-wrap text-center text-sm mt-4 font-light no-underline text-gray-700"></div></a><a id="" class="w-[200px] h-fit space-y-3 flex-none select-none no-underline" style="scroll-snap-align:center;text-decoration:none" href="/view/streamlining-biosimilar-access-how-ehr-automation-transforms-patient-care"><div class="w-full shadow-md shadow-gray-800 overflow-hidden relative bg-white aspect-video"><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="" title="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:contain"/><noscript><img alt="" title="" sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F3e4a63e88ad5b31c674e712be57a560d50cc9ce5-2880x1617.png%2FDisalle.png%3Ffit%3Dcrop%26auto%3Dformat&w=640&q=30 640w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F3e4a63e88ad5b31c674e712be57a560d50cc9ce5-2880x1617.png%2FDisalle.png%3Ffit%3Dcrop%26auto%3Dformat&w=750&q=30 750w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F3e4a63e88ad5b31c674e712be57a560d50cc9ce5-2880x1617.png%2FDisalle.png%3Ffit%3Dcrop%26auto%3Dformat&w=828&q=30 828w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F3e4a63e88ad5b31c674e712be57a560d50cc9ce5-2880x1617.png%2FDisalle.png%3Ffit%3Dcrop%26auto%3Dformat&w=1080&q=30 1080w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F3e4a63e88ad5b31c674e712be57a560d50cc9ce5-2880x1617.png%2FDisalle.png%3Ffit%3Dcrop%26auto%3Dformat&w=1200&q=30 1200w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F3e4a63e88ad5b31c674e712be57a560d50cc9ce5-2880x1617.png%2FDisalle.png%3Ffit%3Dcrop%26auto%3Dformat&w=1920&q=30 1920w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F3e4a63e88ad5b31c674e712be57a560d50cc9ce5-2880x1617.png%2FDisalle.png%3Ffit%3Dcrop%26auto%3Dformat&w=2048&q=30 2048w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F3e4a63e88ad5b31c674e712be57a560d50cc9ce5-2880x1617.png%2FDisalle.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=30 3840w" src="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F3e4a63e88ad5b31c674e712be57a560d50cc9ce5-2880x1617.png%2FDisalle.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=30" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:contain" loading="lazy"/></noscript></span></div><div class="w-full flex-wrap text-center text-sm mt-4 font-light no-underline text-gray-700"></div></a><a id="" class="w-[200px] h-fit space-y-3 flex-none select-none no-underline" style="scroll-snap-align:center;text-decoration:none" href="/view/the-top-5-biosimilar-articles-for-the-week-of-january-6"><div class="w-full shadow-md shadow-gray-800 overflow-hidden relative bg-white aspect-video"><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="" title="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:contain"/><noscript><img alt="" title="" sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F5eb52adcc9e0032611f3bed75bf9b7a71e4d3d95-1920x1080.png%2FScreenshot%25202025-01-08%2520at%25204.28.17%2520PM%2520(2).png%3Ffit%3Dcrop%26auto%3Dformat&w=640&q=30 640w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F5eb52adcc9e0032611f3bed75bf9b7a71e4d3d95-1920x1080.png%2FScreenshot%25202025-01-08%2520at%25204.28.17%2520PM%2520(2).png%3Ffit%3Dcrop%26auto%3Dformat&w=750&q=30 750w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F5eb52adcc9e0032611f3bed75bf9b7a71e4d3d95-1920x1080.png%2FScreenshot%25202025-01-08%2520at%25204.28.17%2520PM%2520(2).png%3Ffit%3Dcrop%26auto%3Dformat&w=828&q=30 828w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F5eb52adcc9e0032611f3bed75bf9b7a71e4d3d95-1920x1080.png%2FScreenshot%25202025-01-08%2520at%25204.28.17%2520PM%2520(2).png%3Ffit%3Dcrop%26auto%3Dformat&w=1080&q=30 1080w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F5eb52adcc9e0032611f3bed75bf9b7a71e4d3d95-1920x1080.png%2FScreenshot%25202025-01-08%2520at%25204.28.17%2520PM%2520(2).png%3Ffit%3Dcrop%26auto%3Dformat&w=1200&q=30 1200w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F5eb52adcc9e0032611f3bed75bf9b7a71e4d3d95-1920x1080.png%2FScreenshot%25202025-01-08%2520at%25204.28.17%2520PM%2520(2).png%3Ffit%3Dcrop%26auto%3Dformat&w=1920&q=30 1920w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F5eb52adcc9e0032611f3bed75bf9b7a71e4d3d95-1920x1080.png%2FScreenshot%25202025-01-08%2520at%25204.28.17%2520PM%2520(2).png%3Ffit%3Dcrop%26auto%3Dformat&w=2048&q=30 2048w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F5eb52adcc9e0032611f3bed75bf9b7a71e4d3d95-1920x1080.png%2FScreenshot%25202025-01-08%2520at%25204.28.17%2520PM%2520(2).png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=30 3840w" src="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F5eb52adcc9e0032611f3bed75bf9b7a71e4d3d95-1920x1080.png%2FScreenshot%25202025-01-08%2520at%25204.28.17%2520PM%2520(2).png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=30" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:contain" loading="lazy"/></noscript></span></div><div class="w-full flex-wrap text-center text-sm mt-4 font-light no-underline text-gray-700"></div></a><a id="" class="w-[200px] h-fit space-y-3 flex-none select-none no-underline" style="scroll-snap-align:center;text-decoration:none" href="/view/reducing-financial-toxicity-in-gi-cancer-care-through-biosimilars"><div class="w-full shadow-md shadow-gray-800 overflow-hidden relative bg-white aspect-video"><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="" title="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:contain"/><noscript><img alt="" title="" sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fa7aa9dfeb54bfe4ba853aaec1b7319864f76ce4d-2880x1800.png%2FTiago%2520Biachi%2520image.png%3Ffit%3Dcrop%26auto%3Dformat&w=640&q=30 640w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fa7aa9dfeb54bfe4ba853aaec1b7319864f76ce4d-2880x1800.png%2FTiago%2520Biachi%2520image.png%3Ffit%3Dcrop%26auto%3Dformat&w=750&q=30 750w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fa7aa9dfeb54bfe4ba853aaec1b7319864f76ce4d-2880x1800.png%2FTiago%2520Biachi%2520image.png%3Ffit%3Dcrop%26auto%3Dformat&w=828&q=30 828w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fa7aa9dfeb54bfe4ba853aaec1b7319864f76ce4d-2880x1800.png%2FTiago%2520Biachi%2520image.png%3Ffit%3Dcrop%26auto%3Dformat&w=1080&q=30 1080w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fa7aa9dfeb54bfe4ba853aaec1b7319864f76ce4d-2880x1800.png%2FTiago%2520Biachi%2520image.png%3Ffit%3Dcrop%26auto%3Dformat&w=1200&q=30 1200w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fa7aa9dfeb54bfe4ba853aaec1b7319864f76ce4d-2880x1800.png%2FTiago%2520Biachi%2520image.png%3Ffit%3Dcrop%26auto%3Dformat&w=1920&q=30 1920w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fa7aa9dfeb54bfe4ba853aaec1b7319864f76ce4d-2880x1800.png%2FTiago%2520Biachi%2520image.png%3Ffit%3Dcrop%26auto%3Dformat&w=2048&q=30 2048w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fa7aa9dfeb54bfe4ba853aaec1b7319864f76ce4d-2880x1800.png%2FTiago%2520Biachi%2520image.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=30 3840w" src="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fa7aa9dfeb54bfe4ba853aaec1b7319864f76ce4d-2880x1800.png%2FTiago%2520Biachi%2520image.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=30" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:contain" loading="lazy"/></noscript></span></div><div class="w-full flex-wrap text-center text-sm mt-4 font-light no-underline text-gray-700"></div></a><a id="" class="w-[200px] h-fit space-y-3 flex-none select-none no-underline" style="scroll-snap-align:center;text-decoration:none" href="/view/the-top-5-biosimilar-articles-for-the-week-of-december-30"><div class="w-full shadow-md shadow-gray-800 overflow-hidden relative bg-white aspect-video"><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="" title="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:contain"/><noscript><img alt="" title="" sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F25005283b8219e218c7961322d21ab162bc53f10-1920x1080.png%2FTop5CFBThumbnail.12.30.24.png%3Ffit%3Dcrop%26auto%3Dformat&w=640&q=30 640w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F25005283b8219e218c7961322d21ab162bc53f10-1920x1080.png%2FTop5CFBThumbnail.12.30.24.png%3Ffit%3Dcrop%26auto%3Dformat&w=750&q=30 750w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F25005283b8219e218c7961322d21ab162bc53f10-1920x1080.png%2FTop5CFBThumbnail.12.30.24.png%3Ffit%3Dcrop%26auto%3Dformat&w=828&q=30 828w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F25005283b8219e218c7961322d21ab162bc53f10-1920x1080.png%2FTop5CFBThumbnail.12.30.24.png%3Ffit%3Dcrop%26auto%3Dformat&w=1080&q=30 1080w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F25005283b8219e218c7961322d21ab162bc53f10-1920x1080.png%2FTop5CFBThumbnail.12.30.24.png%3Ffit%3Dcrop%26auto%3Dformat&w=1200&q=30 1200w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F25005283b8219e218c7961322d21ab162bc53f10-1920x1080.png%2FTop5CFBThumbnail.12.30.24.png%3Ffit%3Dcrop%26auto%3Dformat&w=1920&q=30 1920w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F25005283b8219e218c7961322d21ab162bc53f10-1920x1080.png%2FTop5CFBThumbnail.12.30.24.png%3Ffit%3Dcrop%26auto%3Dformat&w=2048&q=30 2048w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F25005283b8219e218c7961322d21ab162bc53f10-1920x1080.png%2FTop5CFBThumbnail.12.30.24.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=30 3840w" src="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F25005283b8219e218c7961322d21ab162bc53f10-1920x1080.png%2FTop5CFBThumbnail.12.30.24.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=30" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:contain" loading="lazy"/></noscript></span></div><div class="w-full flex-wrap text-center text-sm mt-4 font-light no-underline text-gray-700"></div></a><a id="" class="w-[200px] h-fit space-y-3 flex-none select-none no-underline" style="scroll-snap-align:center;text-decoration:none" href="/view/the-top-5-biosimilar-articles-for-the-week-of-december-16"><div class="w-full shadow-md shadow-gray-800 overflow-hidden relative bg-white aspect-video"><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="" title="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:contain"/><noscript><img alt="" title="" sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F4003e12726c8587d4dc786cecd46750e801ca5c2-1920x1080.png%2FTop5CFB.Thumbnail.12.16.24.png%3Ffit%3Dcrop%26auto%3Dformat&w=640&q=30 640w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F4003e12726c8587d4dc786cecd46750e801ca5c2-1920x1080.png%2FTop5CFB.Thumbnail.12.16.24.png%3Ffit%3Dcrop%26auto%3Dformat&w=750&q=30 750w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F4003e12726c8587d4dc786cecd46750e801ca5c2-1920x1080.png%2FTop5CFB.Thumbnail.12.16.24.png%3Ffit%3Dcrop%26auto%3Dformat&w=828&q=30 828w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F4003e12726c8587d4dc786cecd46750e801ca5c2-1920x1080.png%2FTop5CFB.Thumbnail.12.16.24.png%3Ffit%3Dcrop%26auto%3Dformat&w=1080&q=30 1080w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F4003e12726c8587d4dc786cecd46750e801ca5c2-1920x1080.png%2FTop5CFB.Thumbnail.12.16.24.png%3Ffit%3Dcrop%26auto%3Dformat&w=1200&q=30 1200w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F4003e12726c8587d4dc786cecd46750e801ca5c2-1920x1080.png%2FTop5CFB.Thumbnail.12.16.24.png%3Ffit%3Dcrop%26auto%3Dformat&w=1920&q=30 1920w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F4003e12726c8587d4dc786cecd46750e801ca5c2-1920x1080.png%2FTop5CFB.Thumbnail.12.16.24.png%3Ffit%3Dcrop%26auto%3Dformat&w=2048&q=30 2048w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F4003e12726c8587d4dc786cecd46750e801ca5c2-1920x1080.png%2FTop5CFB.Thumbnail.12.16.24.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=30 3840w" src="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F4003e12726c8587d4dc786cecd46750e801ca5c2-1920x1080.png%2FTop5CFB.Thumbnail.12.16.24.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=30" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:contain" loading="lazy"/></noscript></span></div><div class="w-full flex-wrap text-center text-sm mt-4 font-light no-underline text-gray-700"></div></a><a id="" class="w-[200px] h-fit space-y-3 flex-none select-none no-underline" style="scroll-snap-align:center;text-decoration:none" href="/view/strategies-for-improving-biosimilar-access-and-utilization"><div class="w-full shadow-md shadow-gray-800 overflow-hidden relative bg-white aspect-video"><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="" title="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:contain"/><noscript><img alt="" title="" sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fe14b8f88d4d2be1b422a9f2ad4561e6c6185d75d-2880x1614.png%2FElie%2520Bahou%2520IVBM%2520image.png%3Ffit%3Dcrop%26auto%3Dformat&w=640&q=30 640w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fe14b8f88d4d2be1b422a9f2ad4561e6c6185d75d-2880x1614.png%2FElie%2520Bahou%2520IVBM%2520image.png%3Ffit%3Dcrop%26auto%3Dformat&w=750&q=30 750w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fe14b8f88d4d2be1b422a9f2ad4561e6c6185d75d-2880x1614.png%2FElie%2520Bahou%2520IVBM%2520image.png%3Ffit%3Dcrop%26auto%3Dformat&w=828&q=30 828w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fe14b8f88d4d2be1b422a9f2ad4561e6c6185d75d-2880x1614.png%2FElie%2520Bahou%2520IVBM%2520image.png%3Ffit%3Dcrop%26auto%3Dformat&w=1080&q=30 1080w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fe14b8f88d4d2be1b422a9f2ad4561e6c6185d75d-2880x1614.png%2FElie%2520Bahou%2520IVBM%2520image.png%3Ffit%3Dcrop%26auto%3Dformat&w=1200&q=30 1200w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fe14b8f88d4d2be1b422a9f2ad4561e6c6185d75d-2880x1614.png%2FElie%2520Bahou%2520IVBM%2520image.png%3Ffit%3Dcrop%26auto%3Dformat&w=1920&q=30 1920w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fe14b8f88d4d2be1b422a9f2ad4561e6c6185d75d-2880x1614.png%2FElie%2520Bahou%2520IVBM%2520image.png%3Ffit%3Dcrop%26auto%3Dformat&w=2048&q=30 2048w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fe14b8f88d4d2be1b422a9f2ad4561e6c6185d75d-2880x1614.png%2FElie%2520Bahou%2520IVBM%2520image.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=30 3840w" src="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fe14b8f88d4d2be1b422a9f2ad4561e6c6185d75d-2880x1614.png%2FElie%2520Bahou%2520IVBM%2520image.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=30" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:contain" loading="lazy"/></noscript></span></div><div class="w-full flex-wrap text-center text-sm mt-4 font-light no-underline text-gray-700"></div></a><a id="" class="w-[200px] h-fit space-y-3 flex-none select-none no-underline" style="scroll-snap-align:center;text-decoration:none" href="/view/the-top-5-biosimilar-articles-for-the-week-of-december-9"><div class="w-full shadow-md shadow-gray-800 overflow-hidden relative bg-white aspect-video"><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="" title="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:contain"/><noscript><img alt="" title="" sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fc9a4d82d9a880c76cb2e91c1ab4f33f4aff36f29-1920x1080.png%2FTop5.Thumbnail.12.9.png%3Ffit%3Dcrop%26auto%3Dformat&w=640&q=30 640w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fc9a4d82d9a880c76cb2e91c1ab4f33f4aff36f29-1920x1080.png%2FTop5.Thumbnail.12.9.png%3Ffit%3Dcrop%26auto%3Dformat&w=750&q=30 750w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fc9a4d82d9a880c76cb2e91c1ab4f33f4aff36f29-1920x1080.png%2FTop5.Thumbnail.12.9.png%3Ffit%3Dcrop%26auto%3Dformat&w=828&q=30 828w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fc9a4d82d9a880c76cb2e91c1ab4f33f4aff36f29-1920x1080.png%2FTop5.Thumbnail.12.9.png%3Ffit%3Dcrop%26auto%3Dformat&w=1080&q=30 1080w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fc9a4d82d9a880c76cb2e91c1ab4f33f4aff36f29-1920x1080.png%2FTop5.Thumbnail.12.9.png%3Ffit%3Dcrop%26auto%3Dformat&w=1200&q=30 1200w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fc9a4d82d9a880c76cb2e91c1ab4f33f4aff36f29-1920x1080.png%2FTop5.Thumbnail.12.9.png%3Ffit%3Dcrop%26auto%3Dformat&w=1920&q=30 1920w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fc9a4d82d9a880c76cb2e91c1ab4f33f4aff36f29-1920x1080.png%2FTop5.Thumbnail.12.9.png%3Ffit%3Dcrop%26auto%3Dformat&w=2048&q=30 2048w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fc9a4d82d9a880c76cb2e91c1ab4f33f4aff36f29-1920x1080.png%2FTop5.Thumbnail.12.9.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=30 3840w" src="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fc9a4d82d9a880c76cb2e91c1ab4f33f4aff36f29-1920x1080.png%2FTop5.Thumbnail.12.9.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=30" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:contain" loading="lazy"/></noscript></span></div><div class="w-full flex-wrap text-center text-sm mt-4 font-light no-underline text-gray-700"></div></a></div></div><div class="my-6"><div class="relative w-full h-full max-w-[984px] rounded-md mx-auto"><div class="flex flex-col-reverse lg:flex-row items-center justify-center mx-auto rounded-md"><div class="w-full lg:w-[610px] xl:w-3/4 h-[280px] xs:h-[260px] sm:h-[250px] lg:h-[243px] xl:h-[311px] pb-[90px] pt-2 sm:pt-4 lg:pt-3 xl:pt-4 pl-3 xs:pl-4 sm:pl-6 pr-3 rounded-tl-none lg:rounded-tl-md rounded-bl-md rounded-br-md lg:rounded-br-none" style="background:var(--primary)"><h2 class="text-md sm:text-lg xl:text-xl leading-tight lg:leading-none xl:sleading-tight text-white font-bold font-lora my-2">Register for IGBA's Global Biosimilars Week LIVE Webinar!</h2><p class=" font-light font-rubik text-white text-xs xl:text-sm"></p><div style="color:var(--primary)"><a class="font-bold font-rubik text-xs flex items-center gap-2 mt-2.5 xs:mt-4 lg:mt-2.5 xl:mt-3.5 py-2 px-3 cursor-pointer max-w-fit bg-white hover:bg-gray-300 rounded-md" href="https://globalmeet.webcasts.com/starthere.jsp?ei=1638244&tp_key=c6a2ad3d2d">Visit Now</a></div></div><div class="w-full max-h-[385px] lg:max-h-[243px] xl:max-h-[311px] overflow-hidden flex justify-center items-center rounded-br-none rounded-tr-md rounded-tl-md lg:rounded-r-md lg:rounded-tl-none pointer-events-none"><span style="box-sizing:border-box;display:inline-block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:relative;max-width:100%"><span style="box-sizing:border-box;display:block;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;max-width:100%"><img style="display:block;max-width:100%;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0" alt="" aria-hidden="true" src="data:image/svg+xml,%3csvg%20xmlns=%27http://www.w3.org/2000/svg%27%20version=%271.1%27%20width=%27959%27%20height=%27539.5%27/%3e"/></span><img alt="Register for IGBA's Global Biosimilars Week LIVE Webinar!" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="intrinsic" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/><noscript><img alt="Register for IGBA's Global Biosimilars Week LIVE Webinar!" srcSet="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F77889d8ba2155bfc61aad147e5ba3b38c8b536a4-1600x900.png&w=1080&q=75 1x, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F77889d8ba2155bfc61aad147e5ba3b38c8b536a4-1600x900.png&w=1920&q=75 2x" src="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F77889d8ba2155bfc61aad147e5ba3b38c8b536a4-1600x900.png&w=1920&q=75" decoding="async" data-nimg="intrinsic" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" loading="lazy"/></noscript></span></div></div><div class="absolute bottom-0 left-0 flex justify-between lg:justify-start gap-2 w-full lg:w-[22rem] xl:w-[27rem] px-3 xs:px-4 sm:px-6 pb-3 xs:pb-6 lg:pb-3 xl:pb-6"><button class="w-8 h-8 rounded-2xl flex items-center justify-center"><svg fill="none" height="32" viewBox="0 0 24 24" width="32" xmlns="http://www.w3.org/2000/svg"><g stroke="#fff" stroke-width="2"><circle cx="12" cy="12" r="10"></circle><path d="m13.5 8-4 4 4 4" stroke-linecap="round" stroke-linejoin="round"></path></g></svg></button><div class="flex items-center justify-around w-full gap-[3px]"><button class="flex-1 h-[3px] rounded-full bg-white"></button><button class="flex-1 h-[3px] rounded-full bg-white bg-opacity-40"></button><button class="flex-1 h-[3px] rounded-full bg-white bg-opacity-40"></button><button class="flex-1 h-[3px] rounded-full bg-white bg-opacity-40"></button><button class="flex-1 h-[3px] rounded-full bg-white bg-opacity-40"></button></div><button class="w-8 h-8 rounded-2xl flex items-center justify-center"><svg fill="none" height="32" viewBox="0 0 24 24" width="32" xmlns="http://www.w3.org/2000/svg"><g stroke="#fff" stroke-width="2"><circle cx="12" cy="12" r="10"></circle><path d="m10.5 8 4 4-4 4" stroke-linecap="round" stroke-linejoin="round"></path></g></svg></button></div></div></div><div class="jsx-19ede9f0a5a45918 py-4 relative px-0"><div class="jsx-19ede9f0a5a45918 "><div class="flex justify-between items-center py-1 space-x-4 border-0 select-none sm:border-b border-secondary"><div class="text-primary text-3xl">Continuing Medical Education</div></div></div><div style="scroll-snap-type:none" class="jsx-19ede9f0a5a45918 flex items-start overflow-x-auto space-x-4 py-4 relative mx-auto w-full md:w-[calc(100%-64px)]"><a target="_blank" style="scroll-snap-align:center;text-decoration:none" class="jsx-276744038 w-[250px] h-[350px] flex flex-col space-y-3 flex-none select-none no-underline" href="https://www.pharmacytimes.org/courses/navigating-the-advances-in-the-treatment-of-geographic-atrophy-updates-and-strategies-for-managed-care?utm_source=centerforbiosimilars&utm_medium=homePage&utm_campaign=cmeDeck"><div class="jsx-276744038 w-full h-full flex flex-col rounded-b-[10px] rounded-t-[15px] overflow-hidden relative bg-white shadow-[0_3px_7px_0px_#37393d]"><div class="jsx-276744038 relative rounded-t-[15px]"><span style="box-sizing:border-box;display:inline-block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:relative;max-width:100%"><span style="box-sizing:border-box;display:block;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;max-width:100%"><img style="display:block;max-width:100%;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0" alt="" aria-hidden="true" src="data:image/svg+xml,%3csvg%20xmlns=%27http://www.w3.org/2000/svg%27%20version=%271.1%27%20width=%27250%27%20height=%27125%27/%3e"/></span><img alt="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="intrinsic" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:fill"/><noscript><img alt="" srcSet="/_next/image?url=https%3A%2F%2Fd36ai2hkxl16us.cloudfront.net%2Fthoughtindustries%2Fimage%2Fupload%2Fv1%2Fcourse-uploads%2Fd2afb412-3c3e-4f73-b3d6-2388078622a3%2Fgvw8bdhuzy42-PTCE_GA_Enduring_AJMC-Supplement_050924v1_800x385.png&w=256&q=75 1x, /_next/image?url=https%3A%2F%2Fd36ai2hkxl16us.cloudfront.net%2Fthoughtindustries%2Fimage%2Fupload%2Fv1%2Fcourse-uploads%2Fd2afb412-3c3e-4f73-b3d6-2388078622a3%2Fgvw8bdhuzy42-PTCE_GA_Enduring_AJMC-Supplement_050924v1_800x385.png&w=640&q=75 2x" src="/_next/image?url=https%3A%2F%2Fd36ai2hkxl16us.cloudfront.net%2Fthoughtindustries%2Fimage%2Fupload%2Fv1%2Fcourse-uploads%2Fd2afb412-3c3e-4f73-b3d6-2388078622a3%2Fgvw8bdhuzy42-PTCE_GA_Enduring_AJMC-Supplement_050924v1_800x385.png&w=640&q=75" decoding="async" data-nimg="intrinsic" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:fill" loading="lazy"/></noscript></span></div><div class="jsx-276744038 bottomDiv"></div><div class="jsx-276744038 border-div"></div><div class="jsx-276744038 pill"></div><noscript class="jsx-276744038">AJMC Supplement</noscript><noscript class="jsx-276744038">On-Demand</noscript><div class="jsx-276744038 content-wrap"><div class="jsx-276744038 w-full h-fit mb-4"><p class="jsx-276744038 text-xs px-4 text-center text-[#39485F] font-bold">Navigating the Advances in the Treatment of Geographic Atrophy: Updates and Strategies for Managed Care</p></div><p class="jsx-276744038 text-center text-xs font-semibold px-4">2.0 Credits / Ophthalmology/Optometry</p></div><div class="jsx-276744038 view-more-wrap01165eb6b-e5ea-405c-a68b-f614a03b306e"><div class="jsx-276744038 flex justify-center w-[50%]"><p id="viewMoreText01165eb6b-e5ea-405c-a68b-f614a03b306e" class="jsx-276744038 text-sm text-[#ffffff]">View More</p></div><div id="viewMore01165eb6b-e5ea-405c-a68b-f614a03b306e" class="jsx-276744038 flex w-[15%] h-full justify-center items-center bg-secondary z-[9999]"><div class="jsx-276744038"><svg stroke="currentColor" fill="currentColor" stroke-width="0" viewBox="0 0 16 16" style="color:var(--primary);width:100%;height:100%" height="1em" width="1em" xmlns="http://www.w3.org/2000/svg"><path fill-rule="evenodd" d="M1 8a.5.5 0 0 1 .5-.5h11.793l-3.147-3.146a.5.5 0 0 1 .708-.708l4 4a.5.5 0 0 1 0 .708l-4 4a.5.5 0 0 1-.708-.708L13.293 8.5H1.5A.5.5 0 0 1 1 8z"></path></svg></div></div></div></div><div class="jsx-276744038 button"></div></a><a target="_blank" style="scroll-snap-align:center;text-decoration:none" class="jsx-726976786 w-[250px] h-[350px] flex flex-col space-y-3 flex-none select-none no-underline" href="https://www.pharmacytimes.org/courses/amcp-annual?utm_source=centerforbiosimilars&utm_medium=homePage&utm_campaign=cmeDeck"><div class="jsx-726976786 w-full h-full flex flex-col rounded-b-[10px] rounded-t-[15px] overflow-hidden relative bg-white shadow-[0_3px_7px_0px_#37393d]"><div class="jsx-726976786 relative rounded-t-[15px]"><span style="box-sizing:border-box;display:inline-block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:relative;max-width:100%"><span style="box-sizing:border-box;display:block;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;max-width:100%"><img style="display:block;max-width:100%;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0" alt="" aria-hidden="true" src="data:image/svg+xml,%3csvg%20xmlns=%27http://www.w3.org/2000/svg%27%20version=%271.1%27%20width=%27250%27%20height=%27125%27/%3e"/></span><img alt="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="intrinsic" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:fill"/><noscript><img alt="" srcSet="/_next/image?url=https%3A%2F%2Fd36ai2hkxl16us.cloudfront.net%2Fthoughtindustries%2Fimage%2Fupload%2Fv1%2Fcourse-uploads%2Fd2afb412-3c3e-4f73-b3d6-2388078622a3%2Fokzqrmcs4s10-PTCE_AMCP-2025_General-Banners_022425v1_800x385.png&w=256&q=75 1x, /_next/image?url=https%3A%2F%2Fd36ai2hkxl16us.cloudfront.net%2Fthoughtindustries%2Fimage%2Fupload%2Fv1%2Fcourse-uploads%2Fd2afb412-3c3e-4f73-b3d6-2388078622a3%2Fokzqrmcs4s10-PTCE_AMCP-2025_General-Banners_022425v1_800x385.png&w=640&q=75 2x" src="/_next/image?url=https%3A%2F%2Fd36ai2hkxl16us.cloudfront.net%2Fthoughtindustries%2Fimage%2Fupload%2Fv1%2Fcourse-uploads%2Fd2afb412-3c3e-4f73-b3d6-2388078622a3%2Fokzqrmcs4s10-PTCE_AMCP-2025_General-Banners_022425v1_800x385.png&w=640&q=75" decoding="async" data-nimg="intrinsic" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:fill" loading="lazy"/></noscript></span></div><div class="jsx-726976786 bottomDiv"></div><div class="jsx-726976786 border-div"></div><div class="jsx-726976786 pill"></div><noscript class="jsx-726976786">Live Event</noscript><noscript class="jsx-726976786">Live</noscript><div class="jsx-726976786 content-wrap"><div class="jsx-726976786 w-full h-fit mb-4"><p class="jsx-726976786 text-xs px-4 text-center text-[#39485F] font-bold">AMCP Annual 2025</p></div><p class="jsx-726976786 text-center text-xs font-semibold px-4">March 31, 2025 - April 3, 2025</p></div><div class="jsx-726976786 view-more-wrap1d6c81f31-e9ec-4815-833b-818bf5602646"><div class="jsx-726976786 flex justify-center w-[50%]"><p id="viewMoreText1d6c81f31-e9ec-4815-833b-818bf5602646" class="jsx-726976786 text-sm text-[#ffffff]">View More</p></div><div id="viewMore1d6c81f31-e9ec-4815-833b-818bf5602646" class="jsx-726976786 flex w-[15%] h-full justify-center items-center bg-secondary z-[9999]"><div class="jsx-726976786"><svg stroke="currentColor" fill="currentColor" stroke-width="0" viewBox="0 0 16 16" style="color:var(--primary);width:100%;height:100%" height="1em" width="1em" xmlns="http://www.w3.org/2000/svg"><path fill-rule="evenodd" d="M1 8a.5.5 0 0 1 .5-.5h11.793l-3.147-3.146a.5.5 0 0 1 .708-.708l4 4a.5.5 0 0 1 0 .708l-4 4a.5.5 0 0 1-.708-.708L13.293 8.5H1.5A.5.5 0 0 1 1 8z"></path></svg></div></div></div></div><div class="jsx-726976786 button"></div></a><a target="_blank" style="scroll-snap-align:center;text-decoration:none" class="jsx-4247410062 w-[250px] h-[350px] flex flex-col space-y-3 flex-none select-none no-underline" href="https://www.pharmacytimes.org/courses/novel-therapies-and-emerging-strategies-for-hrher2-metastatic-breast-cancer-and-the-impact-on-patient-outcomes-un97?utm_source=centerforbiosimilars&utm_medium=homePage&utm_campaign=cmeDeck"><div class="jsx-4247410062 w-full h-full flex flex-col rounded-b-[10px] rounded-t-[15px] overflow-hidden relative bg-white shadow-[0_3px_7px_0px_#37393d]"><div class="jsx-4247410062 relative rounded-t-[15px]"><span style="box-sizing:border-box;display:inline-block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:relative;max-width:100%"><span style="box-sizing:border-box;display:block;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;max-width:100%"><img style="display:block;max-width:100%;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0" alt="" aria-hidden="true" src="data:image/svg+xml,%3csvg%20xmlns=%27http://www.w3.org/2000/svg%27%20version=%271.1%27%20width=%27250%27%20height=%27125%27/%3e"/></span><img alt="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="intrinsic" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:fill"/><noscript><img alt="" srcSet="/_next/image?url=https%3A%2F%2Fd36ai2hkxl16us.cloudfront.net%2Fthoughtindustries%2Fimage%2Fupload%2Fv1%2Fcourse-uploads%2Fd2afb412-3c3e-4f73-b3d6-2388078622a3%2Fs5c623upsbyd-PTCE_AMCP-2024_HR_Enduring_043024v2_800x385.png&w=256&q=75 1x, /_next/image?url=https%3A%2F%2Fd36ai2hkxl16us.cloudfront.net%2Fthoughtindustries%2Fimage%2Fupload%2Fv1%2Fcourse-uploads%2Fd2afb412-3c3e-4f73-b3d6-2388078622a3%2Fs5c623upsbyd-PTCE_AMCP-2024_HR_Enduring_043024v2_800x385.png&w=640&q=75 2x" src="/_next/image?url=https%3A%2F%2Fd36ai2hkxl16us.cloudfront.net%2Fthoughtindustries%2Fimage%2Fupload%2Fv1%2Fcourse-uploads%2Fd2afb412-3c3e-4f73-b3d6-2388078622a3%2Fs5c623upsbyd-PTCE_AMCP-2024_HR_Enduring_043024v2_800x385.png&w=640&q=75" decoding="async" data-nimg="intrinsic" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:fill" loading="lazy"/></noscript></span></div><div class="jsx-4247410062 bottomDiv"></div><div class="jsx-4247410062 border-div"></div><div class="jsx-4247410062 pill"></div><noscript class="jsx-4247410062">On-Demand Virtual Symposium</noscript><noscript class="jsx-4247410062">On-Demand</noscript><div class="jsx-4247410062 content-wrap"><div class="jsx-4247410062 w-full h-fit mb-4"><p class="jsx-4247410062 text-xs px-4 text-center text-[#39485F] font-bold">Novel Therapies and Emerging Strategies for HR+/HER2- Metastatic Breast Cancer and the Impact on Patient Outco...</p></div><p class="jsx-4247410062 text-center text-xs font-semibold px-4">1.5 Credits / Oncology, Breast Cancer</p></div><div class="jsx-4247410062 view-more-wrap200a8213b-95a7-4fc6-9391-1307b6b90ab1"><div class="jsx-4247410062 flex justify-center w-[50%]"><p id="viewMoreText200a8213b-95a7-4fc6-9391-1307b6b90ab1" class="jsx-4247410062 text-sm text-[#ffffff]">View More</p></div><div id="viewMore200a8213b-95a7-4fc6-9391-1307b6b90ab1" class="jsx-4247410062 flex w-[15%] h-full justify-center items-center bg-secondary z-[9999]"><div class="jsx-4247410062"><svg stroke="currentColor" fill="currentColor" stroke-width="0" viewBox="0 0 16 16" style="color:var(--primary);width:100%;height:100%" height="1em" width="1em" xmlns="http://www.w3.org/2000/svg"><path fill-rule="evenodd" d="M1 8a.5.5 0 0 1 .5-.5h11.793l-3.147-3.146a.5.5 0 0 1 .708-.708l4 4a.5.5 0 0 1 0 .708l-4 4a.5.5 0 0 1-.708-.708L13.293 8.5H1.5A.5.5 0 0 1 1 8z"></path></svg></div></div></div></div><div class="jsx-4247410062 button"></div></a><a target="_blank" style="scroll-snap-align:center;text-decoration:none" class="jsx-985042568 w-[250px] h-[350px] flex flex-col space-y-3 flex-none select-none no-underline" href="https://www.pharmacytimes.org/courses/addressing-the-gaps-and-clinical-challenges-in-chronic-lymphocytic-leukemia-updates-and-strategies-for-managed-care-dxq5?utm_source=centerforbiosimilars&utm_medium=homePage&utm_campaign=cmeDeck"><div class="jsx-985042568 w-full h-full flex flex-col rounded-b-[10px] rounded-t-[15px] overflow-hidden relative bg-white shadow-[0_3px_7px_0px_#37393d]"><div class="jsx-985042568 relative rounded-t-[15px]"><span style="box-sizing:border-box;display:inline-block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:relative;max-width:100%"><span style="box-sizing:border-box;display:block;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;max-width:100%"><img style="display:block;max-width:100%;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0" alt="" aria-hidden="true" src="data:image/svg+xml,%3csvg%20xmlns=%27http://www.w3.org/2000/svg%27%20version=%271.1%27%20width=%27250%27%20height=%27125%27/%3e"/></span><img alt="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="intrinsic" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:fill"/><noscript><img alt="" srcSet="/_next/image?url=https%3A%2F%2Fd36ai2hkxl16us.cloudfront.net%2Fthoughtindustries%2Fimage%2Fupload%2Fv1%2Fcourse-uploads%2Fd2afb412-3c3e-4f73-b3d6-2388078622a3%2F22wqid3lilcb-PTCE_AMCP-2024_CLL_Enduring_043024v2_800x385.png&w=256&q=75 1x, /_next/image?url=https%3A%2F%2Fd36ai2hkxl16us.cloudfront.net%2Fthoughtindustries%2Fimage%2Fupload%2Fv1%2Fcourse-uploads%2Fd2afb412-3c3e-4f73-b3d6-2388078622a3%2F22wqid3lilcb-PTCE_AMCP-2024_CLL_Enduring_043024v2_800x385.png&w=640&q=75 2x" src="/_next/image?url=https%3A%2F%2Fd36ai2hkxl16us.cloudfront.net%2Fthoughtindustries%2Fimage%2Fupload%2Fv1%2Fcourse-uploads%2Fd2afb412-3c3e-4f73-b3d6-2388078622a3%2F22wqid3lilcb-PTCE_AMCP-2024_CLL_Enduring_043024v2_800x385.png&w=640&q=75" decoding="async" data-nimg="intrinsic" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:fill" loading="lazy"/></noscript></span></div><div class="jsx-985042568 bottomDiv"></div><div class="jsx-985042568 border-div"></div><div class="jsx-985042568 pill"></div><noscript class="jsx-985042568">On-Demand Virtual Symposium</noscript><noscript class="jsx-985042568">On-Demand</noscript><div class="jsx-985042568 content-wrap"><div class="jsx-985042568 w-full h-fit mb-4"><p class="jsx-985042568 text-xs px-4 text-center text-[#39485F] font-bold">Addressing the Gaps and Clinical Challenges in Chronic Lymphocytic Leukemia: Updates and Strategies for Manage...</p></div><p class="jsx-985042568 text-center text-xs font-semibold px-4">1.5 Credits / Hematology, Hematologic Cancer, Oncology</p></div><div class="jsx-985042568 view-more-wrap35f2f9f0c-ffe1-4536-a7f0-60e033a46312"><div class="jsx-985042568 flex justify-center w-[50%]"><p id="viewMoreText35f2f9f0c-ffe1-4536-a7f0-60e033a46312" class="jsx-985042568 text-sm text-[#ffffff]">View More</p></div><div id="viewMore35f2f9f0c-ffe1-4536-a7f0-60e033a46312" class="jsx-985042568 flex w-[15%] h-full justify-center items-center bg-secondary z-[9999]"><div class="jsx-985042568"><svg stroke="currentColor" fill="currentColor" stroke-width="0" viewBox="0 0 16 16" style="color:var(--primary);width:100%;height:100%" height="1em" width="1em" xmlns="http://www.w3.org/2000/svg"><path fill-rule="evenodd" d="M1 8a.5.5 0 0 1 .5-.5h11.793l-3.147-3.146a.5.5 0 0 1 .708-.708l4 4a.5.5 0 0 1 0 .708l-4 4a.5.5 0 0 1-.708-.708L13.293 8.5H1.5A.5.5 0 0 1 1 8z"></path></svg></div></div></div></div><div class="jsx-985042568 button"></div></a><a target="_blank" style="scroll-snap-align:center;text-decoration:none" class="jsx-2548275183 w-[250px] h-[350px] flex flex-col space-y-3 flex-none select-none no-underline" href="https://www.pharmacytimes.org/courses/keeping-pace-with-new-developments-in-multiple-myeloma-updates-and-strategies-to-optimize-bispecific-antibodies-and-car-t-cell-therapy-tcdv?utm_source=centerforbiosimilars&utm_medium=homePage&utm_campaign=cmeDeck"><div class="jsx-2548275183 w-full h-full flex flex-col rounded-b-[10px] rounded-t-[15px] overflow-hidden relative bg-white shadow-[0_3px_7px_0px_#37393d]"><div class="jsx-2548275183 relative rounded-t-[15px]"><span style="box-sizing:border-box;display:inline-block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:relative;max-width:100%"><span style="box-sizing:border-box;display:block;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;max-width:100%"><img style="display:block;max-width:100%;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0" alt="" aria-hidden="true" src="data:image/svg+xml,%3csvg%20xmlns=%27http://www.w3.org/2000/svg%27%20version=%271.1%27%20width=%27250%27%20height=%27125%27/%3e"/></span><img alt="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="intrinsic" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:fill"/><noscript><img alt="" srcSet="/_next/image?url=https%3A%2F%2Fd36ai2hkxl16us.cloudfront.net%2Fthoughtindustries%2Fimage%2Fupload%2Fv1%2Fcourse-uploads%2Fd2afb412-3c3e-4f73-b3d6-2388078622a3%2Fhvzihm9lmt65-PTCE_AMCP-2024_MM_Enduring_043024v1_800x385.png&w=256&q=75 1x, /_next/image?url=https%3A%2F%2Fd36ai2hkxl16us.cloudfront.net%2Fthoughtindustries%2Fimage%2Fupload%2Fv1%2Fcourse-uploads%2Fd2afb412-3c3e-4f73-b3d6-2388078622a3%2Fhvzihm9lmt65-PTCE_AMCP-2024_MM_Enduring_043024v1_800x385.png&w=640&q=75 2x" src="/_next/image?url=https%3A%2F%2Fd36ai2hkxl16us.cloudfront.net%2Fthoughtindustries%2Fimage%2Fupload%2Fv1%2Fcourse-uploads%2Fd2afb412-3c3e-4f73-b3d6-2388078622a3%2Fhvzihm9lmt65-PTCE_AMCP-2024_MM_Enduring_043024v1_800x385.png&w=640&q=75" decoding="async" data-nimg="intrinsic" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:fill" loading="lazy"/></noscript></span></div><div class="jsx-2548275183 bottomDiv"></div><div class="jsx-2548275183 border-div"></div><div class="jsx-2548275183 pill"></div><noscript class="jsx-2548275183">On-Demand Virtual Symposium</noscript><noscript class="jsx-2548275183">On-Demand</noscript><div class="jsx-2548275183 content-wrap"><div class="jsx-2548275183 w-full h-fit mb-4"><p class="jsx-2548275183 text-xs px-4 text-center text-[#39485F] font-bold">Keeping Pace With New Developments in Multiple Myeloma: Updates and Strategies to Optimize Bispecific Antibodi...</p></div><p class="jsx-2548275183 text-center text-xs font-semibold px-4">1.5 Credits / Oncology, Hematology, Hematologic Cancer</p></div><div class="jsx-2548275183 view-more-wrap4b3692513-63e3-4143-be46-fedbcb8387a5"><div class="jsx-2548275183 flex justify-center w-[50%]"><p id="viewMoreText4b3692513-63e3-4143-be46-fedbcb8387a5" class="jsx-2548275183 text-sm text-[#ffffff]">View More</p></div><div id="viewMore4b3692513-63e3-4143-be46-fedbcb8387a5" class="jsx-2548275183 flex w-[15%] h-full justify-center items-center bg-secondary z-[9999]"><div class="jsx-2548275183"><svg stroke="currentColor" fill="currentColor" stroke-width="0" viewBox="0 0 16 16" style="color:var(--primary);width:100%;height:100%" height="1em" width="1em" xmlns="http://www.w3.org/2000/svg"><path fill-rule="evenodd" d="M1 8a.5.5 0 0 1 .5-.5h11.793l-3.147-3.146a.5.5 0 0 1 .708-.708l4 4a.5.5 0 0 1 0 .708l-4 4a.5.5 0 0 1-.708-.708L13.293 8.5H1.5A.5.5 0 0 1 1 8z"></path></svg></div></div></div></div><div class="jsx-2548275183 button"></div></a><a target="_blank" style="scroll-snap-align:center;text-decoration:none" class="jsx-3728211798 w-[250px] h-[350px] flex flex-col space-y-3 flex-none select-none no-underline" href="https://www.pharmacytimes.org/courses/application-of-recent-data-in-neovascular-age-related-macular-degeneration-and-diabetic-macular-edema-managed-care-insights-and-strategies-z4ru?utm_source=centerforbiosimilars&utm_medium=homePage&utm_campaign=cmeDeck"><div class="jsx-3728211798 w-full h-full flex flex-col rounded-b-[10px] rounded-t-[15px] overflow-hidden relative bg-white shadow-[0_3px_7px_0px_#37393d]"><div class="jsx-3728211798 relative rounded-t-[15px]"><span style="box-sizing:border-box;display:inline-block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:relative;max-width:100%"><span style="box-sizing:border-box;display:block;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;max-width:100%"><img style="display:block;max-width:100%;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0" alt="" aria-hidden="true" src="data:image/svg+xml,%3csvg%20xmlns=%27http://www.w3.org/2000/svg%27%20version=%271.1%27%20width=%27250%27%20height=%27125%27/%3e"/></span><img alt="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="intrinsic" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:fill"/><noscript><img alt="" srcSet="/_next/image?url=https%3A%2F%2Fd36ai2hkxl16us.cloudfront.net%2Fthoughtindustries%2Fimage%2Fupload%2Fv1%2Fcourse-uploads%2Fd2afb412-3c3e-4f73-b3d6-2388078622a3%2F9k0f7jlluuzn-PTCE_AMCP-2024_AMD-DME_Enduring_043024v1_800x385.png&w=256&q=75 1x, /_next/image?url=https%3A%2F%2Fd36ai2hkxl16us.cloudfront.net%2Fthoughtindustries%2Fimage%2Fupload%2Fv1%2Fcourse-uploads%2Fd2afb412-3c3e-4f73-b3d6-2388078622a3%2F9k0f7jlluuzn-PTCE_AMCP-2024_AMD-DME_Enduring_043024v1_800x385.png&w=640&q=75 2x" src="/_next/image?url=https%3A%2F%2Fd36ai2hkxl16us.cloudfront.net%2Fthoughtindustries%2Fimage%2Fupload%2Fv1%2Fcourse-uploads%2Fd2afb412-3c3e-4f73-b3d6-2388078622a3%2F9k0f7jlluuzn-PTCE_AMCP-2024_AMD-DME_Enduring_043024v1_800x385.png&w=640&q=75" decoding="async" data-nimg="intrinsic" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:fill" loading="lazy"/></noscript></span></div><div class="jsx-3728211798 bottomDiv"></div><div class="jsx-3728211798 border-div"></div><div class="jsx-3728211798 pill"></div><noscript class="jsx-3728211798">On-Demand Virtual Symposium</noscript><noscript class="jsx-3728211798">On-Demand</noscript><div class="jsx-3728211798 content-wrap"><div class="jsx-3728211798 w-full h-fit mb-4"><p class="jsx-3728211798 text-xs px-4 text-center text-[#39485F] font-bold">Application of Recent Data in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: Managed...</p></div><p class="jsx-3728211798 text-center text-xs font-semibold px-4">1.5 Credits / Ophthalmology, Optometry</p></div><div class="jsx-3728211798 view-more-wrap51de83d65-461b-4a03-bfc2-3c44b1f983c9"><div class="jsx-3728211798 flex justify-center w-[50%]"><p id="viewMoreText51de83d65-461b-4a03-bfc2-3c44b1f983c9" class="jsx-3728211798 text-sm text-[#ffffff]">View More</p></div><div id="viewMore51de83d65-461b-4a03-bfc2-3c44b1f983c9" class="jsx-3728211798 flex w-[15%] h-full justify-center items-center bg-secondary z-[9999]"><div class="jsx-3728211798"><svg stroke="currentColor" fill="currentColor" stroke-width="0" viewBox="0 0 16 16" style="color:var(--primary);width:100%;height:100%" height="1em" width="1em" xmlns="http://www.w3.org/2000/svg"><path fill-rule="evenodd" d="M1 8a.5.5 0 0 1 .5-.5h11.793l-3.147-3.146a.5.5 0 0 1 .708-.708l4 4a.5.5 0 0 1 0 .708l-4 4a.5.5 0 0 1-.708-.708L13.293 8.5H1.5A.5.5 0 0 1 1 8z"></path></svg></div></div></div></div><div class="jsx-3728211798 button"></div></a><a target="_blank" style="scroll-snap-align:center;text-decoration:none" class="jsx-2374338299 w-[250px] h-[350px] flex flex-col space-y-3 flex-none select-none no-underline" href="https://www.pharmacytimes.org/courses/emerging-concepts-and-approaches-in-the-treatment-of-food-allergy-what-managed-care-professionals-need-to-know-ky75?utm_source=centerforbiosimilars&utm_medium=homePage&utm_campaign=cmeDeck"><div class="jsx-2374338299 w-full h-full flex flex-col rounded-b-[10px] rounded-t-[15px] overflow-hidden relative bg-white shadow-[0_3px_7px_0px_#37393d]"><div class="jsx-2374338299 relative rounded-t-[15px]"><span style="box-sizing:border-box;display:inline-block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:relative;max-width:100%"><span style="box-sizing:border-box;display:block;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;max-width:100%"><img style="display:block;max-width:100%;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0" alt="" aria-hidden="true" src="data:image/svg+xml,%3csvg%20xmlns=%27http://www.w3.org/2000/svg%27%20version=%271.1%27%20width=%27250%27%20height=%27125%27/%3e"/></span><img alt="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="intrinsic" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:fill"/><noscript><img alt="" srcSet="/_next/image?url=https%3A%2F%2Fd36ai2hkxl16us.cloudfront.net%2Fthoughtindustries%2Fimage%2Fupload%2Fv1%2Fcourse-uploads%2Fd2afb412-3c3e-4f73-b3d6-2388078622a3%2Ffzp3g3z7u7z1-PTCE_AMCP-2024_Food-Allergy_Enduring_043024v1_800x385.png&w=256&q=75 1x, /_next/image?url=https%3A%2F%2Fd36ai2hkxl16us.cloudfront.net%2Fthoughtindustries%2Fimage%2Fupload%2Fv1%2Fcourse-uploads%2Fd2afb412-3c3e-4f73-b3d6-2388078622a3%2Ffzp3g3z7u7z1-PTCE_AMCP-2024_Food-Allergy_Enduring_043024v1_800x385.png&w=640&q=75 2x" src="/_next/image?url=https%3A%2F%2Fd36ai2hkxl16us.cloudfront.net%2Fthoughtindustries%2Fimage%2Fupload%2Fv1%2Fcourse-uploads%2Fd2afb412-3c3e-4f73-b3d6-2388078622a3%2Ffzp3g3z7u7z1-PTCE_AMCP-2024_Food-Allergy_Enduring_043024v1_800x385.png&w=640&q=75" decoding="async" data-nimg="intrinsic" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:fill" loading="lazy"/></noscript></span></div><div class="jsx-2374338299 bottomDiv"></div><div class="jsx-2374338299 border-div"></div><div class="jsx-2374338299 pill"></div><noscript class="jsx-2374338299">On-Demand Virtual Symposium</noscript><noscript class="jsx-2374338299">On-Demand</noscript><div class="jsx-2374338299 content-wrap"><div class="jsx-2374338299 w-full h-fit mb-4"><p class="jsx-2374338299 text-xs px-4 text-center text-[#39485F] font-bold">Emerging Concepts and Approaches in the Treatment of Food Allergy: What Managed Care Professionals Need to Kno...</p></div><p class="jsx-2374338299 text-center text-xs font-semibold px-4">1.5 Credits / Immunology, Allergy</p></div><div class="jsx-2374338299 view-more-wrap6fe815760-37e8-45aa-9a66-be0aae5f9319"><div class="jsx-2374338299 flex justify-center w-[50%]"><p id="viewMoreText6fe815760-37e8-45aa-9a66-be0aae5f9319" class="jsx-2374338299 text-sm text-[#ffffff]">View More</p></div><div id="viewMore6fe815760-37e8-45aa-9a66-be0aae5f9319" class="jsx-2374338299 flex w-[15%] h-full justify-center items-center bg-secondary z-[9999]"><div class="jsx-2374338299"><svg stroke="currentColor" fill="currentColor" stroke-width="0" viewBox="0 0 16 16" style="color:var(--primary);width:100%;height:100%" height="1em" width="1em" xmlns="http://www.w3.org/2000/svg"><path fill-rule="evenodd" d="M1 8a.5.5 0 0 1 .5-.5h11.793l-3.147-3.146a.5.5 0 0 1 .708-.708l4 4a.5.5 0 0 1 0 .708l-4 4a.5.5 0 0 1-.708-.708L13.293 8.5H1.5A.5.5 0 0 1 1 8z"></path></svg></div></div></div></div><div class="jsx-2374338299 button"></div></a><a target="_blank" style="scroll-snap-align:center;text-decoration:none" class="jsx-651135293 w-[250px] h-[350px] flex flex-col space-y-3 flex-none select-none no-underline" href="https://www.pharmacytimes.org/courses/novel-agents-as-proactive-approaches-to-addressing-food-allergy-the-role-of-the-pharmacist-in-guiding-optimal-treatment-w7re?utm_source=centerforbiosimilars&utm_medium=homePage&utm_campaign=cmeDeck"><div class="jsx-651135293 w-full h-full flex flex-col rounded-b-[10px] rounded-t-[15px] overflow-hidden relative bg-white shadow-[0_3px_7px_0px_#37393d]"><div class="jsx-651135293 relative rounded-t-[15px]"><span style="box-sizing:border-box;display:inline-block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:relative;max-width:100%"><span style="box-sizing:border-box;display:block;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;max-width:100%"><img style="display:block;max-width:100%;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0" alt="" aria-hidden="true" src="data:image/svg+xml,%3csvg%20xmlns=%27http://www.w3.org/2000/svg%27%20version=%271.1%27%20width=%27250%27%20height=%27125%27/%3e"/></span><img alt="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="intrinsic" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:fill"/><noscript><img alt="" srcSet="/_next/image?url=https%3A%2F%2Fd36ai2hkxl16us.cloudfront.net%2Fthoughtindustries%2Fimage%2Fupload%2Fv1%2Fcourse-uploads%2Fd2afb412-3c3e-4f73-b3d6-2388078622a3%2F1pzr08zu6qre-PTCE_Asembia-2024_Food-Allergy_Enduring_051024v1_800x385.png&w=256&q=75 1x, /_next/image?url=https%3A%2F%2Fd36ai2hkxl16us.cloudfront.net%2Fthoughtindustries%2Fimage%2Fupload%2Fv1%2Fcourse-uploads%2Fd2afb412-3c3e-4f73-b3d6-2388078622a3%2F1pzr08zu6qre-PTCE_Asembia-2024_Food-Allergy_Enduring_051024v1_800x385.png&w=640&q=75 2x" src="/_next/image?url=https%3A%2F%2Fd36ai2hkxl16us.cloudfront.net%2Fthoughtindustries%2Fimage%2Fupload%2Fv1%2Fcourse-uploads%2Fd2afb412-3c3e-4f73-b3d6-2388078622a3%2F1pzr08zu6qre-PTCE_Asembia-2024_Food-Allergy_Enduring_051024v1_800x385.png&w=640&q=75" decoding="async" data-nimg="intrinsic" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:fill" loading="lazy"/></noscript></span></div><div class="jsx-651135293 bottomDiv"></div><div class="jsx-651135293 border-div"></div><div class="jsx-651135293 pill"></div><noscript class="jsx-651135293">On-Demand Virtual Symposium</noscript><noscript class="jsx-651135293">On-Demand</noscript><div class="jsx-651135293 content-wrap"><div class="jsx-651135293 w-full h-fit mb-4"><p class="jsx-651135293 text-xs px-4 text-center text-[#39485F] font-bold">Novel Agents as Proactive Approaches to Addressing Food Allergy: The Role of the Pharmacist in Guiding Optimal...</p></div><p class="jsx-651135293 text-center text-xs font-semibold px-4">1.5 Credits / Allergy</p></div><div class="jsx-651135293 view-more-wrap77cbe0326-0e0d-4b64-8868-95c41183767c"><div class="jsx-651135293 flex justify-center w-[50%]"><p id="viewMoreText77cbe0326-0e0d-4b64-8868-95c41183767c" class="jsx-651135293 text-sm text-[#ffffff]">View More</p></div><div id="viewMore77cbe0326-0e0d-4b64-8868-95c41183767c" class="jsx-651135293 flex w-[15%] h-full justify-center items-center bg-secondary z-[9999]"><div class="jsx-651135293"><svg stroke="currentColor" fill="currentColor" stroke-width="0" viewBox="0 0 16 16" style="color:var(--primary);width:100%;height:100%" height="1em" width="1em" xmlns="http://www.w3.org/2000/svg"><path fill-rule="evenodd" d="M1 8a.5.5 0 0 1 .5-.5h11.793l-3.147-3.146a.5.5 0 0 1 .708-.708l4 4a.5.5 0 0 1 0 .708l-4 4a.5.5 0 0 1-.708-.708L13.293 8.5H1.5A.5.5 0 0 1 1 8z"></path></svg></div></div></div></div><div class="jsx-651135293 button"></div></a></div></div><div class="m-2 pt-4"><h2 class="text-3xl">All News</h2><div class="w-full border border-primary"></div><div class="grid gap-2 md:gap-4 grid-cols-1"><div class="w-full h-full"><div class="flex mt-4"><a class="w-full mt-3 md:flex-none md:w-48" href="/view/biosimilar-natalizumab-sztn-shows-comparable-efficacy-and-safety-to-tysabri-in-rrms"><div class=""><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:relative"><span style="box-sizing:border-box;display:block;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;padding-top:66.67272727272727%"></span><img alt="Multiple Sclerosis. | Image Credit: Vitalii Vodolazskyi - stock.adobe.com " title="Multiple Sclerosis. | Image Credit: Vitalii Vodolazskyi - stock.adobe.com " src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="responsive" class="shrink-0" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/><noscript><img alt="Multiple Sclerosis. | Image Credit: Vitalii Vodolazskyi - stock.adobe.com " title="Multiple Sclerosis. | Image Credit: Vitalii Vodolazskyi - stock.adobe.com " sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fd0ab7e9d1f822e5110ccc662e47383e2a136403e-5500x3667.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=640&q=75 640w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fd0ab7e9d1f822e5110ccc662e47383e2a136403e-5500x3667.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=750&q=75 750w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fd0ab7e9d1f822e5110ccc662e47383e2a136403e-5500x3667.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=828&q=75 828w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fd0ab7e9d1f822e5110ccc662e47383e2a136403e-5500x3667.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=1080&q=75 1080w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fd0ab7e9d1f822e5110ccc662e47383e2a136403e-5500x3667.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=1200&q=75 1200w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fd0ab7e9d1f822e5110ccc662e47383e2a136403e-5500x3667.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=1920&q=75 1920w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fd0ab7e9d1f822e5110ccc662e47383e2a136403e-5500x3667.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=2048&q=75 2048w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fd0ab7e9d1f822e5110ccc662e47383e2a136403e-5500x3667.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75 3840w" src="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fd0ab7e9d1f822e5110ccc662e47383e2a136403e-5500x3667.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75" decoding="async" data-nimg="responsive" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" class="shrink-0" loading="lazy"/></noscript></span></div></a><div class="w-[200%] md:w-[auto] flex-auto p-2 ml-2"><p class="font-bold"><a class="" href="/view/biosimilar-natalizumab-sztn-shows-comparable-efficacy-and-safety-to-tysabri-in-rrms">Biosimilar Natalizumab-sztn Shows Comparable Efficacy and Safety to Tysabri in RRMS</a></p><div><span class="text-md "><span class="mr-1 italic">By </span><a class="mr-1 text-sky-800 hover:text-primary" href="/authors/cameron-santoro">Cameron Santoro</a></span></div><a href="/view/biosimilar-natalizumab-sztn-shows-comparable-efficacy-and-safety-to-tysabri-in-rrms"><span class="text-sm text-gray-500">March 25th 2025</span><div class="mt-2"></div><p class="mt-4 text-gray-800">Biosimilar natalizumab demonstrated comparable efficacy, safety, and immunogenicity to reference drug Tysabri in patients with relapsing-remitting multiple sclerosis (RRMS), supporting its potential as a cost-effective treatment option.</p></a><div class="flex mt-4"></div></div></div></div><div class="w-full h-full"><div class="flex mt-4"><a class="w-full mt-3 md:flex-none md:w-48" href="/view/biorationality-how-developers-can-expand-their-monoclonal-antibody-biosimilar-portfolio"><div class=""><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:relative"><span style="box-sizing:border-box;display:block;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;padding-top:66.64819944598338%"></span><img alt="vials | Image credit: pixardi - stock.adobe.com" title="vials | Image credit: pixardi - stock.adobe.com" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="responsive" class="shrink-0" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/><noscript><img alt="vials | Image credit: pixardi - stock.adobe.com" title="vials | Image credit: pixardi - stock.adobe.com" sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F037ba6e825d5bb15eddd755c1ca3177cc1969175-3610x2406.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=640&q=75 640w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F037ba6e825d5bb15eddd755c1ca3177cc1969175-3610x2406.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=750&q=75 750w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F037ba6e825d5bb15eddd755c1ca3177cc1969175-3610x2406.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=828&q=75 828w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F037ba6e825d5bb15eddd755c1ca3177cc1969175-3610x2406.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=1080&q=75 1080w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F037ba6e825d5bb15eddd755c1ca3177cc1969175-3610x2406.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=1200&q=75 1200w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F037ba6e825d5bb15eddd755c1ca3177cc1969175-3610x2406.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=1920&q=75 1920w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F037ba6e825d5bb15eddd755c1ca3177cc1969175-3610x2406.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=2048&q=75 2048w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F037ba6e825d5bb15eddd755c1ca3177cc1969175-3610x2406.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75 3840w" src="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F037ba6e825d5bb15eddd755c1ca3177cc1969175-3610x2406.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75" decoding="async" data-nimg="responsive" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" class="shrink-0" loading="lazy"/></noscript></span></div></a><div class="w-[200%] md:w-[auto] flex-auto p-2 ml-2"><p class="font-bold"><a class="" href="/view/biorationality-how-developers-can-expand-their-monoclonal-antibody-biosimilar-portfolio">BioRationality: How Developers Can Expand Their Monoclonal Antibody Biosimilar Portfolio</a></p><div><span class="text-md "><span class="mr-1 italic">By </span><a class="mr-1 text-sky-800 hover:text-primary" href="/authors/sarfaraz-k-niazi-phd">Sarfaraz K. Niazi, PhD</a></span></div><a href="/view/biorationality-how-developers-can-expand-their-monoclonal-antibody-biosimilar-portfolio"><span class="text-sm text-gray-500">March 24th 2025</span><div class="mt-2"></div><p class="mt-4 text-gray-800">Monoclonal antibodies lead biosimilar approvals because of their large market size, well-defined regulatory pathways, and technological feasibility, whereas other biologics encounter development challenges but may see increased adoption as regulatory frameworks advance.</p></a><div class="flex mt-4"></div></div></div></div><div class="w-full h-full"><div class="flex mt-4"><a class="w-full mt-3 md:flex-none md:w-48" href="/view/patients-with-ibd-maintain-therapy-2-years-post-switching-to-infliximab-biosimilar"><div class=""><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:relative"><span style="box-sizing:border-box;display:block;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;padding-top:66.66666666666666%"></span><img alt="ibd | Image credit: eddows - stock.adobe.com" title="ibd | Image credit: eddows - stock.adobe.com" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="responsive" class="shrink-0" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/><noscript><img alt="ibd | Image credit: eddows - stock.adobe.com" title="ibd | Image credit: eddows - stock.adobe.com" sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F029904b32ea54f066770a7e724ce48ed0f3937ba-5472x3648.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=640&q=75 640w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F029904b32ea54f066770a7e724ce48ed0f3937ba-5472x3648.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=750&q=75 750w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F029904b32ea54f066770a7e724ce48ed0f3937ba-5472x3648.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=828&q=75 828w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F029904b32ea54f066770a7e724ce48ed0f3937ba-5472x3648.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=1080&q=75 1080w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F029904b32ea54f066770a7e724ce48ed0f3937ba-5472x3648.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=1200&q=75 1200w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F029904b32ea54f066770a7e724ce48ed0f3937ba-5472x3648.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=1920&q=75 1920w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F029904b32ea54f066770a7e724ce48ed0f3937ba-5472x3648.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=2048&q=75 2048w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F029904b32ea54f066770a7e724ce48ed0f3937ba-5472x3648.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75 3840w" src="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F029904b32ea54f066770a7e724ce48ed0f3937ba-5472x3648.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75" decoding="async" data-nimg="responsive" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" class="shrink-0" loading="lazy"/></noscript></span></div></a><div class="w-[200%] md:w-[auto] flex-auto p-2 ml-2"><p class="font-bold"><a class="" href="/view/patients-with-ibd-maintain-therapy-2-years-post-switching-to-infliximab-biosimilar">Patients With IBD Maintain Therapy 2 Years Post Switching to Infliximab Biosimilar</a></p><div><span class="text-md "><span class="mr-1 italic">By </span><a class="mr-1 text-sky-800 hover:text-primary" href="/authors/deana-ferreri-phd">Deana Ferreri, PhD</a></span></div><a href="/view/patients-with-ibd-maintain-therapy-2-years-post-switching-to-infliximab-biosimilar"><span class="text-sm text-gray-500">March 23rd 2025</span><div class="mt-2"></div><p class="mt-4 text-gray-800">People with inflammatory bowel disease (IBD) who switched to the infliximab biosimilar CT-P13 had higher treatment persistence (84% and 91%) than those new to infliximab (66% and 53%), with no new safety concerns.</p></a><div class="flex mt-4"></div></div></div></div><div class="w-full h-full"><div class="flex mt-4"><a class="w-full mt-3 md:flex-none md:w-48" href="/view/smart-tendering-policies-unlock-greater-biosimilar-savings"><div class=""><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:relative"><span style="box-sizing:border-box;display:block;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;padding-top:66.74057649667405%"></span><img alt="anti-tnf biologics and savings in Europe | Image credit: gopixa - stock.adobe.com" title="anti-tnf biologics and savings in Europe | Image credit: gopixa - stock.adobe.com" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="responsive" class="shrink-0" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/><noscript><img alt="anti-tnf biologics and savings in Europe | Image credit: gopixa - stock.adobe.com" title="anti-tnf biologics and savings in Europe | Image credit: gopixa - stock.adobe.com" sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F1de84fdef1b73c894e44d3656d03ca79406c6288-5863x3913.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=640&q=75 640w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F1de84fdef1b73c894e44d3656d03ca79406c6288-5863x3913.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=750&q=75 750w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F1de84fdef1b73c894e44d3656d03ca79406c6288-5863x3913.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=828&q=75 828w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F1de84fdef1b73c894e44d3656d03ca79406c6288-5863x3913.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=1080&q=75 1080w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F1de84fdef1b73c894e44d3656d03ca79406c6288-5863x3913.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=1200&q=75 1200w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F1de84fdef1b73c894e44d3656d03ca79406c6288-5863x3913.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=1920&q=75 1920w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F1de84fdef1b73c894e44d3656d03ca79406c6288-5863x3913.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=2048&q=75 2048w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F1de84fdef1b73c894e44d3656d03ca79406c6288-5863x3913.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75 3840w" src="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F1de84fdef1b73c894e44d3656d03ca79406c6288-5863x3913.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75" decoding="async" data-nimg="responsive" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" class="shrink-0" loading="lazy"/></noscript></span></div></a><div class="w-[200%] md:w-[auto] flex-auto p-2 ml-2"><p class="font-bold"><a class="" href="/view/smart-tendering-policies-unlock-greater-biosimilar-savings">Smart Tendering Policies Unlock Greater Biosimilar Savings</a></p><div><span class="text-md "><span class="mr-1 italic">By </span><a class="mr-1 text-sky-800 hover:text-primary" href="/authors/skylar-jeremias">Skylar Jeremias</a></span></div><a href="/view/smart-tendering-policies-unlock-greater-biosimilar-savings"><span class="text-sm text-gray-500">March 20th 2025</span><div class="mt-2"></div><p class="mt-4 text-gray-800">Tendering emerged as the most effective strategy for reducing costs and increasing biosimilar uptake in the retail setting, while price-linked discounts and prescribing quotas have shown mixed or uncertain results.</p></a><div class="flex mt-4"></div></div></div></div><div class="w-full h-full"><div class="flex mt-4"><a class="w-full mt-3 md:flex-none md:w-48" href="/view/multiple-switches-between-adalimumab-biosimilar-gp2017-and-humira-for-psoriasis-maintains-biosimilarity"><div class=""><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:relative"><span style="box-sizing:border-box;display:block;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;padding-top:66.66666666666666%"></span><img alt="Plaque psoriasis. | Image Credit: pimentos - stock.adobe.com " title="Plaque psoriasis. | Image Credit: pimentos - stock.adobe.com " src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="responsive" class="shrink-0" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/><noscript><img alt="Plaque psoriasis. | Image Credit: pimentos - stock.adobe.com " title="Plaque psoriasis. | Image Credit: pimentos - stock.adobe.com " sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F1d9e52f022f5262620c6e572b854f87e40781b95-8256x5504.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=640&q=75 640w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F1d9e52f022f5262620c6e572b854f87e40781b95-8256x5504.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=750&q=75 750w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F1d9e52f022f5262620c6e572b854f87e40781b95-8256x5504.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=828&q=75 828w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F1d9e52f022f5262620c6e572b854f87e40781b95-8256x5504.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=1080&q=75 1080w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F1d9e52f022f5262620c6e572b854f87e40781b95-8256x5504.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=1200&q=75 1200w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F1d9e52f022f5262620c6e572b854f87e40781b95-8256x5504.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=1920&q=75 1920w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F1d9e52f022f5262620c6e572b854f87e40781b95-8256x5504.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=2048&q=75 2048w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F1d9e52f022f5262620c6e572b854f87e40781b95-8256x5504.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75 3840w" src="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F1d9e52f022f5262620c6e572b854f87e40781b95-8256x5504.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75" decoding="async" data-nimg="responsive" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" class="shrink-0" loading="lazy"/></noscript></span></div></a><div class="w-[200%] md:w-[auto] flex-auto p-2 ml-2"><p class="font-bold"><a class="" href="/view/multiple-switches-between-adalimumab-biosimilar-gp2017-and-humira-for-psoriasis-maintains-biosimilarity">Multiple Switches Between Adalimumab Biosimilar GP2017 and Humira for Psoriasis Maintain Biosimilarity</a></p><div><span class="text-md "><span class="mr-1 italic">By </span><a class="mr-1 text-sky-800 hover:text-primary" href="/authors/cameron-santoro">Cameron Santoro</a></span></div><a href="/view/multiple-switches-between-adalimumab-biosimilar-gp2017-and-humira-for-psoriasis-maintains-biosimilarity"><span class="text-sm text-gray-500">March 20th 2025</span><div class="mt-2"></div><p class="mt-4 text-gray-800">Patients with moderate to severe plaque psoriasis who switched between the adalimumab biosimilar GP2017 and reference adalimumab did not impact immunogenicity, safety, or efficacy following up to 4 switches between both drugs.</p></a><div class="flex mt-4"></div></div></div></div><div class="w-full h-full"><div class="flex mt-4"><a class="w-full mt-3 md:flex-none md:w-48" href="/view/real-world-data-confirm-safety-of-switching-between-ranibizumab-biosimilars"><div class=""><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:relative"><span style="box-sizing:border-box;display:block;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;padding-top:66.67292879954913%"></span><img alt="retinal conditions and ranibizumab | Image credit: Orawan - stock.adobe.com" title="retinal conditions and ranibizumab | Image credit: Orawan - stock.adobe.com" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="responsive" class="shrink-0" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/><noscript><img alt="retinal conditions and ranibizumab | Image credit: Orawan - stock.adobe.com" title="retinal conditions and ranibizumab | Image credit: Orawan - stock.adobe.com" sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F4d564a4d6b9682ae29a4e32018496463cdb92cb2-5323x3549.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=640&q=75 640w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F4d564a4d6b9682ae29a4e32018496463cdb92cb2-5323x3549.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=750&q=75 750w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F4d564a4d6b9682ae29a4e32018496463cdb92cb2-5323x3549.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=828&q=75 828w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F4d564a4d6b9682ae29a4e32018496463cdb92cb2-5323x3549.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=1080&q=75 1080w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F4d564a4d6b9682ae29a4e32018496463cdb92cb2-5323x3549.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=1200&q=75 1200w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F4d564a4d6b9682ae29a4e32018496463cdb92cb2-5323x3549.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=1920&q=75 1920w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F4d564a4d6b9682ae29a4e32018496463cdb92cb2-5323x3549.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=2048&q=75 2048w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F4d564a4d6b9682ae29a4e32018496463cdb92cb2-5323x3549.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75 3840w" src="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F4d564a4d6b9682ae29a4e32018496463cdb92cb2-5323x3549.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75" decoding="async" data-nimg="responsive" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" class="shrink-0" loading="lazy"/></noscript></span></div></a><div class="w-[200%] md:w-[auto] flex-auto p-2 ml-2"><p class="font-bold"><a class="" href="/view/real-world-data-confirm-safety-of-switching-between-ranibizumab-biosimilars">Real-World Data Confirm Safety of Switching Between Ranibizumab Biosimilars</a></p><div><span class="text-md "><span class="mr-1 italic">By </span><a class="mr-1 text-sky-800 hover:text-primary" href="/authors/skylar-jeremias">Skylar Jeremias</a></span></div><a href="/view/real-world-data-confirm-safety-of-switching-between-ranibizumab-biosimilars"><span class="text-sm text-gray-500">March 19th 2025</span><div class="mt-2"></div><p class="mt-4 text-gray-800">Patients with diabetic macular edema previously treated with a ranibizumab biosimilar in India experience comparable safety and efficacy after being switched to another ranibizumab biosimilar, demonstrating real-world safety of biosimilar-to-biosimilar switching.</p></a><div class="flex mt-4"></div></div></div></div><div class="w-full h-full"><div class="flex mt-4"><a class="w-full mt-3 md:flex-none md:w-48" href="/view/promising-results-for-ustekinumab-adalimumab-biosimilars-presented-at-aad"><div class=""><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:relative"><span style="box-sizing:border-box;display:block;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;padding-top:66.66666666666666%"></span><img alt="doctor treating plaque psoriasis | Image credit: fusssergei - stock.adobe.com" title="doctor treating plaque psoriasis | Image credit: fusssergei - stock.adobe.com" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="responsive" class="shrink-0" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/><noscript><img alt="doctor treating plaque psoriasis | Image credit: fusssergei - stock.adobe.com" title="doctor treating plaque psoriasis | Image credit: fusssergei - stock.adobe.com" sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F38d862d9f51254894805c6c0ce8878d8a61db662-1200x800.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=640&q=75 640w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F38d862d9f51254894805c6c0ce8878d8a61db662-1200x800.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=750&q=75 750w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F38d862d9f51254894805c6c0ce8878d8a61db662-1200x800.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=828&q=75 828w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F38d862d9f51254894805c6c0ce8878d8a61db662-1200x800.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=1080&q=75 1080w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F38d862d9f51254894805c6c0ce8878d8a61db662-1200x800.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=1200&q=75 1200w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F38d862d9f51254894805c6c0ce8878d8a61db662-1200x800.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=1920&q=75 1920w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F38d862d9f51254894805c6c0ce8878d8a61db662-1200x800.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=2048&q=75 2048w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F38d862d9f51254894805c6c0ce8878d8a61db662-1200x800.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75 3840w" src="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F38d862d9f51254894805c6c0ce8878d8a61db662-1200x800.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75" decoding="async" data-nimg="responsive" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" class="shrink-0" loading="lazy"/></noscript></span></div></a><div class="w-[200%] md:w-[auto] flex-auto p-2 ml-2"><p class="font-bold"><a class="" href="/view/promising-results-for-ustekinumab-adalimumab-biosimilars-presented-at-aad">Promising Results for Ustekinumab, Adalimumab Biosimilars Presented at AAD</a></p><div><span class="text-md "><span class="mr-1 italic">By </span><a class="mr-1 text-sky-800 hover:text-primary" href="/authors/skylar-jeremias">Skylar Jeremias</a></span></div><a href="/view/promising-results-for-ustekinumab-adalimumab-biosimilars-presented-at-aad"><span class="text-sm text-gray-500">March 18th 2025</span><div class="mt-2"></div><p class="mt-4 text-gray-800">Biocon’s ustekinumab biosimilar matched reference ustekinumab in efficacy and safety, while an adalimumab biosimilar proved interchangeable with reference adalimumab, according to posters at the American Academy of Dermatology (AAD) annual meeting.</p></a><div class="flex mt-4"></div></div></div></div><div class="w-full h-full"><div class="flex mt-4"><a class="w-full mt-3 md:flex-none md:w-48" href="/view/review-calls-for-path-to-global-harmonization-of-biosimilar-development-regulations"><div class=""><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:relative"><span style="box-sizing:border-box;display:block;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;padding-top:56.043956043956044%"></span><img alt="global biosimilar development regulations | Image credit: Planetz - stock.adobe.com" title="global biosimilar development regulations | Image credit: Planetz - stock.adobe.com" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="responsive" class="shrink-0" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/><noscript><img alt="global biosimilar development regulations | Image credit: Planetz - stock.adobe.com" title="global biosimilar development regulations | Image credit: Planetz - stock.adobe.com" sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F5fa4725d0d2ab169801d8099d592b779952fbcc3-5824x3264.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=640&q=75 640w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F5fa4725d0d2ab169801d8099d592b779952fbcc3-5824x3264.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=750&q=75 750w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F5fa4725d0d2ab169801d8099d592b779952fbcc3-5824x3264.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=828&q=75 828w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F5fa4725d0d2ab169801d8099d592b779952fbcc3-5824x3264.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=1080&q=75 1080w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F5fa4725d0d2ab169801d8099d592b779952fbcc3-5824x3264.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=1200&q=75 1200w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F5fa4725d0d2ab169801d8099d592b779952fbcc3-5824x3264.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=1920&q=75 1920w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F5fa4725d0d2ab169801d8099d592b779952fbcc3-5824x3264.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=2048&q=75 2048w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F5fa4725d0d2ab169801d8099d592b779952fbcc3-5824x3264.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75 3840w" src="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F5fa4725d0d2ab169801d8099d592b779952fbcc3-5824x3264.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75" decoding="async" data-nimg="responsive" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" class="shrink-0" loading="lazy"/></noscript></span></div></a><div class="w-[200%] md:w-[auto] flex-auto p-2 ml-2"><p class="font-bold"><a class="" href="/view/review-calls-for-path-to-global-harmonization-of-biosimilar-development-regulations">Review Calls for Path to Global Harmonization of Biosimilar Development Regulations</a></p><div><span class="text-md "><span class="mr-1 italic">By </span><a class="mr-1 text-sky-800 hover:text-primary" href="/authors/skylar-jeremias">Skylar Jeremias</a></span></div><a href="/view/review-calls-for-path-to-global-harmonization-of-biosimilar-development-regulations"><span class="text-sm text-gray-500">March 17th 2025</span><div class="mt-2"></div><p class="mt-4 text-gray-800">Global biosimilar regulatory harmonization will be needed to reduce development costs and improve patient access, despite challenges posed by differing national requirements and regulatory frameworks, according to review authors.</p></a><div class="flex mt-4"></div></div></div></div><div class="w-full h-full"><div class="flex mt-4"><a class="w-full mt-3 md:flex-none md:w-48" href="/view/retina-specialists-evolving-view-on-biosimilars-in-amd-treatment"><div class=""><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:relative"><span style="box-sizing:border-box;display:block;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;padding-top:55.833333333333336%"></span><img alt="Paul Hahn, MD, PhD" title="Paul Hahn, MD, PhD" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="responsive" class="shrink-0" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/><noscript><img alt="Paul Hahn, MD, PhD" title="Paul Hahn, MD, PhD" sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Ffcf357a9c4bdf6dcbafc0805856653df9e658adf-1200x670.png%3Ffit%3Dcrop%26auto%3Dformat&w=640&q=75 640w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Ffcf357a9c4bdf6dcbafc0805856653df9e658adf-1200x670.png%3Ffit%3Dcrop%26auto%3Dformat&w=750&q=75 750w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Ffcf357a9c4bdf6dcbafc0805856653df9e658adf-1200x670.png%3Ffit%3Dcrop%26auto%3Dformat&w=828&q=75 828w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Ffcf357a9c4bdf6dcbafc0805856653df9e658adf-1200x670.png%3Ffit%3Dcrop%26auto%3Dformat&w=1080&q=75 1080w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Ffcf357a9c4bdf6dcbafc0805856653df9e658adf-1200x670.png%3Ffit%3Dcrop%26auto%3Dformat&w=1200&q=75 1200w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Ffcf357a9c4bdf6dcbafc0805856653df9e658adf-1200x670.png%3Ffit%3Dcrop%26auto%3Dformat&w=1920&q=75 1920w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Ffcf357a9c4bdf6dcbafc0805856653df9e658adf-1200x670.png%3Ffit%3Dcrop%26auto%3Dformat&w=2048&q=75 2048w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Ffcf357a9c4bdf6dcbafc0805856653df9e658adf-1200x670.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75 3840w" src="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Ffcf357a9c4bdf6dcbafc0805856653df9e658adf-1200x670.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75" decoding="async" data-nimg="responsive" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" class="shrink-0" loading="lazy"/></noscript></span></div></a><div class="w-[200%] md:w-[auto] flex-auto p-2 ml-2"><p class="font-bold"><a class="" href="/view/retina-specialists-evolving-view-on-biosimilars-in-amd-treatment">Retina Specialists’ Evolving View on Biosimilars in AMD Treatment</a></p><div><span class="text-md "><span class="mr-1 italic">By </span><a class="mr-1 text-sky-800 hover:text-primary" href="/authors/skylar-jeremias">Skylar Jeremias</a></span></div><a href="/view/retina-specialists-evolving-view-on-biosimilars-in-amd-treatment"><span class="text-sm text-gray-500">March 16th 2025</span><div class="mt-2"></div><p class="mt-4 text-gray-800">The introduction of biosimilars in the treatment of age-related macular degeneration (AMD) is raising concerns among physicians about cost-driven mandates and the autonomy to choose the best therapies for their patients, according to Paul Hahn, MD, PhD, FASRS, a retina specialist at NJ Retina.</p></a><div class="flex mt-4"></div></div></div></div><div class="w-full h-full"><div class="flex mt-4"><a class="w-full mt-3 md:flex-none md:w-48" href="/view/comparable-pregnancy-and-infant-milestones-with-infliximab-biosimilars-vs-originator-in-ibd"><div class=""><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:relative"><span style="box-sizing:border-box;display:block;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;padding-top:66.66666666666666%"></span><img alt="pregnant woman taking biosimilar for IBD | Image credit: pressmaster - stock.adobe.com" title="pregnant woman taking biosimilar for IBD | Image credit: pressmaster - stock.adobe.com" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="responsive" class="shrink-0" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/><noscript><img alt="pregnant woman taking biosimilar for IBD | Image credit: pressmaster - stock.adobe.com" title="pregnant woman taking biosimilar for IBD | Image credit: pressmaster - stock.adobe.com" sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F009b12e7a5586ae473c59e099206b0fb2992476c-5760x3840.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=640&q=75 640w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F009b12e7a5586ae473c59e099206b0fb2992476c-5760x3840.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=750&q=75 750w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F009b12e7a5586ae473c59e099206b0fb2992476c-5760x3840.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=828&q=75 828w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F009b12e7a5586ae473c59e099206b0fb2992476c-5760x3840.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=1080&q=75 1080w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F009b12e7a5586ae473c59e099206b0fb2992476c-5760x3840.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=1200&q=75 1200w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F009b12e7a5586ae473c59e099206b0fb2992476c-5760x3840.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=1920&q=75 1920w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F009b12e7a5586ae473c59e099206b0fb2992476c-5760x3840.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=2048&q=75 2048w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F009b12e7a5586ae473c59e099206b0fb2992476c-5760x3840.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75 3840w" src="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F009b12e7a5586ae473c59e099206b0fb2992476c-5760x3840.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75" decoding="async" data-nimg="responsive" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" class="shrink-0" loading="lazy"/></noscript></span></div></a><div class="w-[200%] md:w-[auto] flex-auto p-2 ml-2"><p class="font-bold"><a class="" href="/view/comparable-pregnancy-and-infant-milestones-with-infliximab-biosimilars-vs-originator-in-ibd">Comparable Pregnancy and Infant Milestones With Infliximab Biosimilars vs Originator in IBD</a></p><div><span class="text-md "><span class="mr-1 italic">By </span><a class="mr-1 text-sky-800 hover:text-primary" href="/authors/deana-ferreri-phd">Deana Ferreri, PhD</a></span></div><a href="/view/comparable-pregnancy-and-infant-milestones-with-infliximab-biosimilars-vs-originator-in-ibd"><span class="text-sm text-gray-500">March 15th 2025</span><div class="mt-2"></div><p class="mt-4 text-gray-800">A study evaluating pregnancy outcomes and infant developmental milestones found similar outcomes between pregnant women with inflammatory bowel disease (IBD) who received reference infliximab and those who received a biosimilar. </p></a><div class="flex mt-4"></div></div></div></div><div class="w-full h-full"><div class="flex mt-4"><a class="w-full mt-3 md:flex-none md:w-48" href="/view/more-ustekinumab-biosimilars-join-us-market-share-fight"><div class=""><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:relative"><span style="box-sizing:border-box;display:block;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;padding-top:66.66666666666666%"></span><img alt="AI generated ustekinumab pens | Image credit: Napat - stock.adobe.com" title="AI generated ustekinumab pens | Image credit: Napat - stock.adobe.com" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="responsive" class="shrink-0" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/><noscript><img alt="AI generated ustekinumab pens | Image credit: Napat - stock.adobe.com" title="AI generated ustekinumab pens | Image credit: Napat - stock.adobe.com" sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fde4fdf7df1fc9f5ff7e0fb043ae61360f3ace910-2688x1792.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=640&q=75 640w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fde4fdf7df1fc9f5ff7e0fb043ae61360f3ace910-2688x1792.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=750&q=75 750w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fde4fdf7df1fc9f5ff7e0fb043ae61360f3ace910-2688x1792.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=828&q=75 828w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fde4fdf7df1fc9f5ff7e0fb043ae61360f3ace910-2688x1792.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=1080&q=75 1080w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fde4fdf7df1fc9f5ff7e0fb043ae61360f3ace910-2688x1792.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=1200&q=75 1200w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fde4fdf7df1fc9f5ff7e0fb043ae61360f3ace910-2688x1792.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=1920&q=75 1920w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fde4fdf7df1fc9f5ff7e0fb043ae61360f3ace910-2688x1792.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=2048&q=75 2048w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fde4fdf7df1fc9f5ff7e0fb043ae61360f3ace910-2688x1792.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75 3840w" src="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fde4fdf7df1fc9f5ff7e0fb043ae61360f3ace910-2688x1792.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75" decoding="async" data-nimg="responsive" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" class="shrink-0" loading="lazy"/></noscript></span></div></a><div class="w-[200%] md:w-[auto] flex-auto p-2 ml-2"><p class="font-bold"><a class="" href="/view/more-ustekinumab-biosimilars-join-us-market-share-fight">More Ustekinumab Biosimilars Join US Market Share Fight</a></p><div><span class="text-md "><span class="mr-1 italic">By </span><a class="mr-1 text-sky-800 hover:text-primary" href="/authors/skylar-jeremias">Skylar Jeremias</a></span></div><a href="/view/more-ustekinumab-biosimilars-join-us-market-share-fight"><span class="text-sm text-gray-500">March 13th 2025</span><div class="mt-2"></div><p class="mt-4 text-gray-800">Celltrion and Formycon with Fresenius Kabi launched their respective ustekinumab biosimilars (Steqeyma and Otulfi), joining 4 others that launched earlier this year.</p></a><div class="flex mt-4"></div></div></div></div><div class="w-full h-full"><div class="flex mt-4"><a class="w-full mt-3 md:flex-none md:w-48" href="/view/updates-on-the-use-of-biosimilars-for-pediatric-patients-with-rheumatic-disease"><div class=""><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:relative"><span style="box-sizing:border-box;display:block;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;padding-top:54.166666666666664%"></span><img alt="Child with rheumatic disease | Image credit: luismolinero | stock.adobe.com" title="Child with rheumatic disease | Image credit: luismolinero | stock.adobe.com" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="responsive" class="shrink-0" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/><noscript><img alt="Child with rheumatic disease | Image credit: luismolinero | stock.adobe.com" title="Child with rheumatic disease | Image credit: luismolinero | stock.adobe.com" sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Feecb35b16271720dbe0e7b9b752e1ec4718b7775-1200x650.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=640&q=75 640w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Feecb35b16271720dbe0e7b9b752e1ec4718b7775-1200x650.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=750&q=75 750w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Feecb35b16271720dbe0e7b9b752e1ec4718b7775-1200x650.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=828&q=75 828w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Feecb35b16271720dbe0e7b9b752e1ec4718b7775-1200x650.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=1080&q=75 1080w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Feecb35b16271720dbe0e7b9b752e1ec4718b7775-1200x650.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=1200&q=75 1200w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Feecb35b16271720dbe0e7b9b752e1ec4718b7775-1200x650.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=1920&q=75 1920w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Feecb35b16271720dbe0e7b9b752e1ec4718b7775-1200x650.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=2048&q=75 2048w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Feecb35b16271720dbe0e7b9b752e1ec4718b7775-1200x650.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75 3840w" src="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Feecb35b16271720dbe0e7b9b752e1ec4718b7775-1200x650.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75" decoding="async" data-nimg="responsive" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" class="shrink-0" loading="lazy"/></noscript></span></div></a><div class="w-[200%] md:w-[auto] flex-auto p-2 ml-2"><p class="font-bold"><a class="" href="/view/updates-on-the-use-of-biosimilars-for-pediatric-patients-with-rheumatic-disease">Updates on the Use of Biosimilars for Pediatric Patients With Rheumatic Disease</a></p><div><span class="text-md "><span class="mr-1 italic">By </span><a class="mr-1 text-sky-800 hover:text-primary" href="/authors/sabina-alikhanov-palmieri-pharmd">Sabina Alikhanov Palmieri, PharmD</a></span></div><a href="/view/updates-on-the-use-of-biosimilars-for-pediatric-patients-with-rheumatic-disease"><span class="text-sm text-gray-500">March 12th 2025</span><div class="mt-2"></div><p class="mt-4 text-gray-800">Although more research is needed in pediatric patients, biosimilars could improve treatment access and reduce costs.</p></a><div class="flex mt-4"></div></div></div></div><div class="w-full h-full"><div class="flex mt-4"><a class="w-full mt-3 md:flex-none md:w-48" href="/view/biosimilar-cases-to-watch-prolia-xgeva-and-denosumab-competitors"><div class=""><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:relative"><span style="box-sizing:border-box;display:block;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;padding-top:68.03983703033046%"></span><img alt="gavel and money | Image credit: BillionPhotos.com - stock.adobe.com" title="gavel and money | Image credit: BillionPhotos.com - stock.adobe.com" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="responsive" class="shrink-0" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/><noscript><img alt="gavel and money | Image credit: BillionPhotos.com - stock.adobe.com" title="gavel and money | Image credit: BillionPhotos.com - stock.adobe.com" sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fa74124d4c23d45fb124377c7f46ace6c163ac5c1-4418x3006.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=640&q=75 640w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fa74124d4c23d45fb124377c7f46ace6c163ac5c1-4418x3006.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=750&q=75 750w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fa74124d4c23d45fb124377c7f46ace6c163ac5c1-4418x3006.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=828&q=75 828w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fa74124d4c23d45fb124377c7f46ace6c163ac5c1-4418x3006.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=1080&q=75 1080w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fa74124d4c23d45fb124377c7f46ace6c163ac5c1-4418x3006.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=1200&q=75 1200w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fa74124d4c23d45fb124377c7f46ace6c163ac5c1-4418x3006.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=1920&q=75 1920w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fa74124d4c23d45fb124377c7f46ace6c163ac5c1-4418x3006.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=2048&q=75 2048w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fa74124d4c23d45fb124377c7f46ace6c163ac5c1-4418x3006.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75 3840w" src="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fa74124d4c23d45fb124377c7f46ace6c163ac5c1-4418x3006.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75" decoding="async" data-nimg="responsive" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" class="shrink-0" loading="lazy"/></noscript></span></div></a><div class="w-[200%] md:w-[auto] flex-auto p-2 ml-2"><p class="font-bold"><a class="" href="/view/biosimilar-cases-to-watch-prolia-xgeva-and-denosumab-competitors">Biosimilar Cases to Watch: Prolia/Xgeva and Denosumab Competitors</a></p><div><span class="text-md "><span class="mr-1 italic">By </span><a class="mr-1 text-sky-800 hover:text-primary" href="/authors/ha-kung-wong-jd">Ha Kung Wong, JD</a></span><span class="text-md "><span class="mr-1 italic"><br/></span><a class="mr-1 text-sky-800 hover:text-primary" href="/authors/april-breyer-menon-jd">April Breyer Menon, JD</a></span></div><a href="/view/biosimilar-cases-to-watch-prolia-xgeva-and-denosumab-competitors"><span class="text-sm text-gray-500">March 11th 2025</span><div class="mt-2"></div><p class="mt-4 text-gray-800">The denosumab biosimilar market is poised for disruption with 3 FDA-approved biosimilars, at least 5 awaiting approval, and launches anticipated to start in May 2025, while ongoing patent litigation continues to shape the competitive landscape.</p></a><div class="flex mt-4"></div></div></div></div><div class="w-full h-full"><div class="flex mt-4"><a class="w-full mt-3 md:flex-none md:w-48" href="/view/biorationality-fda-needs-more-time-before-working-with-usp-on-biosimilars-development"><div class=""><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:relative"><span style="box-sizing:border-box;display:block;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;padding-top:69.77192982456141%"></span><img alt="laboratory development | Image credit: Cavan - stock.adobe.com" title="laboratory development | Image credit: Cavan - stock.adobe.com" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="responsive" class="shrink-0" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/><noscript><img alt="laboratory development | Image credit: Cavan - stock.adobe.com" title="laboratory development | Image credit: Cavan - stock.adobe.com" sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F1ef38342e79cbc0fd1077d458aa6b28ca5265a49-5700x3977.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=640&q=75 640w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F1ef38342e79cbc0fd1077d458aa6b28ca5265a49-5700x3977.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=750&q=75 750w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F1ef38342e79cbc0fd1077d458aa6b28ca5265a49-5700x3977.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=828&q=75 828w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F1ef38342e79cbc0fd1077d458aa6b28ca5265a49-5700x3977.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=1080&q=75 1080w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F1ef38342e79cbc0fd1077d458aa6b28ca5265a49-5700x3977.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=1200&q=75 1200w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F1ef38342e79cbc0fd1077d458aa6b28ca5265a49-5700x3977.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=1920&q=75 1920w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F1ef38342e79cbc0fd1077d458aa6b28ca5265a49-5700x3977.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=2048&q=75 2048w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F1ef38342e79cbc0fd1077d458aa6b28ca5265a49-5700x3977.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75 3840w" src="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F1ef38342e79cbc0fd1077d458aa6b28ca5265a49-5700x3977.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75" decoding="async" data-nimg="responsive" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" class="shrink-0" loading="lazy"/></noscript></span></div></a><div class="w-[200%] md:w-[auto] flex-auto p-2 ml-2"><p class="font-bold"><a class="" href="/view/biorationality-fda-needs-more-time-before-working-with-usp-on-biosimilars-development">BioRationality: FDA Needs More Time Before Working With USP on Biosimilars Development</a></p><div><span class="text-md "><span class="mr-1 italic">By </span><a class="mr-1 text-sky-800 hover:text-primary" href="/authors/sarfaraz-k-niazi-phd">Sarfaraz K. Niazi, PhD</a></span></div><a href="/view/biorationality-fda-needs-more-time-before-working-with-usp-on-biosimilars-development"><span class="text-sm text-gray-500">March 10th 2025</span><div class="mt-2"></div><p class="mt-4 text-gray-800">Sarfaraz Niazi, PhD, urges the FDA to let the USPharmacopeia (USP) create product release specifications for biosimilars to cut costs, speed development, and enhance accessibility.</p></a><div class="flex mt-4"></div></div></div></div><div class="w-full h-full"><div class="flex mt-4"><a class="w-full mt-3 md:flex-none md:w-48" href="/view/how-ai-can-help-address-cost-related-nonadherence-to-biologic-biosimilar-treatment"><div class=""><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:relative"><span style="box-sizing:border-box;display:block;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;padding-top:49.98828216545582%"></span><img alt="CFB podcast banner" title="CFB podcast banner" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="responsive" class="shrink-0" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/><noscript><img alt="CFB podcast banner" title="CFB podcast banner" sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fdb262aac8277d65bc597c5302dacb7a0fce141cd-4267x2133.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=640&q=75 640w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fdb262aac8277d65bc597c5302dacb7a0fce141cd-4267x2133.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=750&q=75 750w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fdb262aac8277d65bc597c5302dacb7a0fce141cd-4267x2133.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=828&q=75 828w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fdb262aac8277d65bc597c5302dacb7a0fce141cd-4267x2133.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=1080&q=75 1080w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fdb262aac8277d65bc597c5302dacb7a0fce141cd-4267x2133.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=1200&q=75 1200w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fdb262aac8277d65bc597c5302dacb7a0fce141cd-4267x2133.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=1920&q=75 1920w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fdb262aac8277d65bc597c5302dacb7a0fce141cd-4267x2133.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=2048&q=75 2048w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fdb262aac8277d65bc597c5302dacb7a0fce141cd-4267x2133.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75 3840w" src="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fdb262aac8277d65bc597c5302dacb7a0fce141cd-4267x2133.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75" decoding="async" data-nimg="responsive" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" class="shrink-0" loading="lazy"/></noscript></span></div></a><div class="w-[200%] md:w-[auto] flex-auto p-2 ml-2"><p class="font-bold"><a class="" href="/view/how-ai-can-help-address-cost-related-nonadherence-to-biologic-biosimilar-treatment">How AI Can Help Address Cost-Related Nonadherence to Biologic, Biosimilar Treatment</a></p><div><span class="text-md "><span class="mr-1 italic">By </span><a class="mr-1 text-sky-800 hover:text-primary" href="/authors/skylar-jeremias">Skylar Jeremias</a></span><span class="text-md "><span class="mr-1 italic"><br/></span><a class="mr-1 text-sky-800 hover:text-primary" href="/authors/josh-canavan-pharmd">Josh Canavan, PharmD</a></span></div><a href="/view/how-ai-can-help-address-cost-related-nonadherence-to-biologic-biosimilar-treatment"><span class="text-sm text-gray-500">March 9th 2025</span><div class="mt-2"></div><p class="mt-4 text-gray-800">Despite saving billions, biosimilars still account for only a small share of the biologics market—what's standing in the way of broader adoption and how can artificial intelligence (AI) help change that?</p></a><div class="flex mt-4"></div></div></div></div><div class="w-full h-full"><div class="flex mt-4"><a class="w-full mt-3 md:flex-none md:w-48" href="/view/fda-approves-first-omalizumab-biosimilar"><div class=""><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:relative"><span style="box-sizing:border-box;display:block;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;padding-top:66.66666666666666%"></span><img alt="FDA approved omalizumab biosimilar | Image credit: Rafael Henrique - stock.adobe.com" title="FDA approved omalizumab biosimilar | Image credit: Rafael Henrique - stock.adobe.com" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="responsive" class="shrink-0" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/><noscript><img alt="FDA approved omalizumab biosimilar | Image credit: Rafael Henrique - stock.adobe.com" title="FDA approved omalizumab biosimilar | Image credit: Rafael Henrique - stock.adobe.com" sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fe7a7072af56a61543e5780c33a2786953164a679-6000x4000.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=640&q=75 640w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fe7a7072af56a61543e5780c33a2786953164a679-6000x4000.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=750&q=75 750w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fe7a7072af56a61543e5780c33a2786953164a679-6000x4000.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=828&q=75 828w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fe7a7072af56a61543e5780c33a2786953164a679-6000x4000.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=1080&q=75 1080w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fe7a7072af56a61543e5780c33a2786953164a679-6000x4000.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=1200&q=75 1200w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fe7a7072af56a61543e5780c33a2786953164a679-6000x4000.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=1920&q=75 1920w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fe7a7072af56a61543e5780c33a2786953164a679-6000x4000.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=2048&q=75 2048w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fe7a7072af56a61543e5780c33a2786953164a679-6000x4000.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75 3840w" src="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fe7a7072af56a61543e5780c33a2786953164a679-6000x4000.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75" decoding="async" data-nimg="responsive" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" class="shrink-0" loading="lazy"/></noscript></span></div></a><div class="w-[200%] md:w-[auto] flex-auto p-2 ml-2"><p class="font-bold"><a class="" href="/view/fda-approves-first-omalizumab-biosimilar">FDA Approves First Omalizumab Biosimilar</a></p><div><span class="text-md "><span class="mr-1 italic">By </span><a class="mr-1 text-sky-800 hover:text-primary" href="/authors/skylar-jeremias">Skylar Jeremias</a></span></div><a href="/view/fda-approves-first-omalizumab-biosimilar"><span class="text-sm text-gray-500">March 7th 2025</span><div class="mt-2"></div><p class="mt-4 text-gray-800">Celltrion's Omlyclo (omalizumab-igec) is the first omalizumab biosimilar to be approved for US patients, and it was approved with interchangeability, making it easier for patients to switch to the Xolair competitor.</p></a><div class="flex mt-4"></div></div></div></div><div class="w-full h-full"><div class="flex mt-4"><a class="w-full mt-3 md:flex-none md:w-48" href="/view/from-amjevita-to-zarxio-a-decade-of-us-biosimilar-approvals"><div class=""><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:relative"><span style="box-sizing:border-box;display:block;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;padding-top:58.333333333333336%"></span><img alt="10 anniversary for biosimilars in US | Image credit: ink drop - stock.adobe.com" title="10 anniversary for biosimilars in US | Image credit: ink drop - stock.adobe.com" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="responsive" class="shrink-0" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/><noscript><img alt="10 anniversary for biosimilars in US | Image credit: ink drop - stock.adobe.com" title="10 anniversary for biosimilars in US | Image credit: ink drop - stock.adobe.com" sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fc2c48922290eeb8946220a271cd7045d60b78e8e-1200x700.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=640&q=75 640w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fc2c48922290eeb8946220a271cd7045d60b78e8e-1200x700.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=750&q=75 750w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fc2c48922290eeb8946220a271cd7045d60b78e8e-1200x700.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=828&q=75 828w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fc2c48922290eeb8946220a271cd7045d60b78e8e-1200x700.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=1080&q=75 1080w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fc2c48922290eeb8946220a271cd7045d60b78e8e-1200x700.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=1200&q=75 1200w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fc2c48922290eeb8946220a271cd7045d60b78e8e-1200x700.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=1920&q=75 1920w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fc2c48922290eeb8946220a271cd7045d60b78e8e-1200x700.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=2048&q=75 2048w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fc2c48922290eeb8946220a271cd7045d60b78e8e-1200x700.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75 3840w" src="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fc2c48922290eeb8946220a271cd7045d60b78e8e-1200x700.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75" decoding="async" data-nimg="responsive" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" class="shrink-0" loading="lazy"/></noscript></span></div></a><div class="w-[200%] md:w-[auto] flex-auto p-2 ml-2"><p class="font-bold"><a class="" href="/view/from-amjevita-to-zarxio-a-decade-of-us-biosimilar-approvals">From Amjevita to Zarxio: A Decade of US Biosimilar Approvals</a></p><div><span class="text-md "><span class="mr-1 italic">By </span><a class="mr-1 text-sky-800 hover:text-primary" href="/authors/skylar-jeremias">Skylar Jeremias</a></span></div><a href="/view/from-amjevita-to-zarxio-a-decade-of-us-biosimilar-approvals"><span class="text-sm text-gray-500">March 6th 2025</span><div class="mt-2"></div><p class="mt-4 text-gray-800">Since the FDA’s groundbreaking approval of Zarxio in 2015, the US biosimilars market has surged to 67 approvals across 18 originators—though the journey has been anything but smooth, with adoption facing hurdles along the way.</p></a><div class="flex mt-4"></div></div></div></div><div class="w-full h-full"><div class="flex mt-4"><a class="w-full mt-3 md:flex-none md:w-48" href="/view/pharmacists-play-a-crucial-role-in-adalimumab-biosimilars-for-patient-care"><div class=""><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:relative"><span style="box-sizing:border-box;display:block;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;padding-top:66.66666666666666%"></span><img alt="syringe | Image credit: DachAI - stock.adobe.com" title="syringe | Image credit: DachAI - stock.adobe.com" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="responsive" class="shrink-0" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/><noscript><img alt="syringe | Image credit: DachAI - stock.adobe.com" title="syringe | Image credit: DachAI - stock.adobe.com" sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Ffc34983eba6d5b5828a0a5e2e64dd8822eb46cf8-5376x3584.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=640&q=75 640w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Ffc34983eba6d5b5828a0a5e2e64dd8822eb46cf8-5376x3584.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=750&q=75 750w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Ffc34983eba6d5b5828a0a5e2e64dd8822eb46cf8-5376x3584.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=828&q=75 828w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Ffc34983eba6d5b5828a0a5e2e64dd8822eb46cf8-5376x3584.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=1080&q=75 1080w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Ffc34983eba6d5b5828a0a5e2e64dd8822eb46cf8-5376x3584.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=1200&q=75 1200w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Ffc34983eba6d5b5828a0a5e2e64dd8822eb46cf8-5376x3584.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=1920&q=75 1920w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Ffc34983eba6d5b5828a0a5e2e64dd8822eb46cf8-5376x3584.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=2048&q=75 2048w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Ffc34983eba6d5b5828a0a5e2e64dd8822eb46cf8-5376x3584.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75 3840w" src="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Ffc34983eba6d5b5828a0a5e2e64dd8822eb46cf8-5376x3584.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75" decoding="async" data-nimg="responsive" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" class="shrink-0" loading="lazy"/></noscript></span></div></a><div class="w-[200%] md:w-[auto] flex-auto p-2 ml-2"><p class="font-bold"><a class="" href="/view/pharmacists-play-a-crucial-role-in-adalimumab-biosimilars-for-patient-care">Pharmacists Play a Crucial Role in Adalimumab Biosimilars for Patient Care</a></p><div><span class="text-md "><span class="mr-1 italic">By </span><a class="mr-1 text-sky-800 hover:text-primary" href="/authors/kennedy-ferruggia">Kennedy Ferruggia</a></span></div><a href="/view/pharmacists-play-a-crucial-role-in-adalimumab-biosimilars-for-patient-care"><span class="text-sm text-gray-500">March 5th 2025</span><div class="mt-2"></div><p class="mt-4 text-gray-800">Adalimumab biosimilars differ from adalimumab in approved indications, concentration and dosage, and formulation.</p></a><div class="flex mt-4"></div></div></div></div><div class="w-full h-full"><div class="flex mt-4"><a class="w-full mt-3 md:flex-none md:w-48" href="/view/fda-approves-third-pair-of-denosumab-biosimilars"><div class=""><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:relative"><span style="box-sizing:border-box;display:block;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;padding-top:56.25%"></span><img alt="osteoporosis and denosumab | Image credit: crevis - stock.adobe.com" title="osteoporosis and denosumab | Image credit: crevis - stock.adobe.com" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="responsive" class="shrink-0" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/><noscript><img alt="osteoporosis and denosumab | Image credit: crevis - stock.adobe.com" title="osteoporosis and denosumab | Image credit: crevis - stock.adobe.com" sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fab6fdf045a0e41309388af6577237c379d0809c2-6000x3375.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=640&q=75 640w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fab6fdf045a0e41309388af6577237c379d0809c2-6000x3375.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=750&q=75 750w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fab6fdf045a0e41309388af6577237c379d0809c2-6000x3375.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=828&q=75 828w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fab6fdf045a0e41309388af6577237c379d0809c2-6000x3375.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=1080&q=75 1080w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fab6fdf045a0e41309388af6577237c379d0809c2-6000x3375.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=1200&q=75 1200w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fab6fdf045a0e41309388af6577237c379d0809c2-6000x3375.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=1920&q=75 1920w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fab6fdf045a0e41309388af6577237c379d0809c2-6000x3375.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=2048&q=75 2048w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fab6fdf045a0e41309388af6577237c379d0809c2-6000x3375.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75 3840w" src="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fab6fdf045a0e41309388af6577237c379d0809c2-6000x3375.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75" decoding="async" data-nimg="responsive" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" class="shrink-0" loading="lazy"/></noscript></span></div></a><div class="w-[200%] md:w-[auto] flex-auto p-2 ml-2"><p class="font-bold"><a class="" href="/view/fda-approves-third-pair-of-denosumab-biosimilars">FDA Approves Third Pair of Denosumab Biosimilars</a></p><div><span class="text-md "><span class="mr-1 italic">By </span><a class="mr-1 text-sky-800 hover:text-primary" href="/authors/skylar-jeremias">Skylar Jeremias</a></span><span class="text-md "><span class="mr-1 italic"><br/></span><a class="mr-1 text-sky-800 hover:text-primary" href="/authors/rose-mcnulty">Rose McNulty</a></span></div><a href="/view/fda-approves-third-pair-of-denosumab-biosimilars"><span class="text-sm text-gray-500">March 4th 2025</span><div class="mt-2"></div><p class="mt-4 text-gray-800">The approvals for Celltrion's denosumab-bmwo (Stoboclo and Osenvelt) mark the third FDA green light for a biosimilar to treat osteoporosis and bone metastases.</p></a><div class="flex mt-4"></div></div></div></div><div class="w-full h-full"><div class="flex mt-4"><a class="w-full mt-3 md:flex-none md:w-48" href="/view/no-ibd-activity-changes-following-switch-from-biosimilar-to-originator-infliximab"><div class=""><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:relative"><span style="box-sizing:border-box;display:block;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;padding-top:66.66666666666666%"></span><img alt="digestive tract | Image credit: eddows - stock.adobe.com" title="digestive tract | Image credit: eddows - stock.adobe.com" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="responsive" class="shrink-0" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/><noscript><img alt="digestive tract | Image credit: eddows - stock.adobe.com" title="digestive tract | Image credit: eddows - stock.adobe.com" sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fa2f2d7dc4192e2fca00045d857a32e807c362347-5400x3600.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=640&q=75 640w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fa2f2d7dc4192e2fca00045d857a32e807c362347-5400x3600.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=750&q=75 750w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fa2f2d7dc4192e2fca00045d857a32e807c362347-5400x3600.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=828&q=75 828w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fa2f2d7dc4192e2fca00045d857a32e807c362347-5400x3600.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=1080&q=75 1080w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fa2f2d7dc4192e2fca00045d857a32e807c362347-5400x3600.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=1200&q=75 1200w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fa2f2d7dc4192e2fca00045d857a32e807c362347-5400x3600.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=1920&q=75 1920w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fa2f2d7dc4192e2fca00045d857a32e807c362347-5400x3600.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=2048&q=75 2048w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fa2f2d7dc4192e2fca00045d857a32e807c362347-5400x3600.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75 3840w" src="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fa2f2d7dc4192e2fca00045d857a32e807c362347-5400x3600.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75" decoding="async" data-nimg="responsive" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" class="shrink-0" loading="lazy"/></noscript></span></div></a><div class="w-[200%] md:w-[auto] flex-auto p-2 ml-2"><p class="font-bold"><a class="" href="/view/no-ibd-activity-changes-following-switch-from-biosimilar-to-originator-infliximab">No IBD Activity Changes Following Switch From Biosimilar to Originator Infliximab </a></p><div><span class="text-md "><span class="mr-1 italic">By </span><a class="mr-1 text-sky-800 hover:text-primary" href="/authors/deana-ferreri-phd">Deana Ferreri, PhD</a></span></div><a href="/view/no-ibd-activity-changes-following-switch-from-biosimilar-to-originator-infliximab"><span class="text-sm text-gray-500">March 3rd 2025</span><div class="mt-2"></div><p class="mt-4 text-gray-800">A prospective cohort study found that switching back from the biosimilar SB2 to the reference infliximab did not affect clinical disease activity or safety in inflammatory bowel disease (IBD). </p></a><div class="flex mt-4"></div></div></div></div><div class="w-full h-full"><div class="flex mt-4"><a class="w-full mt-3 md:flex-none md:w-48" href="/view/biosimilars-regulatory-roundup-february-2025"><div class=""><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:relative"><span style="box-sizing:border-box;display:block;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;padding-top:49.70414201183432%"></span><img alt="Biosimilars Regulatory Roundup: February 2025" title="Biosimilars Regulatory Roundup: February 2025" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="responsive" class="shrink-0" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/><noscript><img alt="Biosimilars Regulatory Roundup: February 2025" title="Biosimilars Regulatory Roundup: February 2025" sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Ff0b1c983c646107d6d36ff565cb79690b1854c6b-676x336.png%3Ffit%3Dcrop%26auto%3Dformat&w=640&q=75 640w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Ff0b1c983c646107d6d36ff565cb79690b1854c6b-676x336.png%3Ffit%3Dcrop%26auto%3Dformat&w=750&q=75 750w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Ff0b1c983c646107d6d36ff565cb79690b1854c6b-676x336.png%3Ffit%3Dcrop%26auto%3Dformat&w=828&q=75 828w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Ff0b1c983c646107d6d36ff565cb79690b1854c6b-676x336.png%3Ffit%3Dcrop%26auto%3Dformat&w=1080&q=75 1080w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Ff0b1c983c646107d6d36ff565cb79690b1854c6b-676x336.png%3Ffit%3Dcrop%26auto%3Dformat&w=1200&q=75 1200w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Ff0b1c983c646107d6d36ff565cb79690b1854c6b-676x336.png%3Ffit%3Dcrop%26auto%3Dformat&w=1920&q=75 1920w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Ff0b1c983c646107d6d36ff565cb79690b1854c6b-676x336.png%3Ffit%3Dcrop%26auto%3Dformat&w=2048&q=75 2048w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Ff0b1c983c646107d6d36ff565cb79690b1854c6b-676x336.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75 3840w" src="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Ff0b1c983c646107d6d36ff565cb79690b1854c6b-676x336.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75" decoding="async" data-nimg="responsive" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" class="shrink-0" loading="lazy"/></noscript></span></div></a><div class="w-[200%] md:w-[auto] flex-auto p-2 ml-2"><p class="font-bold"><a class="" href="/view/biosimilars-regulatory-roundup-february-2025">Biosimilars Regulatory Roundup: February 2025</a></p><div><span class="text-md "><span class="mr-1 italic">By </span><a class="mr-1 text-sky-800 hover:text-primary" href="/authors/rose-mcnulty">Rose McNulty</a></span></div><a href="/view/biosimilars-regulatory-roundup-february-2025"><span class="text-sm text-gray-500">March 1st 2025</span><div class="mt-2"></div><p class="mt-4 text-gray-800">February brought policy updates and several biosimilar approvals, including the first FDA approval for an insulin aspart biosimilar.</p></a><div class="flex mt-4"></div></div></div></div><div class="w-full h-full"><div class="flex mt-4"><a class="w-full mt-3 md:flex-none md:w-48" href="/view/bevacizumab-biosimilars-show-similar-efficacy-safety-in-nsclc"><div class=""><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:relative"><span style="box-sizing:border-box;display:block;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;padding-top:56.043956043956044%"></span><img alt="Non-small cell lung cancer. | Image Credit: Ekaterina - stock.adobe.com " title="Non-small cell lung cancer. | Image Credit: Ekaterina - stock.adobe.com " src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="responsive" class="shrink-0" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/><noscript><img alt="Non-small cell lung cancer. | Image Credit: Ekaterina - stock.adobe.com " title="Non-small cell lung cancer. | Image Credit: Ekaterina - stock.adobe.com " sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F4b48505dcfb159a9f515daaee19da3435c01c039-5824x3264.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=640&q=75 640w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F4b48505dcfb159a9f515daaee19da3435c01c039-5824x3264.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=750&q=75 750w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F4b48505dcfb159a9f515daaee19da3435c01c039-5824x3264.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=828&q=75 828w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F4b48505dcfb159a9f515daaee19da3435c01c039-5824x3264.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=1080&q=75 1080w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F4b48505dcfb159a9f515daaee19da3435c01c039-5824x3264.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=1200&q=75 1200w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F4b48505dcfb159a9f515daaee19da3435c01c039-5824x3264.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=1920&q=75 1920w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F4b48505dcfb159a9f515daaee19da3435c01c039-5824x3264.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=2048&q=75 2048w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F4b48505dcfb159a9f515daaee19da3435c01c039-5824x3264.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75 3840w" src="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F4b48505dcfb159a9f515daaee19da3435c01c039-5824x3264.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75" decoding="async" data-nimg="responsive" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" class="shrink-0" loading="lazy"/></noscript></span></div></a><div class="w-[200%] md:w-[auto] flex-auto p-2 ml-2"><p class="font-bold"><a class="" href="/view/bevacizumab-biosimilars-show-similar-efficacy-safety-in-nsclc">Bevacizumab Biosimilars Show Similar Efficacy, Safety in NSCLC</a></p><div><span class="text-md "><span class="mr-1 italic">By </span><a class="mr-1 text-sky-800 hover:text-primary" href="/authors/cameron-santoro">Cameron Santoro</a></span></div><a href="/view/bevacizumab-biosimilars-show-similar-efficacy-safety-in-nsclc"><span class="text-sm text-gray-500">February 27th 2025</span><div class="mt-2"></div><p class="mt-4 text-gray-800">Patients with non-small cell lung cancer (NSCLC) taking bevacizumab biosimilars demonstrated equivalent therapeutic efficacy and similar safety profiles to those taking the originator product, Avastin.</p></a><div class="flex mt-4"></div></div></div></div><div class="w-full h-full"><div class="flex mt-4"><a class="w-full mt-3 md:flex-none md:w-48" href="/view/adalimumab-biosimilar-switching-policy-shows-long-term-success-in-ibd"><div class=""><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:relative"><span style="box-sizing:border-box;display:block;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;padding-top:66.30004943153732%"></span><img alt="biosimilar switching | Image credit: SOPONE - stock.adobe.com" title="biosimilar switching | Image credit: SOPONE - stock.adobe.com" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="responsive" class="shrink-0" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/><noscript><img alt="biosimilar switching | Image credit: SOPONE - stock.adobe.com" title="biosimilar switching | Image credit: SOPONE - stock.adobe.com" sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F88d6c2e9528a6ab13dfe67dfeaebaf95ac47ce14-8092x5365.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=640&q=75 640w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F88d6c2e9528a6ab13dfe67dfeaebaf95ac47ce14-8092x5365.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=750&q=75 750w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F88d6c2e9528a6ab13dfe67dfeaebaf95ac47ce14-8092x5365.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=828&q=75 828w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F88d6c2e9528a6ab13dfe67dfeaebaf95ac47ce14-8092x5365.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=1080&q=75 1080w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F88d6c2e9528a6ab13dfe67dfeaebaf95ac47ce14-8092x5365.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=1200&q=75 1200w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F88d6c2e9528a6ab13dfe67dfeaebaf95ac47ce14-8092x5365.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=1920&q=75 1920w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F88d6c2e9528a6ab13dfe67dfeaebaf95ac47ce14-8092x5365.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=2048&q=75 2048w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F88d6c2e9528a6ab13dfe67dfeaebaf95ac47ce14-8092x5365.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75 3840w" src="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F88d6c2e9528a6ab13dfe67dfeaebaf95ac47ce14-8092x5365.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75" decoding="async" data-nimg="responsive" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" class="shrink-0" loading="lazy"/></noscript></span></div></a><div class="w-[200%] md:w-[auto] flex-auto p-2 ml-2"><p class="font-bold"><a class="" href="/view/adalimumab-biosimilar-switching-policy-shows-long-term-success-in-ibd">Adalimumab Biosimilar Switching Policy Shows Long-Term Success in IBD </a></p><div><span class="text-md "><span class="mr-1 italic">By </span><a class="mr-1 text-sky-800 hover:text-primary" href="/authors/skylar-jeremias">Skylar Jeremias</a></span></div><a href="/view/adalimumab-biosimilar-switching-policy-shows-long-term-success-in-ibd"><span class="text-sm text-gray-500">February 26th 2025</span><div class="mt-2"></div><p class="mt-4 text-gray-800">Patients with inflammatory bowel disease (IBD) who switched from reference adalimumab (Humira) to a biosimilar under a mandatory nonmedical switching policy maintained long-term safety, efficacy, and treatment persistence comparable to those who remained on the originator drug, according to a Canadian study.</p></a><div class="flex mt-4"></div></div></div></div><div class="w-full h-full"><div class="flex mt-4"><a class="w-full mt-3 md:flex-none md:w-48" href="/view/biosimilar-approvals-streamlined-with-advanced-statistics-amidst-differing-regulatory-requirements"><div class=""><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:relative"><span style="box-sizing:border-box;display:block;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;padding-top:75.32467532467533%"></span><img alt="Innovative research. | Image Credit: thien - stock.adobe.com" title="Innovative research. | Image Credit: thien - stock.adobe.com" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="responsive" class="shrink-0" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/><noscript><img alt="Innovative research. | Image Credit: thien - stock.adobe.com" title="Innovative research. | Image Credit: thien - stock.adobe.com" sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F3d31723ad800751440b3c3590a34934593ed2541-4928x3712.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=640&q=75 640w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F3d31723ad800751440b3c3590a34934593ed2541-4928x3712.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=750&q=75 750w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F3d31723ad800751440b3c3590a34934593ed2541-4928x3712.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=828&q=75 828w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F3d31723ad800751440b3c3590a34934593ed2541-4928x3712.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=1080&q=75 1080w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F3d31723ad800751440b3c3590a34934593ed2541-4928x3712.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=1200&q=75 1200w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F3d31723ad800751440b3c3590a34934593ed2541-4928x3712.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=1920&q=75 1920w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F3d31723ad800751440b3c3590a34934593ed2541-4928x3712.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=2048&q=75 2048w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F3d31723ad800751440b3c3590a34934593ed2541-4928x3712.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75 3840w" src="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2F3d31723ad800751440b3c3590a34934593ed2541-4928x3712.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75" decoding="async" data-nimg="responsive" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" class="shrink-0" loading="lazy"/></noscript></span></div></a><div class="w-[200%] md:w-[auto] flex-auto p-2 ml-2"><p class="font-bold"><a class="" href="/view/biosimilar-approvals-streamlined-with-advanced-statistics-amidst-differing-regulatory-requirements">Biosimilar Approvals Streamlined With Advanced Statistics Amidst Differing Regulatory Requirements</a></p><div><span class="text-md "><span class="mr-1 italic">By </span><a class="mr-1 text-sky-800 hover:text-primary" href="/authors/cameron-santoro">Cameron Santoro</a></span></div><a href="/view/biosimilar-approvals-streamlined-with-advanced-statistics-amidst-differing-regulatory-requirements"><span class="text-sm text-gray-500">February 25th 2025</span><div class="mt-2"></div><p class="mt-4 text-gray-800">The FDA and European Medicines Agency (EMA) mandate high similarity between biosimilars and reference products, but their regulatory processes differ, especially with multiple reference products.</p></a><div class="flex mt-4"></div></div></div></div><div class="w-full h-full"><div class="flex mt-4"><a class="w-full mt-3 md:flex-none md:w-48" href="/view/3-ustekinumab-biosimilars-launch-on-us-market"><div class=""><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:relative"><span style="box-sizing:border-box;display:block;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;padding-top:66.66666666666666%"></span><img alt="ustekinumab biosimilars | Image credit: MQ-Illustrations - stock.adobe.com" title="ustekinumab biosimilars | Image credit: MQ-Illustrations - stock.adobe.com" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="responsive" class="shrink-0" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/><noscript><img alt="ustekinumab biosimilars | Image credit: MQ-Illustrations - stock.adobe.com" title="ustekinumab biosimilars | Image credit: MQ-Illustrations - stock.adobe.com" sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fb2fab6bba0569cb1d87bbccad31d6a7af9666a39-5742x3828.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=640&q=75 640w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fb2fab6bba0569cb1d87bbccad31d6a7af9666a39-5742x3828.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=750&q=75 750w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fb2fab6bba0569cb1d87bbccad31d6a7af9666a39-5742x3828.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=828&q=75 828w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fb2fab6bba0569cb1d87bbccad31d6a7af9666a39-5742x3828.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=1080&q=75 1080w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fb2fab6bba0569cb1d87bbccad31d6a7af9666a39-5742x3828.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=1200&q=75 1200w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fb2fab6bba0569cb1d87bbccad31d6a7af9666a39-5742x3828.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=1920&q=75 1920w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fb2fab6bba0569cb1d87bbccad31d6a7af9666a39-5742x3828.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=2048&q=75 2048w, /_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fb2fab6bba0569cb1d87bbccad31d6a7af9666a39-5742x3828.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75 3840w" src="/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fbiosimilars%2Fb2fab6bba0569cb1d87bbccad31d6a7af9666a39-5742x3828.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75" decoding="async" data-nimg="responsive" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" class="shrink-0" loading="lazy"/></noscript></span></div></a><div class="w-[200%] md:w-[auto] flex-auto p-2 ml-2"><p class="font-bold"><a class="" href="/view/3-ustekinumab-biosimilars-launch-on-us-market">3 Ustekinumab Biosimilars Launch on US Market</a></p><div><span class="text-md "><span class="mr-1 italic">By </span><a class="mr-1 text-sky-800 hover:text-primary" href="/authors/skylar-jeremias">Skylar Jeremias</a></span></div><a href="/view/3-ustekinumab-biosimilars-launch-on-us-market"><span class="text-sm text-gray-500">February 25th 2025</span><div class="mt-2"></div><p class="mt-4 text-gray-800">Three ustekinumab biosimilars enter the US market, expanding access to more affordable options referencing Stelara (ustekinumab), one of the most profitable drugs in the world.</p></a><div class="flex mt-4"></div></div></div></div></div><div class="text-center w-full pt-4 text-2xl font-bold pb-24"><a class="text-lg hover:text-gray-400 hover:underline" href="/news">See All News ></a></div></div></div><div class="flex-none w-[300px] z-[9999] relative hidden md:block"><div style="top:5rem" class="sticky custom-spacing"><div class="collapse-container " style="overflow:hidden;max-height:900px;transition:max-height .4s ease-in-out"></div></div></div></div><div id="div-gpt-ad-pixel" style="width:1px;height:1px" class=""></div><noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-P2DHQJ7" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript><div id="footerOuterWrap" class="w-full bg-primary flex flex-col items-center justify-center customClassHideFooter"><div class="container w-[1340px]"><div id="footerInnerWrap" class="bg-primary w-full py-12"><div class="py-4 pl-4 flex flex-row items-center"><div class="flex flex-row flex-wrap w-[55%] h-full"><div class="w-[33%] p-1 my-0 cursor-pointer text-footer-text-color hover:text-footer-text-color/80 hover:underline"><a class="text-md" target="_self" href="/about">About</a></div><div class="w-[33%] p-1 my-0 cursor-pointer text-footer-text-color hover:text-footer-text-color/80 hover:underline"><a class="text-md" target="_self" href="/editorial-info">Editorial</a></div><div class="w-[33%] p-1 my-0 cursor-pointer text-footer-text-color hover:text-footer-text-color/80 hover:underline"><a class="text-md" target="_self" href="/contactus">Contact</a></div><div class="w-[33%] p-1 my-0 cursor-pointer text-footer-text-color hover:text-footer-text-color/80 hover:underline"><a class="text-md" target="_self" href="/advisory-board">Advisory Board</a></div><div class="w-[33%] p-1 my-0 cursor-pointer text-footer-text-color hover:text-footer-text-color/80 hover:underline"><a class="text-md" target="_blank" href="https://www.mjhlifesciences.com/ccpa?domain=www.centerforbiosimilars.com">Do Not Sell My Information</a></div><div class="w-[33%] p-1 my-0 cursor-pointer text-footer-text-color hover:text-footer-text-color/80 hover:underline"><a class="text-md" target="_self" href="/terms">Terms & Conditions</a></div><div class="w-[33%] p-1 my-0 cursor-pointer text-footer-text-color hover:text-footer-text-color/80 hover:underline"><a class="text-md" target="_self" href="/privacy">Privacy Policy</a></div></div><div class="w-[45%] flex flex-row"><div class="w-[1px] bg-footer-vertical-rule"></div><div class="text-center flex w-[50%] flex-col gap-4 px-8 text-footer-text-color"><div class="py-2 text-xl">Contact Info</div><div class="mx-auto"><div class="flex flex-row gap-4 mb-4"><svg stroke="currentColor" fill="currentColor" stroke-width="0" viewBox="0 0 24 24" class="text-footer-icon-color" font-size="30" style="margin-top:0.2rem" height="1em" width="1em" xmlns="http://www.w3.org/2000/svg"><path fill="none" d="M0 0h24v24H0z"></path><path d="M12 2C8.13 2 5 5.13 5 9c0 1.74.5 3.37 1.41 4.84.95 1.54 2.2 2.86 3.16 4.4.47.75.81 1.45 1.17 2.26.26.55.47 1.5 1.26 1.5s1-.95 1.25-1.5c.37-.81.7-1.51 1.17-2.26.96-1.53 2.21-2.85 3.16-4.4C18.5 12.37 19 10.74 19 9c0-3.87-3.13-7-7-7zm0 9.75a2.5 2.5 0 010-5 2.5 2.5 0 010 5z"></path></svg><p class="text-left text-sm">2 Commerce Drive <br/>Cranbury, NJ 08512</p></div><div class="flex flex-row gap-4 mb-4"><svg stroke="currentColor" fill="currentColor" stroke-width="0" viewBox="0 0 16 16" class="text-footer-icon-color ml-2" font-size="25" height="1em" width="1em" xmlns="http://www.w3.org/2000/svg"><path fill-rule="evenodd" d="M1.885.511a1.745 1.745 0 0 1 2.61.163L6.29 2.98c.329.423.445.974.315 1.494l-.547 2.19a.678.678 0 0 0 .178.643l2.457 2.457a.678.678 0 0 0 .644.178l2.189-.547a1.745 1.745 0 0 1 1.494.315l2.306 1.794c.829.645.905 1.87.163 2.611l-1.034 1.034c-.74.74-1.846 1.065-2.877.702a18.634 18.634 0 0 1-7.01-4.42 18.634 18.634 0 0 1-4.42-7.009c-.362-1.03-.037-2.137.703-2.877L1.885.511z"></path></svg><p class="text-sm"><a href="tel:609-716-7777">609-716-7777</a></p></div></div></div><div class="w-[1px] bg-footer-vertical-rule"></div><div class="flex flex-col gap-8 items-center justify-center" style="margin:0 auto"><span style="box-sizing:border-box;display:inline-block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:relative;max-width:100%"><span style="box-sizing:border-box;display:block;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;max-width:100%"><img style="display:block;max-width:100%;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0" alt="" aria-hidden="true" src="data:image/svg+xml,%3csvg%20xmlns=%27http://www.w3.org/2000/svg%27%20version=%271.1%27%20width=%27200%27%20height=%2733%27/%3e"/></span><img alt="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="intrinsic" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/><noscript><img alt="" srcSet="/_next/image?url=%2Fan_mjhls_brand_ko.png&w=256&q=75 1x, /_next/image?url=%2Fan_mjhls_brand_ko.png&w=640&q=75 2x" src="/_next/image?url=%2Fan_mjhls_brand_ko.png&w=640&q=75" decoding="async" data-nimg="intrinsic" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" loading="lazy"/></noscript></span><div class="flex flex-wrap self-start pt-6 pl-2"><a href="https://www.facebook.com/centerforbiosimilars/" class="social-icon mx-0.5 mb-1" target="_blank" rel="noopener noreferrer" style="display:inline-block;width:30px;height:30px;position:relative;overflow:hidden;vertical-align:middle" aria-label="facebook"><span class="social-container" style="position:absolute;top:0;left:0;width:100%;height:100%"><svg role="img" aria-label="facebook social icon" class="social-svg" viewBox="0 0 64 64" style="position:absolute;top:0;left:0;width:100%;height:100%;border-radius:50%;fill-rule:evenodd"><g class="social-svg-icon" style="transition:fill 170ms ease-in-out;fill:white"><path d="M0,0H64V64H0ZM0 0v64h64V0zm39.6 22h-2.8c-2.2 0-2.6 1.1-2.6 2.6V28h5.3l-.7 5.3h-4.6V47h-5.5V33.3H24V28h4.6v-4c0-4.6 2.8-7 6.9-7 2 0 3.6.1 4.1.2z"></path></g><g class="social-svg-mask" style="transition:fill 170ms ease-in-out;fill:#3b5998"><path d="M0 0v64h64V0zm39.6 22h-2.8c-2.2 0-2.6 1.1-2.6 2.6V28h5.3l-.7 5.3h-4.6V47h-5.5V33.3H24V28h4.6v-4c0-4.6 2.8-7 6.9-7 2 0 3.6.1 4.1.2z"></path></g></svg></span></a><a href="https://twitter.com/biosimcenter" class="social-icon mx-0.5 mb-1" target="_blank" rel="noopener noreferrer" style="display:inline-block;width:30px;height:30px;position:relative;overflow:hidden;vertical-align:middle" aria-label="twitter"><span class="social-container" style="position:absolute;top:0;left:0;width:100%;height:100%"><svg role="img" aria-label="twitter social icon" class="social-svg" viewBox="0 0 64 64" style="position:absolute;top:0;left:0;width:100%;height:100%;border-radius:50%;fill-rule:evenodd"><g class="social-svg-icon" style="transition:fill 170ms ease-in-out;fill:white"><path d="M0,0H64V64H0ZM0 0v64h64V0zm44.7 25.5v.8C44.7 35 38.1 45 26.1 45c-3.7 0-7.2-1.1-10.1-2.9.5.1 1 .1 1.6.1 3.1 0 5.9-1 8.2-2.8-2.9-.1-5.3-2-6.1-4.6.4.1.8.1 1.2.1.6 0 1.2-.1 1.7-.2-3-.6-5.3-3.3-5.3-6.4v-.1c.9.5 1.9.8 3 .8-1.8-1.2-2.9-3.2-2.9-5.5q0-1.8.9-3.3c3.2 4 8.1 6.6 13.5 6.9-.1-.5-.2-1-.2-1.5 0-3.6 2.9-6.6 6.6-6.6 1.9 0 3.6.8 4.8 2.1 1.5-.3 2.9-.8 4.2-1.6-.5 1.5-1.5 2.8-2.9 3.6 1.3-.2 2.6-.5 3.8-1-1 1.3-2.1 2.4-3.4 3.4"></path></g><g class="social-svg-mask" style="transition:fill 170ms ease-in-out;fill:#00aced"><path d="M0 0v64h64V0zm44.7 25.5v.8C44.7 35 38.1 45 26.1 45c-3.7 0-7.2-1.1-10.1-2.9.5.1 1 .1 1.6.1 3.1 0 5.9-1 8.2-2.8-2.9-.1-5.3-2-6.1-4.6.4.1.8.1 1.2.1.6 0 1.2-.1 1.7-.2-3-.6-5.3-3.3-5.3-6.4v-.1c.9.5 1.9.8 3 .8-1.8-1.2-2.9-3.2-2.9-5.5q0-1.8.9-3.3c3.2 4 8.1 6.6 13.5 6.9-.1-.5-.2-1-.2-1.5 0-3.6 2.9-6.6 6.6-6.6 1.9 0 3.6.8 4.8 2.1 1.5-.3 2.9-.8 4.2-1.6-.5 1.5-1.5 2.8-2.9 3.6 1.3-.2 2.6-.5 3.8-1-1 1.3-2.1 2.4-3.4 3.4"></path></g></svg></span></a><a href="https://www.linkedin.com/company/thecenterforbiosimilars" class="social-icon mx-0.5 mb-1" target="_blank" rel="noopener noreferrer" style="display:inline-block;width:30px;height:30px;position:relative;overflow:hidden;vertical-align:middle" aria-label="linkedin"><span class="social-container" style="position:absolute;top:0;left:0;width:100%;height:100%"><svg role="img" aria-label="linkedin social icon" class="social-svg" viewBox="0 0 64 64" style="position:absolute;top:0;left:0;width:100%;height:100%;border-radius:50%;fill-rule:evenodd"><g class="social-svg-icon" style="transition:fill 170ms ease-in-out;fill:white"><path d="M0,0H64V64H0ZM0 0v64h64V0zm25.8 44h-5.4V26.6h5.4zm-2.7-19.7c-1.7 0-3.1-1.4-3.1-3.1s1.4-3.1 3.1-3.1 3.1 1.4 3.1 3.1-1.4 3.1-3.1 3.1M46 44h-5.4v-8.4c0-2 0-4.6-2.8-4.6s-3.2 2.2-3.2 4.5V44h-5.4V26.6h5.2V29h.1c.7-1.4 2.5-2.8 5.1-2.8 5.5 0 6.5 3.6 6.5 8.3V44z"></path></g><g class="social-svg-mask" style="transition:fill 170ms ease-in-out;fill:#007fb1"><path d="M0 0v64h64V0zm25.8 44h-5.4V26.6h5.4zm-2.7-19.7c-1.7 0-3.1-1.4-3.1-3.1s1.4-3.1 3.1-3.1 3.1 1.4 3.1 3.1-1.4 3.1-3.1 3.1M46 44h-5.4v-8.4c0-2 0-4.6-2.8-4.6s-3.2 2.2-3.2 4.5V44h-5.4V26.6h5.2V29h.1c.7-1.4 2.5-2.8 5.1-2.8 5.5 0 6.5 3.6 6.5 8.3V44z"></path></g></svg></span></a><a href="/rss" class="social-icon mx-0.5 mb-1" target="_blank" rel="noopener noreferrer" style="display:inline-block;width:30px;height:30px;position:relative;overflow:hidden;vertical-align:middle" aria-label="rss"><span class="social-container" style="position:absolute;top:0;left:0;width:100%;height:100%"><svg role="img" aria-label="rss social icon" class="social-svg" viewBox="0 0 64 64" style="position:absolute;top:0;left:0;width:100%;height:100%;border-radius:50%;fill-rule:evenodd"><g class="social-svg-icon" style="transition:fill 170ms ease-in-out;fill:white"><path d="M0,0H64V64H0ZM0 0v64h64V0zm24 44c-2.2 0-4-1.8-4-4s1.8-4 4-4 4 1.8 4 4-1.8 4-4 4m11-1c-1.1 0-2-.9-2-2 0-5.5-4.5-10-10-10-1.1 0-2-.9-2-2s.9-2 2-2c7.7 0 14 6.3 14 14 0 1.1-.9 2-2 2m9 0c-1.1 0-2-.9-2-2 0-10.5-8.5-19-19-19-1.1 0-2-.9-2-2s.9-2 2-2c12.7 0 23 10.3 23 23 0 1.1-.9 2-2 2"></path></g><g class="social-svg-mask" style="transition:fill 170ms ease-in-out;fill:#EF8733"><path d="M0 0v64h64V0zm24 44c-2.2 0-4-1.8-4-4s1.8-4 4-4 4 1.8 4 4-1.8 4-4 4m11-1c-1.1 0-2-.9-2-2 0-5.5-4.5-10-10-10-1.1 0-2-.9-2-2s.9-2 2-2c7.7 0 14 6.3 14 14 0 1.1-.9 2-2 2m9 0c-1.1 0-2-.9-2-2 0-10.5-8.5-19-19-19-1.1 0-2-.9-2-2s.9-2 2-2c12.7 0 23 10.3 23 23 0 1.1-.9 2-2 2"></path></g></svg></span></a></div></div></div></div></div></div><div class="w-full bg-secondary flex justify-center"><div class="bg-secondary w-[85%] text-subfooter-text-color text-sm font-bold"><div class="flex flex-col gap-8 md:flex-row justify-between p-4 md:py-4 md:px-12"><div>© 2025 MJH Life Sciences <br/> <br/> All rights reserved.</div><div class="flex flex-column" style="gap:2rem;align-items:center"></div></div></div></div></div></div></div><script id="__NEXT_DATA__" type="application/json">{"props":{"pageProps":{"pageProps":{},"cache":{"main_menu":[{"subQuery":[{"_id":"58b4a03c-8e70-471a-95c9-ac322f4a72d1","navParent":{"_ref":"7d980965-578f-473c-b6af-d323e8b2f8bb","_type":"reference"},"_createdAt":"2024-03-14T14:51:33Z","_rev":"1ZDoghw0ceFXt1b8vmU9OS","_type":"mainNavigation","children":[],"url":"/news","is_active":true,"name":"All News","_updatedAt":"2024-03-14T14:51:54Z"},{"navParent":{"_ref":"7d980965-578f-473c-b6af-d323e8b2f8bb","_type":"reference"},"_createdAt":"2024-03-14T14:52:01Z","_type":"mainNavigation","is_active":true,"_id":"23ddd799-7a22-43e0-84c9-26387232f35b","url":"/approvals-launches","children":[],"_rev":"1ZDoghw0ceFXt1b8vmUBth","name":"Product Approvals and Launches","_updatedAt":"2024-03-14T14:52:47Z"}],"_createdAt":"2020-08-09T14:44:47Z","_rev":"Lgcx1i9ZmEZPHyiR3ar7Pd","_updatedAt":"2020-08-09T14:44:47Z","url":"/news","sortOrder":1,"_type":"mainNavigation","name":"News","is_active":true,"_id":"7d980965-578f-473c-b6af-d323e8b2f8bb","navParent":null},{"_id":"9ba4516f-0913-4b1c-9118-6b0b23ceb52b","is_active":true,"_updatedAt":"2020-08-09T14:44:56Z","sortOrder":2,"name":"Media","_type":"mainNavigation","_createdAt":"2020-08-09T14:44:51Z","_rev":"Kf2pBuP6hv7gy8TwLlddxl","navParent":null,"subQuery":[{"_type":"mainNavigation","url":"/videos","navParent":{"_ref":"9ba4516f-0913-4b1c-9118-6b0b23ceb52b","_type":"reference"},"_createdAt":"2020-08-09T14:45:04Z","name":"All Videos","_id":"99513dfd-7ea2-4195-90ef-6e9d9dc6d7ba","_rev":"H5VZhhXIdSGa4pAmh0fbQH","_updatedAt":"2020-08-09T14:45:42Z","children":[],"is_active":true},{"name":"Insights","_createdAt":"2020-08-09T14:46:09Z","_type":"mainNavigation","navParent":{"_ref":"9ba4516f-0913-4b1c-9118-6b0b23ceb52b","_type":"reference"},"children":[],"_updatedAt":"2020-08-09T14:46:15Z","is_active":true,"_rev":"Kf2pBuP6hv7gy8TwLldemr","_id":"03b335ee-2ba7-4205-8544-9e38ecb3fbf9","url":"/insights"},{"_id":"275e4e55-2b54-4304-8c2a-564c36e4123c","url":"/interviews","_rev":"Ta5zvuQiedEoSykjik6An8","children":[],"navParent":{"_ref":"9ba4516f-0913-4b1c-9118-6b0b23ceb52b","_type":"reference"},"_createdAt":"2020-08-09T14:45:44Z","_type":"mainNavigation","name":"Interviews","_updatedAt":"2020-08-09T14:45:54Z","is_active":true},{"_updatedAt":"2020-08-09T14:46:06Z","navParent":{"_ref":"9ba4516f-0913-4b1c-9118-6b0b23ceb52b","_type":"reference"},"name":"Peer Exchange","is_active":true,"_rev":"Kf2pBuP6hv7gy8TwLldeib","_type":"mainNavigation","_id":"80d5029c-6af1-4611-b172-5e2830ce0f0b","url":"/peer-exchange","children":[],"_createdAt":"2020-08-09T14:45:57Z"},{"name":"Podcasts","_id":"d8b4a0f7-a07a-4f86-bd81-6382dbde5e14","url":"/podcasts","_updatedAt":"2020-08-09T14:47:51Z","_type":"mainNavigation","is_active":true,"navParent":{"_ref":"9ba4516f-0913-4b1c-9118-6b0b23ceb52b","_type":"reference"},"_createdAt":"2020-08-09T14:46:20Z","_rev":"H5VZhhXIdSGa4pAmh0fi05","children":[]},{"_createdAt":"2023-07-07T12:49:29Z","_id":"de1f4b42-1e4a-4423-a08b-363e6f3fb91e","is_active":true,"navParent":{"_type":"reference","_ref":"9ba4516f-0913-4b1c-9118-6b0b23ceb52b"},"_type":"mainNavigation","url":"/stakeholder-summit","name":"Stakeholder Summit","_updatedAt":"2023-07-07T12:49:40Z","_rev":"g6jQfphPC08g5R6SRqrNDI","children":[]}]},{"_type":"mainNavigation","_rev":"0TowddpnSMVYA5OKF4PyF4","subQuery":[{"_id":"55f10fbe-2421-4fea-abe1-e892f2a0a5b2","url":"/clinical/bone-health","is_active":true,"_rev":"9FmMOHbZubRaZ9Izz5v9pu","_type":"mainNavigation","name":"Bone Health","_updatedAt":"2022-08-01T16:52:56Z","_createdAt":"2022-08-01T16:51:27Z","children":[],"navParent":{"_ref":"2a7671ed-18d7-40e9-9d44-b8af0d407eff","_type":"reference"}},{"_updatedAt":"2020-09-08T21:45:56Z","name":"Dermatology","_createdAt":"2020-09-08T21:45:56Z","_rev":"kHSAga6vQdrwoTeQT6tyym","children":[],"is_active":true,"_id":"54da0f77-9f4e-4fa9-abab-f5e6ea9fd4d2","url":"/clinical/dermatology","navParent":{"_type":"reference","_ref":"2a7671ed-18d7-40e9-9d44-b8af0d407eff"},"_type":"mainNavigation"},{"_id":"3ca55f41-9edf-4294-a231-a32a63e9cc2b","url":"/clinical/diabetes","navParent":{"_ref":"2a7671ed-18d7-40e9-9d44-b8af0d407eff","_type":"reference"},"_createdAt":"2020-09-08T21:46:12Z","name":"Diabetes","is_active":true,"_rev":"l1CwC9FSSvQkCwYdkA5Lkb","_updatedAt":"2022-05-16T19:29:01Z","children":[],"_type":"mainNavigation"},{"url":"/clinical/gastroenterology","_id":"13b3dd33-19e8-420c-b3bf-947711c911c3","navParent":{"_ref":"2a7671ed-18d7-40e9-9d44-b8af0d407eff","_type":"reference"},"_rev":"hEwy1JDraPw3ELC96zkMH0","_type":"mainNavigation","_updatedAt":"2020-09-08T21:46:44Z","is_active":true,"_createdAt":"2020-09-08T21:46:29Z","name":"Gastroenterology","children":[]},{"_rev":"MBXP2u5Q4KlRKlqOxhTjp7","name":"Hematology","_id":"5f447aab-70e2-44a5-8228-d1663ca139ed","is_active":true,"_createdAt":"2022-08-01T16:53:47Z","children":[],"_updatedAt":"2022-08-01T16:54:14Z","navParent":{"_type":"reference","_ref":"2a7671ed-18d7-40e9-9d44-b8af0d407eff"},"_type":"mainNavigation","url":"/clinical/hematology"},{"_createdAt":"2023-06-13T17:10:47Z","name":"Immunology","_type":"mainNavigation","_id":"f9cbaaf2-b433-4621-bfd5-67989e803a17","url":"/clinical/immunology","is_active":true,"_updatedAt":"2023-06-13T17:10:47Z","_rev":"H8zpYhraSXr4uXimD5TCST","navParent":{"_ref":"2a7671ed-18d7-40e9-9d44-b8af0d407eff","_type":"reference"},"children":[]},{"_rev":"gJYSzG7kkH11G1HPQT63DZ","name":"Neurology","children":[],"navParent":{"_type":"reference","_ref":"2a7671ed-18d7-40e9-9d44-b8af0d407eff"},"is_active":true,"_type":"mainNavigation","url":"/clinical/neurology","_createdAt":"2020-09-08T21:46:47Z","_id":"9c150160-b20f-4195-98b1-a076225e227e","_updatedAt":"2020-09-08T21:47:43Z"},{"is_active":true,"_type":"mainNavigation","_id":"88dae47f-f92b-4da4-b890-5d121e1cca83","url":"/clinical/oncology","navParent":{"_ref":"2a7671ed-18d7-40e9-9d44-b8af0d407eff","_type":"reference"},"name":"Oncology","_createdAt":"2020-09-08T21:47:54Z","_rev":"zgvz2vmBMCw5oB6hXqXUSQ","_updatedAt":"2020-09-08T21:47:58Z","children":[]},{"_id":"a8e86af0-b98e-4263-b4dc-3c185501ea4d","children":[],"is_active":true,"navParent":{"_ref":"2a7671ed-18d7-40e9-9d44-b8af0d407eff","_type":"reference"},"_createdAt":"2020-09-08T21:48:42Z","_rev":"qosvO88ddt4DprA5b42hYT","name":"Ophthalmology","_updatedAt":"2020-09-08T21:48:58Z","url":"/clinical/ophthalmology","_type":"mainNavigation"},{"navParent":{"_ref":"2a7671ed-18d7-40e9-9d44-b8af0d407eff","_type":"reference"},"_rev":"qKZt0XU04pglJePLDoXypP","_type":"mainNavigation","_createdAt":"2020-09-08T21:48:31Z","_updatedAt":"2021-02-05T13:14:16Z","url":"/clinical/rare-disease","is_active":true,"name":"Rare Disease","_id":"dd676e47-2a23-4ae0-9a2b-cec681006d76","children":[]},{"is_active":true,"navParent":{"_ref":"2a7671ed-18d7-40e9-9d44-b8af0d407eff","_type":"reference"},"_createdAt":"2022-10-17T13:18:46Z","name":"Respiratory","_rev":"sPo7uhLOLfC5IC8EMozLe0","_type":"mainNavigation","_id":"cb497e52-27b6-4286-9116-68778c10b2fe","_updatedAt":"2023-04-10T14:45:17Z","url":"/clinical/respiratory","children":[]},{"_updatedAt":"2020-09-08T21:48:26Z","name":"Rheumatology","url":"/clinical/rheumatology","is_active":true,"navParent":{"_ref":"2a7671ed-18d7-40e9-9d44-b8af0d407eff","_type":"reference"},"_createdAt":"2020-09-08T21:48:00Z","_id":"30d466ee-9162-4fe5-8fcd-619d451a2a0b","children":[],"_rev":"zgvz2vmBMCw5oB6hXqXV4M","_type":"mainNavigation"}],"is_active":true,"_id":"2a7671ed-18d7-40e9-9d44-b8af0d407eff","_updatedAt":"2022-08-30T15:18:16Z","_createdAt":"2020-08-09T14:46:51Z","name":"Compendia","navParent":null,"sortOrder":3},{"sortOrder":4,"_id":"21f078b5-c8ea-490c-9c8c-1c1620976472","subQuery":[{"url":"/latest-conference","_type":"mainNavigation","_id":"fe764385-ee32-48c6-a2db-d71c88915e4f","_updatedAt":"2020-08-21T17:54:49Z","_rev":"5NSo4DlKj6Rwd777Ay2zaM","name":"Conference Coverage","is_active":true,"navParent":{"_ref":"21f078b5-c8ea-490c-9c8c-1c1620976472","_type":"reference"},"_createdAt":"2020-08-21T17:54:43Z","children":[]},{"is_active":true,"_createdAt":"2020-08-21T17:54:30Z","_rev":"5NSo4DlKj6Rwd777Ay2z33","url":"/conference","navParent":{"_ref":"21f078b5-c8ea-490c-9c8c-1c1620976472","_type":"reference"},"_updatedAt":"2020-08-21T17:54:39Z","children":[],"_type":"mainNavigation","name":"Conference Listing","_id":"2c560b13-9a08-4df7-a046-470d5b266c7c"}],"_rev":"0CgcPe2fHTSHqd5hjkC6ne","_type":"mainNavigation","name":"Conferences","_createdAt":"2020-08-09T14:49:40Z","_updatedAt":"2020-08-13T17:15:59Z","url":"/conference","navParent":null,"is_active":true},{"_type":"mainNavigation","name":"CME/CE","_id":"fddccca1-2115-4130-8605-c6cb562c39d7","url":"/continuing-education","sortOrder":5,"navParent":null,"_updatedAt":"2021-01-28T22:15:22Z","is_active":true,"_createdAt":"2020-08-09T14:51:59Z","_rev":"YhOde3kZoemWRwPqRdTirb","subQuery":[]},{"_updatedAt":"2021-01-28T22:15:16Z","subQuery":[{"navParent":{"_ref":"0e519714-27c5-4939-8302-12d68d9ad3ee","_type":"reference"},"_updatedAt":"2020-09-18T17:31:49Z","_createdAt":"2020-08-26T22:25:34Z","url":"/authors","is_active":true,"children":[],"_rev":"QCup5rUf2xeVHlPXiUJXev","_id":"9b247f4e-bb03-4e75-8455-43010acf8a21","_type":"mainNavigation","name":"Authors"},{"children":[],"_createdAt":"2020-08-09T14:51:23Z","url":"/resources","_rev":"QkmWP1o3mzPTklUjZ7wi54","_id":"90121c85-1600-4c67-9984-e9c060fa5767","is_active":true,"_type":"mainNavigation","name":"Biosimilar Resources","navParent":{"_ref":"0e519714-27c5-4939-8302-12d68d9ad3ee","_type":"reference"},"_updatedAt":"2020-10-08T16:20:45Z"},{"navParent":{"_type":"reference","_ref":"0e519714-27c5-4939-8302-12d68d9ad3ee"},"_type":"mainNavigation","url":"/interactive-tools","is_active":true,"_rev":"lyPumz4JwtPETh8Y1Ib4yr","children":[],"_updatedAt":"2022-11-16T22:30:48Z","_createdAt":"2022-11-16T22:30:48Z","name":"Interactive Tools","_id":"30f5bb80-9a60-476b-ba9b-9ee41bbfdb79"},{"is_active":true,"_rev":"5HObGkyfNibktHt3SyDnHy","name":"Partners","navParent":{"_type":"reference","_ref":"0e519714-27c5-4939-8302-12d68d9ad3ee"},"_createdAt":"2023-10-16T19:03:54Z","_type":"mainNavigation","_id":"d7723105-2009-4216-9f14-7dd61454f51c","children":[],"_updatedAt":"2023-10-16T19:08:06Z","url":"/sap-partners"},{"_updatedAt":"2024-03-14T15:59:38Z","is_active":true,"name":"Polls and Quizzes","children":[],"_type":"mainNavigation","_rev":"x4HEgCqEUGXvPphceM8sdu","url":"/polls","navParent":{"_ref":"0e519714-27c5-4939-8302-12d68d9ad3ee","_type":"reference"},"_createdAt":"2020-10-16T14:16:15Z","_id":"b52d79f7-5041-4abc-91ce-85c8a44e8120"},{"children":[],"is_active":true,"_rev":"1ZDoghw0ceFXt1b8vmUXIJ","url":"/sponsored","navParent":{"_ref":"0e519714-27c5-4939-8302-12d68d9ad3ee","_type":"reference"},"_createdAt":"2024-03-14T14:55:15Z","_id":"c49c51a3-6aa0-4264-9430-569dec5e65bf","_updatedAt":"2024-03-14T14:55:35Z","_type":"mainNavigation","name":"Sponsored"},{"is_active":true,"navParent":{"_ref":"0e519714-27c5-4939-8302-12d68d9ad3ee","_type":"reference"},"_type":"mainNavigation","url":"/when-choice-arrives-competition-consequences","children":[],"_createdAt":"2022-09-06T14:43:03Z","name":"WHEN CHOICE ARRIVES: Competition \u0026 Consequences","_id":"c75c0714-fd2f-4d86-afad-6fe673542106","_rev":"l10r5LpBVJjj3bYjPckOs6","_updatedAt":"2022-09-06T14:44:01Z"}],"_rev":"3ZLFv6zkTKtlSEmNi63p5f","name":"Resources","navParent":null,"_createdAt":"2020-08-09T14:50:21Z","_type":"mainNavigation","is_active":true,"sortOrder":6,"_id":"0e519714-27c5-4939-8302-12d68d9ad3ee"},{"_type":"mainNavigation","needSegmentSupport":true,"url":"https://one.centerforbiosimilars.com/subscribe","_rev":"EO2Zo2JbM8aDgDFpppBJoC","_updatedAt":"2024-04-08T16:13:43Z","navParent":null,"subQuery":[],"blank":false,"is_active":true,"sortOrder":7,"name":"Subscribe","_id":"2d11fd44-7331-44b6-a004-6173fe542e0f","_createdAt":"2020-08-24T13:28:31Z"},{"is_active":true,"url":"/biosimilar-approvals","_createdAt":"2021-04-28T20:27:08Z","_id":"f86593d5-6def-446a-afdc-0b097800133c","navParent":null,"subQuery":[],"_rev":"wyNtuZotY1QmDJCqZSEeJ1","_updatedAt":"2021-05-03T19:21:56Z","sortOrder":8,"_type":"mainNavigation","name":"BIOSIMILAR APPROVALS"}],"sub_menu":[{"is_active":true,"_rev":"hEwy1JDraPw3ELC96zkMQC","name":"Business Practice","url":"/business-practice","navParent":null,"subQuery":[{"_id":"a0ea2a10-461f-4a8f-9344-70a95da877a2","_createdAt":"2020-09-08T21:52:13Z","is_active":true,"name":"Business","_updatedAt":"2020-09-08T21:52:23Z","children":[],"url":"/business-practice/business","navParent":{"_ref":"ee55c789-c238-43f6-86c6-abeb5f37fbd3","_type":"reference"},"_rev":"zgvz2vmBMCw5oB6hXqXaGo","_type":"subNavigation"},{"_type":"subNavigation","_updatedAt":"2020-09-08T21:51:42Z","_rev":"A9Dg68evx7wkFsC4i4fRgP","_id":"1f6dfbca-58af-4237-a52c-85771dd93862","name":"Development","children":[],"url":"/business-practice/development","is_active":true,"navParent":{"_ref":"ee55c789-c238-43f6-86c6-abeb5f37fbd3","_type":"reference"},"_createdAt":"2020-09-08T21:51:34Z"},{"is_active":true,"navParent":{"_type":"reference","_ref":"ee55c789-c238-43f6-86c6-abeb5f37fbd3"},"_createdAt":"2020-09-08T21:51:53Z","_id":"09479321-5609-44a5-acb7-816f09ab67c7","_updatedAt":"2020-09-08T21:51:58Z","url":"/business-practice/legal","children":[],"name":"Legal","_rev":"zgvz2vmBMCw5oB6hXqXZJX","_type":"subNavigation"},{"_type":"subNavigation","url":"/business-practice/policy","is_active":true,"name":"Policy","_updatedAt":"2020-09-08T21:51:20Z","navParent":{"_ref":"ee55c789-c238-43f6-86c6-abeb5f37fbd3","_type":"reference"},"_rev":"gJYSzG7kkH11G1HPQT68RW","_id":"390b50cb-54cc-43bf-b62f-5178f62124c9","children":[],"_createdAt":"2020-09-08T21:51:05Z"},{"_createdAt":"2020-09-08T21:50:30Z","_rev":"sJEfK83EkRwBaVUoBLOqu2","is_active":true,"navParent":{"_ref":"ee55c789-c238-43f6-86c6-abeb5f37fbd3","_type":"reference"},"_type":"subNavigation","name":"Practice","_id":"5b67f398-5cb3-4624-aa44-f26e69ba0ea4","children":[],"_updatedAt":"2020-09-08T21:51:01Z","url":"/business-practice/practice"},{"_type":"subNavigation","name":"Regulatory","_createdAt":"2020-08-09T14:57:35Z","_id":"4a4b0596-0616-46e7-a3e1-d15056b3e4fc","is_active":true,"navParent":{"_ref":"ee55c789-c238-43f6-86c6-abeb5f37fbd3","_type":"reference"},"children":[],"_rev":"4ZuyxDEmzwMm18OIMMuDzn","_updatedAt":"2020-09-08T21:50:15Z","url":"/business-practice/regulatory"}],"_createdAt":"2020-08-09T14:52:42Z","_type":"subNavigation","_id":"ee55c789-c238-43f6-86c6-abeb5f37fbd3","_updatedAt":"2020-09-08T21:47:29Z","sortOrder":2}],"site_setting":{"creativeLayoutLatestNews":null,"creativeLayout":null,"name":"Center for Biosimilars®","_id":"siteSettings","siteURL":"www.centerforbiosimilars.com","footerLinks":[{"url":"/about","blank":false,"_type":"urlArray","_key":"446d58277824","title":"About"},{"_type":"urlArray","_key":"156be510ef64","title":"Editorial","url":"/editorial-info"},{"_type":"urlArray","_key":"58f8abec94ec","title":"Contact","url":"/contactus"},{"_type":"urlArray","_key":"e499e550f754","title":"Advisory Board","url":"/advisory-board","blank":false},{"url":"https://www.mjhlifesciences.com/ccpa?domain=www.centerforbiosimilars.com","blank":true,"_type":"urlArray","_key":"e9567dac9f5e","title":"Do Not Sell My Information"},{"title":"Terms \u0026 Conditions","url":"/terms","_type":"urlArray","_key":"11ba3db95c21"},{"_type":"urlArray","_key":"dd82c5aa7cd9","title":"Privacy Policy","url":"/privacy"}],"_updatedAt":"2024-10-07T20:38:55Z","salesforceDMPId":"tr3xtnqs4","socialLinks":[{"blank":true,"_type":"urlArray","_key":"ab3bc841b062","title":"Facebook","url":"https://www.facebook.com/centerforbiosimilars/"},{"title":"Twitter","url":"https://twitter.com/biosimcenter","blank":true,"_type":"urlArray","_key":"0dc5478aadb2"},{"blank":true,"_type":"urlArray","_key":"e1f8bcdb1cc9","title":"LinkedIn","url":"https://www.linkedin.com/company/thecenterforbiosimilars"},{"blank":true,"_type":"urlArray","_key":"484940393d3b","title":"RSS","url":"/rss"}],"keywords":["biosimilars","biosimilar","interchangeability","interchangeable biosimilars","interchangeable biosimilar","biosimilar resources","bio-betters","biobetters","biologics","biologic drugs","biosimilar savings","biosimilar development","biosimilars in the clinical setting","biologic medications","biosimilar drugs","biosimilar medications","oncology biosimilars","rheumatology biosimilars","ophthalmology biosimilars","biosimilar insulin","biosimilar insulins"],"_rev":"rhDmS6Gdu0v6MDhOtH8BqE","_type":"siteSettings","gaID":"UA-155582410-8,UA-52040367-14","_createdAt":"2020-08-05T14:15:09Z"},"clinicalData":[{"identifier":"bone-health","sortOrder":null,"children":[],"_id":"05e5f38b-70fb-446c-a5f1-730b55ae60c4","name":"Bone Health"},{"_id":"0e0699e0-52d7-44f9-80af-961274664d4e","name":"Immunology","identifier":"immunology","sortOrder":null,"children":[]},{"name":"Hematology","identifier":"hematology","sortOrder":null,"children":[],"_id":"46a8d177-4750-43b6-b678-0cddd4f63c6a"},{"_id":"471b60a8-afe5-43cb-a980-6cc259dedcbf","name":"Respiratory","identifier":"respiratory","sortOrder":null,"children":[]},{"children":[],"_id":"clinical_dermatology","name":"Dermatology","identifier":"dermatology","sortOrder":null},{"sortOrder":null,"children":[],"_id":"clinical_endocrinology","name":"Diabetes","identifier":"diabetes"},{"_id":"clinical_gastroenterology","name":"Gastroenterology","identifier":"gastroenterology","sortOrder":null,"children":[]},{"_id":"clinical_neurology","name":"Neurology","identifier":"neurology","sortOrder":null,"children":[]},{"_id":"clinical_oncology","name":"Oncology","identifier":"oncology","sortOrder":null,"children":[]},{"sortOrder":null,"children":[],"_id":"clinical_ophthalmology","name":"Ophthalmology","identifier":"ophthalmology"},{"_id":"clinical_rare-disease","name":"Rare Disease","identifier":"rare-disease","sortOrder":null,"children":[]},{"_id":"clinical_rheumatology","name":"Rheumatology","identifier":"rheumatology","sortOrder":null,"children":[]}],"seo_data":[],"recent_news":[{"factCheckAuthorMapping":null,"_id":"51aaad69-510e-4f0f-9fe2-d4f404858cb5","summary":"Alvotech's 427% revenue surge in 2024—fueled by its biosimilar portfolio and global expansion—highlights the booming profitability of biosimilars despite financial hurdles.","thumbnail":{"asset":{"_ref":"image-229ca2e182044b95580c7d9dbf79fd1cb5ad2235-1200x673-jpg","_type":"reference"},"_type":"mainImage","alt":"biosimilars and revenue | Image credit: เด็กชาย นุ่มนิ่ม - stock.adobe.com"},"contentCategory":{"_createdAt":"2020-08-04T20:13:00Z","_rev":"4Q6wgk7hVHKTxcqSyF2TXp","_type":"contentCategory","name":"Articles","_id":"eb370a31-7ecb-48a0-b30a-dba92e00ef67","_updatedAt":"2020-08-04T20:13:00Z"},"title":"Biosimilars Help Alvotech Revenues Soar Over 400% Year Over Year","url":{"current":"biosimilars-help-alvotech-revenues-soar-over-400-year-over-year","_type":"slug"},"published":"2025-03-31T11:00:00.000Z","authorMapping":{"_rev":"4ZuyxDEmzwMm18OIMMboYl","_type":"author","_id":"author_23eb58ee573d6006f4342daadc88b50b","_updatedAt":"2020-09-08T17:02:23Z","url":{"current":"skylar-jeremias","_type":"slug"},"displayName":"Skylar Jeremias","_createdAt":"2020-08-04T17:51:57Z"}},{"summary":"Josh Canavan, PharmD, RazorMetrics, and Chris O'Dell, Turquoise Health, predict pharmacy benefit managers (PBMs) will evolve toward value-based care, mirroring the broader shift toward open-cost structures.","thumbnail":{"alt":"Josh Canavan, PharmD, head of pharmacy at RazorMetrics and Chris O'Dell, senior vice president of market solutions at Turquoise Health.","caption":"Josh Canavan, PharmD, head of pharmacy at RazorMetrics and Chris O'Dell, senior vice president of market solutions at Turquoise Health, predict PBMs will evolve towards value-based care, prioritizing patient outcomes and transparency in pharmacy pricing, mirroring the broader health care shift towards open cost structures. | Image Credit: leowolfert - stock.adobe.com ","asset":{"_ref":"image-f7ea168fd491fe55481fad0fd2ca7544df68ea0a-3750x2000-png","_type":"reference"},"_type":"mainImage"},"published":"2025-03-30T11:00:00.000Z","authorMapping":{"_id":"3afbcfbf-b725-4cd8-8e3c-142992f6cc89","_updatedAt":"2023-11-20T18:28:51Z","lastName":"Santoro","displayName":"Cameron Santoro","_createdAt":"2023-11-20T18:28:51Z","biography":[{"style":"normal","_key":"f57ce2e9a319","markDefs":[],"children":[{"text":"Cameron Santoro is an associate editor for The Center for Biosimilars","_key":"9458b389b183","_type":"span","marks":[]},{"_type":"span","marks":["superscript"],"text":"®","_key":"80fe4d24912e"},{"_type":"span","marks":[],"text":", ","_key":"1ad242721b85"},{"_type":"span","marks":["em"],"text":"The American Journal of Managed Care","_key":"5270e21a5c17"},{"_key":"36786075498b","_type":"span","marks":["superscript"],"text":"®"},{"_type":"span","marks":[],"text":" (AJMC), and AJMC.com.","_key":"6191c0c3b149"}],"_type":"block"}],"url":{"current":"cameron-santoro","_type":"slug"},"firstName":"Cameron","_rev":"DgYFbq3Xfr6YTckt9qD7Yh","_type":"author"},"contentCategory":{"_type":"contentCategory","name":"Articles","_id":"eb370a31-7ecb-48a0-b30a-dba92e00ef67","_updatedAt":"2020-08-04T20:13:00Z","_createdAt":"2020-08-04T20:13:00Z","_rev":"4Q6wgk7hVHKTxcqSyF2TXp"},"url":{"current":"pbm-evolution-towards-value-based-care-shifts-to-transparent-pharmacy-pricing","_type":"slug"},"factCheckAuthorMapping":null,"_id":"66cfe33d-74fc-4a7e-a59e-a5a4a9e8aa29","title":"PBM Evolution Toward Value-Based Care Shifts to Transparent Pharmacy Pricing"},{"url":{"_type":"slug","current":"the-top-5-biosimilar-articles-for-the-week-of-march-24"},"factCheckAuthorMapping":null,"contentCategory":{"_id":"6abd2b43-1ffe-4bd4-bcfe-31be0fd63364","_updatedAt":"2020-08-04T20:13:06Z","_createdAt":"2020-08-04T20:13:06Z","_rev":"4Q6wgk7hVHKTxcqSyF2Tqg","_type":"contentCategory","name":"Videos"},"_id":"8fa787cd-a8c0-40be-9a5f-6b0431c9999d","title":"The Top 5 Biosimilar Articles for the Week of March 24","published":"2025-03-28T11:00:00.000Z","authorMapping":{"firstName":"Cameron","_rev":"DgYFbq3Xfr6YTckt9qD7Yh","_type":"author","_id":"3afbcfbf-b725-4cd8-8e3c-142992f6cc89","_updatedAt":"2023-11-20T18:28:51Z","lastName":"Santoro","displayName":"Cameron Santoro","_createdAt":"2023-11-20T18:28:51Z","biography":[{"markDefs":[],"children":[{"text":"Cameron Santoro is an associate editor for The Center for Biosimilars","_key":"9458b389b183","_type":"span","marks":[]},{"_type":"span","marks":["superscript"],"text":"®","_key":"80fe4d24912e"},{"_type":"span","marks":[],"text":", ","_key":"1ad242721b85"},{"_type":"span","marks":["em"],"text":"The American Journal of Managed Care","_key":"5270e21a5c17"},{"_key":"36786075498b","_type":"span","marks":["superscript"],"text":"®"},{"_type":"span","marks":[],"text":" (AJMC), and AJMC.com.","_key":"6191c0c3b149"}],"_type":"block","style":"normal","_key":"f57ce2e9a319"}],"url":{"current":"cameron-santoro","_type":"slug"}},"summary":"Here are the top 5 biosimilar articles for the week of March 24, 2025. ","thumbnail":{"_type":"mainImage","alt":"Here are the top 5 biosimilar articles for the week of March 24, 2025. ","caption":"Here are the top 5 biosimilar articles for the week of March 24, 2025. ","asset":{"_ref":"image-055847b24eb25c4de818dc3f9b17dbcc30f51ca5-1920x1080-png","_type":"reference"}}},{"_id":"1f7a7b8f-c72a-4de0-a3cb-01cc20c42a71","title":"FDA Approves Another Pair of Denosumab Biosimilars, Conexxence and Bomyntra ","summary":"The FDA approved another set of denosumab biosimilars, Conexxence/Bomyntra (denosumab-bnht), expanding treatment options for osteoporosis, bone metastases, and other bone-related conditions, amidst a flurry of similar approvals and legal settlements.","url":{"current":"fda-approves-another-pair-of-denosumab-biosimilars-conexxence-and-bomyntra","_type":"slug"},"thumbnail":{"_type":"mainImage","alt":"FDA Approved. | Image Credit: gguy - stock.adobe.com ","caption":"The FDA approved another set of denosumab biosimilars, Conexxence/Bomyntra (denosumab-bnht) expanding treatment options for osteoporosis, bone metastases, and other bone-related conditions, amidst a flurry of similar approvals and legal settlements. | Image Credit: gguy - stock.adobe.com ","asset":{"_ref":"image-f61e00527e75d813a50dddfd0067d4c76d20d322-5778x3635-jpg","_type":"reference"}},"published":"2025-03-27T20:26:04.436Z","authorMapping":{"firstName":"Cameron","_rev":"DgYFbq3Xfr6YTckt9qD7Yh","_type":"author","_id":"3afbcfbf-b725-4cd8-8e3c-142992f6cc89","_updatedAt":"2023-11-20T18:28:51Z","lastName":"Santoro","displayName":"Cameron Santoro","_createdAt":"2023-11-20T18:28:51Z","biography":[{"markDefs":[],"children":[{"text":"Cameron Santoro is an associate editor for The Center for Biosimilars","_key":"9458b389b183","_type":"span","marks":[]},{"_type":"span","marks":["superscript"],"text":"®","_key":"80fe4d24912e"},{"_type":"span","marks":[],"text":", ","_key":"1ad242721b85"},{"_type":"span","marks":["em"],"text":"The American Journal of Managed Care","_key":"5270e21a5c17"},{"_key":"36786075498b","_type":"span","marks":["superscript"],"text":"®"},{"_type":"span","marks":[],"text":" (AJMC), and AJMC.com.","_key":"6191c0c3b149"}],"_type":"block","style":"normal","_key":"f57ce2e9a319"}],"url":{"current":"cameron-santoro","_type":"slug"}},"factCheckAuthorMapping":null,"contentCategory":{"name":"Articles","_id":"eb370a31-7ecb-48a0-b30a-dba92e00ef67","_updatedAt":"2020-08-04T20:13:00Z","_createdAt":"2020-08-04T20:13:00Z","_rev":"4Q6wgk7hVHKTxcqSyF2TXp","_type":"contentCategory"}}],"isLiveSite":true,"host":"www.centerforbiosimilars.com","settings":{"title":"Center for Biosimilars","networkID":"4688","adUnit":"centerforbiosimilars.com","liveDomain":"www.centerforbiosimilars.com","logo":"/Biosimilars_ajmc_logo.png","white_logo":"/BioSim_white.png","logoWidth":"200px","logoHeight":"30px","marginRightFromLogo":"3rem","mobileNavLogoHeight":"45px","mobileNavLogoWidth":"180px","enableEdgeCache":true,"sMaxAge":300,"staleWhileRevalidate":359,"megaMenuTaxName":"clinical","twitterHandle":"@BiosimCenter","useNewSubNavMegaMenu":true,"gateEnabled":false}},"targeting":{"content_placement":["home"],"document_url":["home"],"document_group":[],"rootDocumentGroup":[]},"data":{"topArticles":[{"authors":[{"displayName":"Skylar Jeremias","url":"skylar-jeremias"}],"title":"Biosimilars Help Alvotech Revenues Soar Over 400% Year Over Year","url":"biosimilars-help-alvotech-revenues-soar-over-400-year-over-year","thumbnail":{"_type":"mainImage","alt":"biosimilars and revenue | Image credit: เด็กชาย นุ่มนิ่ม - stock.adobe.com","asset":{"_type":"reference","_ref":"image-229ca2e182044b95580c7d9dbf79fd1cb5ad2235-1200x673-jpg"}},"summary":"Alvotech's 427% revenue surge in 2024—fueled by its biosimilar portfolio and global expansion—highlights the booming profitability of biosimilars despite financial hurdles.","published":"2025-03-31T11:00:00.000Z"},{"authors":[{"displayName":"Cameron Santoro","url":"cameron-santoro"}],"title":"PBM Evolution Toward Value-Based Care Shifts to Transparent Pharmacy Pricing","url":"pbm-evolution-towards-value-based-care-shifts-to-transparent-pharmacy-pricing","thumbnail":{"_type":"mainImage","alt":"Josh Canavan, PharmD, head of pharmacy at RazorMetrics and Chris O'Dell, senior vice president of market solutions at Turquoise Health.","caption":"Josh Canavan, PharmD, head of pharmacy at RazorMetrics and Chris O'Dell, senior vice president of market solutions at Turquoise Health, predict PBMs will evolve towards value-based care, prioritizing patient outcomes and transparency in pharmacy pricing, mirroring the broader health care shift towards open cost structures. | Image Credit: leowolfert - stock.adobe.com ","asset":{"_type":"reference","_ref":"image-f7ea168fd491fe55481fad0fd2ca7544df68ea0a-3750x2000-png"}},"summary":"Josh Canavan, PharmD, RazorMetrics, and Chris O'Dell, Turquoise Health, predict pharmacy benefit managers (PBMs) will evolve toward value-based care, mirroring the broader shift toward open-cost structures.","published":"2025-03-30T11:00:00.000Z"},{"authors":[{"displayName":"Cameron Santoro","url":"cameron-santoro"}],"title":"FDA Approves Another Pair of Denosumab Biosimilars, Conexxence and Bomyntra ","url":"fda-approves-another-pair-of-denosumab-biosimilars-conexxence-and-bomyntra","thumbnail":{"caption":"The FDA approved another set of denosumab biosimilars, Conexxence/Bomyntra (denosumab-bnht) expanding treatment options for osteoporosis, bone metastases, and other bone-related conditions, amidst a flurry of similar approvals and legal settlements. | Image Credit: gguy - stock.adobe.com ","asset":{"_ref":"image-f61e00527e75d813a50dddfd0067d4c76d20d322-5778x3635-jpg","_type":"reference"},"_type":"mainImage","alt":"FDA Approved. | Image Credit: gguy - stock.adobe.com "},"summary":"The FDA approved another set of denosumab biosimilars, Conexxence/Bomyntra (denosumab-bnht), expanding treatment options for osteoporosis, bone metastases, and other bone-related conditions, amidst a flurry of similar approvals and legal settlements.","published":"2025-03-27T20:26:04.436Z"},{"published":"2025-03-27T11:00:00.000Z","authors":[{"displayName":"Luke Halpern","url":"luke-halpern"}],"title":"As Biosimilar Substitutions Become More Common, Education and Patient Counseling Are Paramount","url":"as-biosimilar-substitutions-become-more-common-education-and-patient-counseling-are-paramount","thumbnail":{"_type":"mainImage","alt":"doctor talking to patient about biosimilars | Image credit: sebra - stock.adobe.com","asset":{"_type":"reference","_ref":"image-33ee25000ca99f7104221be3e70804bff1aed07d-7952x4472-jpg"}},"summary":"Pharmacists play an essential role in counseling patients on biosimilar substitution protocols and following state regulations regarding interchangeable medications."},{"title":"Adalimumab Biosimilars Show Similar Outcomes in Psoriasis After Nonmedical Switch","url":"adalimumab-biosimilars-show-similar-outcomes-in-psoriasis-after-nonmedical-switch","thumbnail":{"_type":"mainImage","alt":"psoraisis | Image credit: pimentos - stock.adobe.com","asset":{"_ref":"image-1d9e52f022f5262620c6e572b854f87e40781b95-8256x5504-jpg","_type":"reference"}},"summary":"Switching between adalimumab products does not affect drug effectiveness or treatment duration in patients who have psoriasis, according to a Danish study.","published":"2025-03-26T16:10:59.939Z","authors":[{"displayName":"Skylar Jeremias","url":"skylar-jeremias"}]}],"newsArticles":[{"title":"Biosimilar Natalizumab-sztn Shows Comparable Efficacy and Safety to Tysabri in RRMS","url":"biosimilar-natalizumab-sztn-shows-comparable-efficacy-and-safety-to-tysabri-in-rrms","thumbnail":{"alt":"Multiple Sclerosis. | Image Credit: Vitalii Vodolazskyi - stock.adobe.com ","caption":"Biosimilar natalizumab demonstrates comparable efficacy, safety, and immunogenicity to reference drug, Tysabri, in patients with relapsing-remitting multiple sclerosis (RRMS), supporting its potential as a cost-effective treatment option. | Image Credit: Vitalii Vodolazskyi - stock.adobe.com ","asset":{"_ref":"image-d0ab7e9d1f822e5110ccc662e47383e2a136403e-5500x3667-jpg","_type":"reference"},"_type":"mainImage"},"summary":"Biosimilar natalizumab demonstrated comparable efficacy, safety, and immunogenicity to reference drug Tysabri in patients with relapsing-remitting multiple sclerosis (RRMS), supporting its potential as a cost-effective treatment option.","published":"2025-03-25T11:00:00.000Z","authors":[{"displayName":"Cameron Santoro","url":"cameron-santoro"}]},{"title":"BioRationality: How Developers Can Expand Their Monoclonal Antibody Biosimilar Portfolio","url":"biorationality-how-developers-can-expand-their-monoclonal-antibody-biosimilar-portfolio","thumbnail":{"alt":"vials | Image credit: pixardi - stock.adobe.com","asset":{"_ref":"image-037ba6e825d5bb15eddd755c1ca3177cc1969175-3610x2406-jpg","_type":"reference"},"_type":"mainImage"},"summary":"Monoclonal antibodies lead biosimilar approvals because of their large market size, well-defined regulatory pathways, and technological feasibility, whereas other biologics encounter development challenges but may see increased adoption as regulatory frameworks advance.","published":"2025-03-24T17:49:27.689Z","authors":[{"displayName":"Sarfaraz K. Niazi, PhD","url":"sarfaraz-k-niazi-phd"}]},{"thumbnail":{"_type":"mainImage","alt":"ibd | Image credit: eddows - stock.adobe.com","asset":{"_type":"reference","_ref":"image-029904b32ea54f066770a7e724ce48ed0f3937ba-5472x3648-jpg"}},"summary":"People with inflammatory bowel disease (IBD) who switched to the infliximab biosimilar CT-P13 had higher treatment persistence (84% and 91%) than those new to infliximab (66% and 53%), with no new safety concerns.","published":"2025-03-23T00:51:57.170Z","authors":[{"displayName":"Deana Ferreri, PhD","url":"deana-ferreri-phd"}],"title":"Patients With IBD Maintain Therapy 2 Years Post Switching to Infliximab Biosimilar","url":"patients-with-ibd-maintain-therapy-2-years-post-switching-to-infliximab-biosimilar"},{"thumbnail":{"asset":{"_type":"reference","_ref":"image-1de84fdef1b73c894e44d3656d03ca79406c6288-5863x3913-jpg"},"_type":"mainImage","alt":"anti-tnf biologics and savings in Europe | Image credit: gopixa - stock.adobe.com"},"summary":"Tendering emerged as the most effective strategy for reducing costs and increasing biosimilar uptake in the retail setting, while price-linked discounts and prescribing quotas have shown mixed or uncertain results.","published":"2025-03-20T18:30:43.570Z","authors":[{"displayName":"Skylar Jeremias","url":"skylar-jeremias"}],"title":"Smart Tendering Policies Unlock Greater Biosimilar Savings","url":"smart-tendering-policies-unlock-greater-biosimilar-savings"},{"title":"Multiple Switches Between Adalimumab Biosimilar GP2017 and Humira for Psoriasis Maintain Biosimilarity","url":"multiple-switches-between-adalimumab-biosimilar-gp2017-and-humira-for-psoriasis-maintains-biosimilarity","thumbnail":{"_type":"mainImage","alt":"Plaque psoriasis. | Image Credit: pimentos - stock.adobe.com ","caption":"Patients with moderate to severe plaque psoriasis who switched between the adalimumab biosimilar GP2017 and reference adalimumab did not impact immunogenicity, safety, or efficacy following up to 4 switches between both drugs. | Image Credit: pimentos - stock.adobe.com ","asset":{"_ref":"image-1d9e52f022f5262620c6e572b854f87e40781b95-8256x5504-jpg","_type":"reference"}},"summary":"Patients with moderate to severe plaque psoriasis who switched between the adalimumab biosimilar GP2017 and reference adalimumab did not impact immunogenicity, safety, or efficacy following up to 4 switches between both drugs.","published":"2025-03-20T18:14:48.066Z","authors":[{"displayName":"Cameron Santoro","url":"cameron-santoro"}]},{"url":"real-world-data-confirm-safety-of-switching-between-ranibizumab-biosimilars","thumbnail":{"_type":"mainImage","alt":"retinal conditions and ranibizumab | Image credit: Orawan - stock.adobe.com","asset":{"_ref":"image-4d564a4d6b9682ae29a4e32018496463cdb92cb2-5323x3549-jpg","_type":"reference"}},"summary":"Patients with diabetic macular edema previously treated with a ranibizumab biosimilar in India experience comparable safety and efficacy after being switched to another ranibizumab biosimilar, demonstrating real-world safety of biosimilar-to-biosimilar switching.","published":"2025-03-19T14:00:00.000Z","authors":[{"displayName":"Skylar Jeremias","url":"skylar-jeremias"}],"title":"Real-World Data Confirm Safety of Switching Between Ranibizumab Biosimilars"},{"title":"Promising Results for Ustekinumab, Adalimumab Biosimilars Presented at AAD","url":"promising-results-for-ustekinumab-adalimumab-biosimilars-presented-at-aad","thumbnail":{"_type":"mainImage","alt":"doctor treating plaque psoriasis | Image credit: fusssergei - stock.adobe.com","asset":{"_ref":"image-38d862d9f51254894805c6c0ce8878d8a61db662-1200x800-jpg","_type":"reference"}},"summary":"Biocon’s ustekinumab biosimilar matched reference ustekinumab in efficacy and safety, while an adalimumab biosimilar proved interchangeable with reference adalimumab, according to posters at the American Academy of Dermatology (AAD) annual meeting.","published":"2025-03-18T17:31:57.226Z","authors":[{"displayName":"Skylar Jeremias","url":"skylar-jeremias"}]},{"title":"Review Calls for Path to Global Harmonization of Biosimilar Development Regulations","url":"review-calls-for-path-to-global-harmonization-of-biosimilar-development-regulations","thumbnail":{"_type":"mainImage","alt":"global biosimilar development regulations | Image credit: Planetz - stock.adobe.com","asset":{"_ref":"image-5fa4725d0d2ab169801d8099d592b779952fbcc3-5824x3264-jpg","_type":"reference"}},"summary":"Global biosimilar regulatory harmonization will be needed to reduce development costs and improve patient access, despite challenges posed by differing national requirements and regulatory frameworks, according to review authors.","published":"2025-03-17T14:00:00.000Z","authors":[{"displayName":"Skylar Jeremias","url":"skylar-jeremias"}]},{"thumbnail":{"alt":"Paul Hahn, MD, PhD","asset":{"_ref":"image-fcf357a9c4bdf6dcbafc0805856653df9e658adf-1200x670-png","_type":"reference"},"_type":"mainImage"},"summary":"The introduction of biosimilars in the treatment of age-related macular degeneration (AMD) is raising concerns among physicians about cost-driven mandates and the autonomy to choose the best therapies for their patients, according to Paul Hahn, MD, PhD, FASRS, a retina specialist at NJ Retina.","published":"2025-03-16T11:01:00.000Z","authors":[{"displayName":"Skylar Jeremias","url":"skylar-jeremias"}],"title":"Retina Specialists’ Evolving View on Biosimilars in AMD Treatment","url":"retina-specialists-evolving-view-on-biosimilars-in-amd-treatment"},{"title":"Comparable Pregnancy and Infant Milestones With Infliximab Biosimilars vs Originator in IBD","url":"comparable-pregnancy-and-infant-milestones-with-infliximab-biosimilars-vs-originator-in-ibd","thumbnail":{"_type":"mainImage","alt":"pregnant woman taking biosimilar for IBD | Image credit: pressmaster - stock.adobe.com","asset":{"_ref":"image-009b12e7a5586ae473c59e099206b0fb2992476c-5760x3840-jpg","_type":"reference"}},"summary":"A study evaluating pregnancy outcomes and infant developmental milestones found similar outcomes between pregnant women with inflammatory bowel disease (IBD) who received reference infliximab and those who received a biosimilar. ","published":"2025-03-15T11:00:00.000Z","authors":[{"displayName":"Deana Ferreri, PhD","url":"deana-ferreri-phd"}]},{"published":"2025-03-13T18:56:43.719Z","authors":[{"displayName":"Skylar Jeremias","url":"skylar-jeremias"}],"title":"More Ustekinumab Biosimilars Join US Market Share Fight","url":"more-ustekinumab-biosimilars-join-us-market-share-fight","thumbnail":{"alt":"AI generated ustekinumab pens | Image credit: Napat - stock.adobe.com","asset":{"_ref":"image-de4fdf7df1fc9f5ff7e0fb043ae61360f3ace910-2688x1792-jpg","_type":"reference"},"_type":"mainImage"},"summary":"Celltrion and Formycon with Fresenius Kabi launched their respective ustekinumab biosimilars (Steqeyma and Otulfi), joining 4 others that launched earlier this year."},{"url":"updates-on-the-use-of-biosimilars-for-pediatric-patients-with-rheumatic-disease","thumbnail":{"_type":"mainImage","alt":"Child with rheumatic disease | Image credit: luismolinero | stock.adobe.com","asset":{"_ref":"image-eecb35b16271720dbe0e7b9b752e1ec4718b7775-1200x650-jpg","_type":"reference"}},"summary":"Although more research is needed in pediatric patients, biosimilars could improve treatment access and reduce costs.","published":"2025-03-12T16:12:40.990Z","authors":[{"displayName":"Sabina Alikhanov Palmieri, PharmD","url":"sabina-alikhanov-palmieri-pharmd"}],"title":"Updates on the Use of Biosimilars for Pediatric Patients With Rheumatic Disease"},{"url":"biosimilar-cases-to-watch-prolia-xgeva-and-denosumab-competitors","thumbnail":{"_type":"mainImage","alt":"gavel and money | Image credit: BillionPhotos.com - stock.adobe.com","asset":{"_ref":"image-a74124d4c23d45fb124377c7f46ace6c163ac5c1-4418x3006-jpg","_type":"reference"}},"summary":"The denosumab biosimilar market is poised for disruption with 3 FDA-approved biosimilars, at least 5 awaiting approval, and launches anticipated to start in May 2025, while ongoing patent litigation continues to shape the competitive landscape.","published":"2025-03-11T11:00:00.000Z","authors":[{"displayName":"Ha Kung Wong, JD","url":"ha-kung-wong-jd"},{"displayName":"April Breyer Menon, JD","url":"april-breyer-menon-jd"}],"title":"Biosimilar Cases to Watch: Prolia/Xgeva and Denosumab Competitors"},{"title":"BioRationality: FDA Needs More Time Before Working With USP on Biosimilars Development","url":"biorationality-fda-needs-more-time-before-working-with-usp-on-biosimilars-development","thumbnail":{"_type":"mainImage","alt":"laboratory development | Image credit: Cavan - stock.adobe.com","asset":{"_ref":"image-1ef38342e79cbc0fd1077d458aa6b28ca5265a49-5700x3977-jpg","_type":"reference"}},"summary":"Sarfaraz Niazi, PhD, urges the FDA to let the USPharmacopeia (USP) create product release specifications for biosimilars to cut costs, speed development, and enhance accessibility.","published":"2025-03-10T15:03:00.149Z","authors":[{"displayName":"Sarfaraz K. Niazi, PhD","url":"sarfaraz-k-niazi-phd"}]},{"published":"2025-03-09T19:33:48.070Z","authors":[{"displayName":"Skylar Jeremias","url":"skylar-jeremias"},{"displayName":"Josh Canavan, PharmD","url":"josh-canavan-pharmd"}],"title":"How AI Can Help Address Cost-Related Nonadherence to Biologic, Biosimilar Treatment","url":"how-ai-can-help-address-cost-related-nonadherence-to-biologic-biosimilar-treatment","thumbnail":{"_type":"mainImage","alt":"CFB podcast banner","asset":{"_ref":"image-db262aac8277d65bc597c5302dacb7a0fce141cd-4267x2133-jpg","_type":"reference"}},"summary":"Despite saving billions, biosimilars still account for only a small share of the biologics market—what's standing in the way of broader adoption and how can artificial intelligence (AI) help change that?"},{"authors":[{"displayName":"Skylar Jeremias","url":"skylar-jeremias"}],"title":"FDA Approves First Omalizumab Biosimilar","url":"fda-approves-first-omalizumab-biosimilar","thumbnail":{"_type":"mainImage","alt":"FDA approved omalizumab biosimilar | Image credit: Rafael Henrique - stock.adobe.com","asset":{"_ref":"image-e7a7072af56a61543e5780c33a2786953164a679-6000x4000-jpg","_type":"reference"}},"summary":"Celltrion's Omlyclo (omalizumab-igec) is the first omalizumab biosimilar to be approved for US patients, and it was approved with interchangeability, making it easier for patients to switch to the Xolair competitor.","published":"2025-03-07T21:24:59.675Z"},{"title":"From Amjevita to Zarxio: A Decade of US Biosimilar Approvals","url":"from-amjevita-to-zarxio-a-decade-of-us-biosimilar-approvals","thumbnail":{"alt":"10 anniversary for biosimilars in US | Image credit: ink drop - stock.adobe.com","asset":{"_type":"reference","_ref":"image-c2c48922290eeb8946220a271cd7045d60b78e8e-1200x700-jpg"},"_type":"mainImage"},"summary":"Since the FDA’s groundbreaking approval of Zarxio in 2015, the US biosimilars market has surged to 67 approvals across 18 originators—though the journey has been anything but smooth, with adoption facing hurdles along the way.","published":"2025-03-06T22:25:41.444Z","authors":[{"displayName":"Skylar Jeremias","url":"skylar-jeremias"}]},{"title":"Pharmacists Play a Crucial Role in Adalimumab Biosimilars for Patient Care","url":"pharmacists-play-a-crucial-role-in-adalimumab-biosimilars-for-patient-care","thumbnail":{"_type":"mainImage","alt":"syringe | Image credit: DachAI - stock.adobe.com","asset":{"_ref":"image-fc34983eba6d5b5828a0a5e2e64dd8822eb46cf8-5376x3584-jpg","_type":"reference"}},"summary":"Adalimumab biosimilars differ from adalimumab in approved indications, concentration and dosage, and formulation.","published":"2025-03-05T20:43:45.661Z","authors":[{"displayName":"Kennedy Ferruggia","url":"kennedy-ferruggia"}]},{"published":"2025-03-04T15:11:36.476Z","authors":[{"displayName":"Skylar Jeremias","url":"skylar-jeremias"},{"displayName":"Rose McNulty","url":"rose-mcnulty"}],"title":"FDA Approves Third Pair of Denosumab Biosimilars","url":"fda-approves-third-pair-of-denosumab-biosimilars","thumbnail":{"_type":"mainImage","alt":"osteoporosis and denosumab | Image credit: crevis - stock.adobe.com","asset":{"_type":"reference","_ref":"image-ab6fdf045a0e41309388af6577237c379d0809c2-6000x3375-jpg"}},"summary":"The approvals for Celltrion's denosumab-bmwo (Stoboclo and Osenvelt) mark the third FDA green light for a biosimilar to treat osteoporosis and bone metastases."},{"authors":[{"displayName":"Deana Ferreri, PhD","url":"deana-ferreri-phd"}],"title":"No IBD Activity Changes Following Switch From Biosimilar to Originator Infliximab ","url":"no-ibd-activity-changes-following-switch-from-biosimilar-to-originator-infliximab","thumbnail":{"_type":"mainImage","alt":"digestive tract | Image credit: eddows - stock.adobe.com","asset":{"_ref":"image-a2f2d7dc4192e2fca00045d857a32e807c362347-5400x3600-jpg","_type":"reference"}},"summary":"A prospective cohort study found that switching back from the biosimilar SB2 to the reference infliximab did not affect clinical disease activity or safety in inflammatory bowel disease (IBD). ","published":"2025-03-03T12:40:59.538Z"},{"title":"Biosimilars Regulatory Roundup: February 2025","url":"biosimilars-regulatory-roundup-february-2025","thumbnail":{"_type":"mainImage","asset":{"_ref":"image-f0b1c983c646107d6d36ff565cb79690b1854c6b-676x336-png","_type":"reference"}},"summary":"February brought policy updates and several biosimilar approvals, including the first FDA approval for an insulin aspart biosimilar.","published":"2025-03-01T15:19:00.000Z","authors":[{"displayName":"Rose McNulty","url":"rose-mcnulty"}]},{"published":"2025-02-27T14:25:48.744Z","authors":[{"displayName":"Cameron Santoro","url":"cameron-santoro"}],"title":"Bevacizumab Biosimilars Show Similar Efficacy, Safety in NSCLC","url":"bevacizumab-biosimilars-show-similar-efficacy-safety-in-nsclc","thumbnail":{"_type":"mainImage","alt":"Non-small cell lung cancer. | Image Credit: Ekaterina - stock.adobe.com ","caption":"Patients with non-small cell lung cancer (NSCLC) taking bevacizumab biosimilars demonstrated equivalent therapeutic efficacy and similar safety profiles to those taking the originator product, Avastin. | Image Credit: Ekaterina - stock.adobe.com ","asset":{"_ref":"image-4b48505dcfb159a9f515daaee19da3435c01c039-5824x3264-jpg","_type":"reference"}},"summary":"Patients with non-small cell lung cancer (NSCLC) taking bevacizumab biosimilars demonstrated equivalent therapeutic efficacy and similar safety profiles to those taking the originator product, Avastin."},{"title":"Adalimumab Biosimilar Switching Policy Shows Long-Term Success in IBD ","url":"adalimumab-biosimilar-switching-policy-shows-long-term-success-in-ibd","thumbnail":{"_type":"mainImage","alt":"biosimilar switching | Image credit: SOPONE - stock.adobe.com","asset":{"_ref":"image-88d6c2e9528a6ab13dfe67dfeaebaf95ac47ce14-8092x5365-jpg","_type":"reference"}},"summary":"Patients with inflammatory bowel disease (IBD) who switched from reference adalimumab (Humira) to a biosimilar under a mandatory nonmedical switching policy maintained long-term safety, efficacy, and treatment persistence comparable to those who remained on the originator drug, according to a Canadian study.","published":"2025-02-26T18:25:39.935Z","authors":[{"displayName":"Skylar Jeremias","url":"skylar-jeremias"}]},{"title":"Biosimilar Approvals Streamlined With Advanced Statistics Amidst Differing Regulatory Requirements","url":"biosimilar-approvals-streamlined-with-advanced-statistics-amidst-differing-regulatory-requirements","thumbnail":{"_type":"mainImage","alt":"Innovative research. | Image Credit: thien - stock.adobe.com","caption":"The FDA and European Medicines Agency (EMA) mandate high similarity between biosimilars and reference products, but their regulatory processes differ, especially with multiple reference products. | Image Credit: thien - stock.adobe.com","asset":{"_ref":"image-3d31723ad800751440b3c3590a34934593ed2541-4928x3712-jpg","_type":"reference"}},"summary":"The FDA and European Medicines Agency (EMA) mandate high similarity between biosimilars and reference products, but their regulatory processes differ, especially with multiple reference products.","published":"2025-02-25T21:00:00.000Z","authors":[{"displayName":"Cameron Santoro","url":"cameron-santoro"}]},{"title":"3 Ustekinumab Biosimilars Launch on US Market","url":"3-ustekinumab-biosimilars-launch-on-us-market","thumbnail":{"_type":"mainImage","alt":"ustekinumab biosimilars | Image credit: MQ-Illustrations - stock.adobe.com","asset":{"_ref":"image-b2fab6bba0569cb1d87bbccad31d6a7af9666a39-5742x3828-jpg","_type":"reference"}},"summary":"Three ustekinumab biosimilars enter the US market, expanding access to more affordable options referencing Stelara (ustekinumab), one of the most profitable drugs in the world.","published":"2025-02-25T02:22:04.135Z","authors":[{"displayName":"Skylar Jeremias","url":"skylar-jeremias"}]}],"latestVideos":[{"_id":"8fa787cd-a8c0-40be-9a5f-6b0431c9999d","title":"The Top 5 Biosimilar Articles for the Week of March 24","url":"the-top-5-biosimilar-articles-for-the-week-of-march-24","thumbnail":{"asset":{"_id":"image-055847b24eb25c4de818dc3f9b17dbcc30f51ca5-1920x1080-png","metadata":{"dimensions":{"_type":"sanity.imageDimensions","width":1920,"aspectRatio":1.7777777777777777,"height":1080},"isOpaque":true,"blurHash":"MiNKhw~V%2%MRiofafaykBj[V@xtj[Rjfk","_type":"sanity.imageMetadata","palette":{"muted":{"foreground":"#fff","title":"#fff","population":0.76,"background":"#587fa3","_type":"sanity.imagePaletteSwatch"},"lightVibrant":{"_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff","population":0.01,"background":"#94c4e4"},"darkVibrant":{"background":"#084485","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":0.07},"lightMuted":{"title":"#fff","population":6.29,"background":"#abb9c8","_type":"sanity.imagePaletteSwatch","foreground":"#000"},"vibrant":{"_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":6.95,"background":"#26568b"},"dominant":{"title":"#fff","population":6.95,"background":"#26568b","_type":"sanity.imagePaletteSwatch","foreground":"#fff"},"_type":"sanity.imagePalette","darkMuted":{"background":"#2e405c","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":1.51}},"hasAlpha":true,"lqip":"data:image/png;base64,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"},"_rev":"90S1ij4rBVkkJpXG9wBSlj","_type":"sanity.imageAsset","size":1004671,"assetId":"055847b24eb25c4de818dc3f9b17dbcc30f51ca5","_createdAt":"2025-03-25T14:32:12Z","uploadId":"bMpTCSLAnQzFHHdRix3l37owizD2nF1p","url":"https://cdn.sanity.io/images/0vv8moc6/biosimilars/055847b24eb25c4de818dc3f9b17dbcc30f51ca5-1920x1080.png","originalFilename":"Screenshot 2025-03-25 at 10.25.37 AM (2).png","extension":"png","mimeType":"image/png","sha1hash":"055847b24eb25c4de818dc3f9b17dbcc30f51ca5","path":"images/0vv8moc6/biosimilars/055847b24eb25c4de818dc3f9b17dbcc30f51ca5-1920x1080.png","_updatedAt":"2025-03-25T14:32:12Z"}},"link":"/view/undefined"},{"_id":"e6dfb637-edd4-457a-86f6-459a4972a3a8","title":"The Top 5 Biosimilar Articles for the Week of March 17","url":"the-top-5-biosimilar-articles-for-the-week-of-march-17","thumbnail":{"asset":{"extension":"png","_rev":"B5CFQINx5ajRxVjTlCZqB3","path":"images/0vv8moc6/biosimilars/41b285c34f4e67bd6f606b2d117671b82f0197dd-1920x1080.png","assetId":"41b285c34f4e67bd6f606b2d117671b82f0197dd","_createdAt":"2025-03-19T15:26:44Z","uploadId":"5ecaSAGPaa3o90elUPuTLlhDs2KlGqc8","mimeType":"image/png","size":1008170,"originalFilename":"Screenshot 2025-03-19 at 11.23.54 AM (2).png","_id":"image-41b285c34f4e67bd6f606b2d117671b82f0197dd-1920x1080-png","_updatedAt":"2025-03-19T15:26:44Z","metadata":{"hasAlpha":true,"lqip":"data:image/png;base64,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","dimensions":{"_type":"sanity.imageDimensions","width":1920,"aspectRatio":1.7777777777777777,"height":1080},"isOpaque":true,"blurHash":"MhNU3P~V%2%MRiofafaykBj[V@xuj[Rjfk","_type":"sanity.imageMetadata","palette":{"muted":{"background":"#587fa3","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":0.78},"lightVibrant":{"title":"#fff","population":0.02,"background":"#90b0dc","_type":"sanity.imagePaletteSwatch","foreground":"#000"},"darkVibrant":{"_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":0.07,"background":"#074486"},"lightMuted":{"background":"#acb9c7","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff","population":5.89},"vibrant":{"foreground":"#fff","title":"#fff","population":0.01,"background":"#5084c4","_type":"sanity.imagePaletteSwatch"},"dominant":{"_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff","population":5.89,"background":"#acb9c7"},"_type":"sanity.imagePalette","darkMuted":{"population":1.6,"background":"#2e415c","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff"}}},"_type":"sanity.imageAsset","sha1hash":"41b285c34f4e67bd6f606b2d117671b82f0197dd","url":"https://cdn.sanity.io/images/0vv8moc6/biosimilars/41b285c34f4e67bd6f606b2d117671b82f0197dd-1920x1080.png"}},"link":"/view/undefined"},{"_id":"924d69e6-1f3d-4def-a093-4b6cf0e23560","title":"The Top 5 Biosimilar Articles for the Week of March 10","url":"the-top-5-biosimilar-articles-for-the-week-of-march-10","thumbnail":{"asset":{"extension":"png","_type":"sanity.imageAsset","mimeType":"image/png","path":"images/0vv8moc6/biosimilars/8783648e307c0d134df1e6baa07d3329aafc5364-1920x1080.png","size":991515,"assetId":"8783648e307c0d134df1e6baa07d3329aafc5364","metadata":{"dimensions":{"_type":"sanity.imageDimensions","width":1920,"aspectRatio":1.7777777777777777,"height":1080},"isOpaque":true,"blurHash":"MhNdm}~V%2%MRiogWBayofj[WAxua}V@fk","_type":"sanity.imageMetadata","palette":{"lightVibrant":{"foreground":"#000","title":"#fff","population":0.01,"background":"#8cacdc","_type":"sanity.imagePaletteSwatch"},"darkVibrant":{"population":0.03,"background":"#0b4787","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff"},"lightMuted":{"foreground":"#000","title":"#fff","population":5.03,"background":"#acb9c8","_type":"sanity.imagePaletteSwatch"},"vibrant":{"background":"#25558b","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":6.98},"dominant":{"background":"#25558b","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":6.98},"_type":"sanity.imagePalette","darkMuted":{"population":1.52,"background":"#30425b","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff"},"muted":{"_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":0.73,"background":"#587fa2"}},"hasAlpha":true,"lqip":"data:image/png;base64,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"},"sha1hash":"8783648e307c0d134df1e6baa07d3329aafc5364","_id":"image-8783648e307c0d134df1e6baa07d3329aafc5364-1920x1080-png","originalFilename":"Top5Thumbnail.CFB.3.10.25.png","_createdAt":"2025-03-12T18:47:23Z","uploadId":"QIaaFUJ1aU1eO74wqBrEZ6JPxE7EAsHQ","_rev":"UGN1EKuQhwR3qIJIisSNI9","url":"https://cdn.sanity.io/images/0vv8moc6/biosimilars/8783648e307c0d134df1e6baa07d3329aafc5364-1920x1080.png","_updatedAt":"2025-03-12T18:47:23Z"}},"link":"/view/undefined"},{"_id":"7836d7a4-de8c-4c78-a6ae-28cb685a6938","title":"The Top 5 Biosimilar Articles for the Week of March 3","url":"the-top-5-biosimilar-articles-for-the-week-of-march-3","thumbnail":{"asset":{"extension":"png","url":"https://cdn.sanity.io/images/0vv8moc6/biosimilars/42296a12b4d4aa3c7d4fa1bf1ab79e35d18c334f-1920x1080.png","assetId":"42296a12b4d4aa3c7d4fa1bf1ab79e35d18c334f","metadata":{"_type":"sanity.imageMetadata","palette":{"dominant":{"background":"#265589","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":7.53},"_type":"sanity.imagePalette","darkMuted":{"foreground":"#fff","title":"#fff","population":1.6,"background":"#2e425c","_type":"sanity.imagePaletteSwatch"},"muted":{"background":"#587ea2","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":0.71},"lightVibrant":{"_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff","population":0.01,"background":"#88a8dc"},"darkVibrant":{"_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":0.1,"background":"#163176"},"lightMuted":{"population":4.92,"background":"#acb8c7","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff"},"vibrant":{"title":"#fff","population":7.53,"background":"#265589","_type":"sanity.imagePaletteSwatch","foreground":"#fff"}},"hasAlpha":true,"lqip":"data:image/png;base64,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","dimensions":{"_type":"sanity.imageDimensions","width":1920,"aspectRatio":1.7777777777777777,"height":1080},"isOpaque":true,"blurHash":"MgNdm}~V%2%fRikCafayj[oeaexta#WBaz"},"uploadId":"dreprkbMVaodaBBhQpNa2cwSMqlFm86q","_type":"sanity.imageAsset","mimeType":"image/png","path":"images/0vv8moc6/biosimilars/42296a12b4d4aa3c7d4fa1bf1ab79e35d18c334f-1920x1080.png","_updatedAt":"2025-03-06T16:33:30Z","_rev":"DC7S8j3GHyJ8xc9YYIA3ZN","sha1hash":"42296a12b4d4aa3c7d4fa1bf1ab79e35d18c334f","_createdAt":"2025-03-06T16:33:30Z","_id":"image-42296a12b4d4aa3c7d4fa1bf1ab79e35d18c334f-1920x1080-png","size":986928,"originalFilename":"Screenshot 2025-03-05 at 3.37.32 PM (2).png"}},"link":"/view/undefined"},{"_id":"31c8bfc6-2b1f-4b0b-8830-29d7625a3be6","title":"The Top 5 Biosimilar Articles for the Week of February 24","url":"the-top-5-biosimilar-articles-for-the-week-of-february-24","thumbnail":{"asset":{"uploadId":"YFbvpY9d8qTrLSRXZvbFLRx5RlxmW1nC","_rev":"NOS6y06bg2Iam8ywG6lthh","_type":"sanity.imageAsset","originalFilename":"Screenshot 2025-02-26 at 10.46.36 AM (2).png","metadata":{"blurHash":"MfNn8l~V%2%gRPkCafayj[j[V@xuj[Rjj[","_type":"sanity.imageMetadata","palette":{"muted":{"title":"#fff","population":0.69,"background":"#587ea2","_type":"sanity.imagePaletteSwatch","foreground":"#fff"},"lightVibrant":{"_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff","population":0.01,"background":"#88a8dc"},"darkVibrant":{"background":"#0b4788","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":0.03},"lightMuted":{"_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff","population":4.69,"background":"#acb8c7"},"vibrant":{"_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":7.46,"background":"#265589"},"dominant":{"title":"#fff","population":7.46,"background":"#265589","_type":"sanity.imagePaletteSwatch","foreground":"#fff"},"_type":"sanity.imagePalette","darkMuted":{"_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":1.64,"background":"#2e425c"}},"hasAlpha":true,"lqip":"data:image/png;base64,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","dimensions":{"_type":"sanity.imageDimensions","width":1920,"aspectRatio":1.7777777777777777,"height":1080},"isOpaque":true},"mimeType":"image/png","sha1hash":"3dffe2d24a371a6e0c2be9b98b25f403ce463eed","path":"images/0vv8moc6/biosimilars/3dffe2d24a371a6e0c2be9b98b25f403ce463eed-1920x1080.png","assetId":"3dffe2d24a371a6e0c2be9b98b25f403ce463eed","_id":"image-3dffe2d24a371a6e0c2be9b98b25f403ce463eed-1920x1080-png","size":974793,"_createdAt":"2025-02-26T15:49:40Z","_updatedAt":"2025-02-26T15:49:40Z","extension":"png","url":"https://cdn.sanity.io/images/0vv8moc6/biosimilars/3dffe2d24a371a6e0c2be9b98b25f403ce463eed-1920x1080.png"}},"link":"/view/undefined"},{"_id":"0c1581f3-2e05-457d-846a-eb22f8822d6e","title":"The Top 5 Biosimilar Articles for the Week of February 17","url":"the-top-5-biosimilar-articles-for-the-week-of-february-17","thumbnail":{"asset":{"_rev":"ivaRGNxFBepXyTXsuLtzAK","url":"https://cdn.sanity.io/images/0vv8moc6/biosimilars/85f6bcb086fc8247455699a21e476787dc8af0fb-1920x1080.png","_createdAt":"2025-02-19T21:56:19Z","extension":"png","mimeType":"image/png","sha1hash":"85f6bcb086fc8247455699a21e476787dc8af0fb","path":"images/0vv8moc6/biosimilars/85f6bcb086fc8247455699a21e476787dc8af0fb-1920x1080.png","assetId":"85f6bcb086fc8247455699a21e476787dc8af0fb","originalFilename":"Top5.CFB.Thumbnail.2.17.25.png","uploadId":"xf5vYrkUAsBBiq4PARjV4etOqfTVsRbY","_type":"sanity.imageAsset","_updatedAt":"2025-02-19T21:56:19Z","metadata":{"palette":{"darkMuted":{"background":"#2e415c","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":1.61},"muted":{"title":"#fff","population":0.79,"background":"#587fa4","_type":"sanity.imagePaletteSwatch","foreground":"#fff"},"lightVibrant":{"population":0.01,"background":"#94b4dc","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff"},"darkVibrant":{"background":"#084485","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":0.08},"lightMuted":{"population":4.84,"background":"#acb8c7","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff"},"vibrant":{"background":"#3b65ac","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":0.23},"dominant":{"foreground":"#000","title":"#fff","population":4.84,"background":"#acb8c7","_type":"sanity.imagePaletteSwatch"},"_type":"sanity.imagePalette"},"hasAlpha":true,"lqip":"data:image/png;base64,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","dimensions":{"aspectRatio":1.7777777777777777,"height":1080,"_type":"sanity.imageDimensions","width":1920},"isOpaque":true,"blurHash":"MfNdm}~V%2%gRPkCayaykBoeWAxufkRja}","_type":"sanity.imageMetadata"},"size":970444,"_id":"image-85f6bcb086fc8247455699a21e476787dc8af0fb-1920x1080-png"}},"link":"/view/undefined"},{"_id":"2740e6ac-f2c5-4455-96f2-079e7c4193ef","title":"Enhancing Biosimilar Adoption in Value-Based Oncology Care","url":"enhancing-biosimilar-adoption-in-value-based-oncology-care","thumbnail":{"asset":{"extension":"png","_rev":"XE9vnGgPXscpvWVDkr6hyT","size":949200,"_type":"sanity.imageAsset","sha1hash":"ccb6a378936d1c19bc0462ee818a856f4625b8a3","url":"https://cdn.sanity.io/images/0vv8moc6/biosimilars/ccb6a378936d1c19bc0462ee818a856f4625b8a3-1200x675.png","originalFilename":"Travis Brewer image.png","mimeType":"image/png","path":"images/0vv8moc6/biosimilars/ccb6a378936d1c19bc0462ee818a856f4625b8a3-1200x675.png","assetId":"ccb6a378936d1c19bc0462ee818a856f4625b8a3","_createdAt":"2025-02-14T21:46:59Z","metadata":{"_type":"sanity.imageMetadata","palette":{"lightVibrant":{"_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#000","population":0.07,"background":"#fbf4e3"},"darkVibrant":{"foreground":"#fff","title":"#fff","population":0,"background":"#745710","_type":"sanity.imagePaletteSwatch"},"lightMuted":{"title":"#fff","population":2.88,"background":"#cdb7b0","_type":"sanity.imagePaletteSwatch","foreground":"#000"},"vibrant":{"title":"#fff","population":0,"background":"#dfa71f","_type":"sanity.imagePaletteSwatch","foreground":"#000"},"dominant":{"population":2.88,"background":"#cdb7b0","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff"},"_type":"sanity.imagePalette","darkMuted":{"title":"#fff","population":1.08,"background":"#503040","_type":"sanity.imagePaletteSwatch","foreground":"#fff"},"muted":{"background":"#9c6866","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":2.42}},"hasAlpha":true,"lqip":"data:image/png;base64,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","dimensions":{"height":675,"_type":"sanity.imageDimensions","width":1200,"aspectRatio":1.7777777777777777},"isOpaque":true,"blurHash":"MpM7P?i_-;Mxn+~WWWD%V[M{Rjt7V@s:t7"},"uploadId":"4lCF9EYULt9uHe0MfsHFlias79m8Fx9T","_id":"image-ccb6a378936d1c19bc0462ee818a856f4625b8a3-1200x675-png","_updatedAt":"2025-02-14T21:46:59Z"}},"link":"/view/undefined"},{"_id":"2375a6fe-cbf1-44b5-bce3-5980fd1a90de","title":"The Top 5 Biosimilar Articles for the Week of February 10","url":"the-top-5-biosimilar-articles-for-the-week-of-february-10","thumbnail":{"asset":{"sha1hash":"136b92b91e67227bbb6f45deca0cdab825a19fbe","url":"https://cdn.sanity.io/images/0vv8moc6/biosimilars/136b92b91e67227bbb6f45deca0cdab825a19fbe-1920x1080.png","assetId":"136b92b91e67227bbb6f45deca0cdab825a19fbe","_updatedAt":"2025-02-12T19:41:33Z","originalFilename":"Top5.thumbnail.2.10.png","_type":"sanity.imageAsset","path":"images/0vv8moc6/biosimilars/136b92b91e67227bbb6f45deca0cdab825a19fbe-1920x1080.png","_id":"image-136b92b91e67227bbb6f45deca0cdab825a19fbe-1920x1080-png","extension":"png","uploadId":"UgIhWinPaQKmjh35KOgUfO8OiDo4Bdns","metadata":{"blurHash":"MhNU3P~V%2%MRiofWBayoej[WAxufkRjj[","_type":"sanity.imageMetadata","palette":{"muted":{"title":"#fff","population":0.75,"background":"#587fa2","_type":"sanity.imagePaletteSwatch","foreground":"#fff"},"lightVibrant":{"population":0.01,"background":"#8cacdc","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff"},"darkVibrant":{"background":"#0b4787","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":0.03},"lightMuted":{"background":"#acb9c7","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff","population":4.89},"vibrant":{"population":7,"background":"#25568a","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff"},"dominant":{"background":"#25568a","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":7},"_type":"sanity.imagePalette","darkMuted":{"title":"#fff","population":1.45,"background":"#30415b","_type":"sanity.imagePaletteSwatch","foreground":"#fff"}},"hasAlpha":true,"lqip":"data:image/png;base64,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","dimensions":{"_type":"sanity.imageDimensions","width":1920,"aspectRatio":1.7777777777777777,"height":1080},"isOpaque":true},"_rev":"wcsTIBGO7X8rh4FCIDBndI","mimeType":"image/png","size":1006198,"_createdAt":"2025-02-12T19:41:33Z"}},"link":"/view/undefined"},{"_id":"602c264e-723e-4673-94dd-4ea09f49e097","title":"The Top 5 Biosimilar Articles for the Week of February 3","url":"the-top-5-biosimilar-articles-for-the-week-of-february-3","thumbnail":{"asset":{"extension":"png","url":"https://cdn.sanity.io/images/0vv8moc6/biosimilars/2d31e4d09ebfc598fdcb71676676a0ff3843bb0c-1920x1080.png","_createdAt":"2025-02-04T21:43:30Z","_id":"image-2d31e4d09ebfc598fdcb71676676a0ff3843bb0c-1920x1080-png","uploadId":"qqZXoy4C95mWJ7fJyv952t0ndrznfXYz","_type":"sanity.imageAsset","mimeType":"image/png","size":994703,"assetId":"2d31e4d09ebfc598fdcb71676676a0ff3843bb0c","originalFilename":"Top5Thumbnail.2.3.25.png","_rev":"8Y7H4d0ldn4zeKtVOJFHBJ","_updatedAt":"2025-02-04T21:43:30Z","metadata":{"lqip":"data:image/png;base64,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","dimensions":{"width":1920,"aspectRatio":1.7777777777777777,"height":1080,"_type":"sanity.imageDimensions"},"isOpaque":true,"blurHash":"MhNU3P~V%2%MRiogWBayofj[WAxtj[Rjaz","_type":"sanity.imageMetadata","palette":{"_type":"sanity.imagePalette","darkMuted":{"background":"#2f415b","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":1.53},"muted":{"foreground":"#fff","title":"#fff","population":0.77,"background":"#587fa3","_type":"sanity.imagePaletteSwatch"},"lightVibrant":{"title":"#fff","population":0.01,"background":"#8eaede","_type":"sanity.imagePaletteSwatch","foreground":"#000"},"darkVibrant":{"_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":0.07,"background":"#074486"},"lightMuted":{"population":5.71,"background":"#abb8c6","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff"},"vibrant":{"background":"#5084c4","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":0.01},"dominant":{"title":"#fff","population":5.71,"background":"#abb8c6","_type":"sanity.imagePaletteSwatch","foreground":"#000"}},"hasAlpha":true},"sha1hash":"2d31e4d09ebfc598fdcb71676676a0ff3843bb0c","path":"images/0vv8moc6/biosimilars/2d31e4d09ebfc598fdcb71676676a0ff3843bb0c-1920x1080.png"}},"link":"/view/undefined"},{"_id":"2eb6d36a-5933-4f5f-9a03-ec5d50ab77e3","title":"Understanding Biosimilars Through Education and PBM Formulary Perspective","url":"understanding-biosimilars-through-education-and-pbm-formulary-perspective","thumbnail":{"asset":{"_rev":"NM6jX99S8M6pthZacIKB40","originalFilename":"Josh Canavan, PharmD thumbnail.png","extension":"png","metadata":{"hasAlpha":true,"lqip":"data:image/png;base64,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","dimensions":{"_type":"sanity.imageDimensions","width":1920,"aspectRatio":1.7777777777777777,"height":1080},"isOpaque":true,"blurHash":"MPGSGpIw.m9Z-n?BnhaJa#RkE3a#nhs,k9","_type":"sanity.imageMetadata","palette":{"lightMuted":{"_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff","population":2.26,"background":"#c4c3b0"},"vibrant":{"title":"#fff","population":0.28,"background":"#1c9ed7","_type":"sanity.imagePaletteSwatch","foreground":"#fff"},"dominant":{"background":"#ddc7b5","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#000","population":6.23},"_type":"sanity.imagePalette","darkMuted":{"background":"#4f3c31","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":2.42},"muted":{"background":"#8e6e61","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":2.08},"lightVibrant":{"_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#000","population":6.23,"background":"#ddc7b5"},"darkVibrant":{"background":"#074589","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":1.98}}},"_type":"sanity.imageAsset","assetId":"89d5757303480ab1520c8dcb016f7f5b2f3e65e9","_id":"image-89d5757303480ab1520c8dcb016f7f5b2f3e65e9-1920x1080-png","mimeType":"image/png","sha1hash":"89d5757303480ab1520c8dcb016f7f5b2f3e65e9","url":"https://cdn.sanity.io/images/0vv8moc6/biosimilars/89d5757303480ab1520c8dcb016f7f5b2f3e65e9-1920x1080.png","size":929165,"_updatedAt":"2025-01-31T18:50:56Z","uploadId":"dI88G4NLMrs5DPGDbWB9xI3i67rVpFk1","path":"images/0vv8moc6/biosimilars/89d5757303480ab1520c8dcb016f7f5b2f3e65e9-1920x1080.png","_createdAt":"2025-01-31T18:50:56Z"}},"link":"/view/undefined"},{"_id":"6a31e03c-24c9-4dd3-9c67-34039e619e40","title":"The Top 5 Biosimilar Articles for the Week of January 27","url":"the-top-5-biosimilar-articles-for-the-week-of-january-27","thumbnail":{"asset":{"path":"images/0vv8moc6/biosimilars/ee18f4823a3ef2d8baf89a83bc96dc574ba6d501-1920x1080.png","extension":"png","mimeType":"image/png","sha1hash":"ee18f4823a3ef2d8baf89a83bc96dc574ba6d501","size":1001073,"_createdAt":"2025-01-28T20:58:26Z","_id":"image-ee18f4823a3ef2d8baf89a83bc96dc574ba6d501-1920x1080-png","metadata":{"palette":{"lightMuted":{"title":"#fff","population":6.04,"background":"#abb9c7","_type":"sanity.imagePaletteSwatch","foreground":"#000"},"vibrant":{"_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":0.01,"background":"#5486c4"},"dominant":{"title":"#fff","population":7.2,"background":"#768da9","_type":"sanity.imagePaletteSwatch","foreground":"#fff"},"_type":"sanity.imagePalette","darkMuted":{"background":"#2c3a55","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":0.84},"muted":{"_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":7.2,"background":"#768da9"},"lightVibrant":{"background":"#94bcdc","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff","population":0.01},"darkVibrant":{"population":0.11,"background":"#073c7b","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff"}},"hasAlpha":true,"lqip":"data:image/png;base64,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","dimensions":{"width":1920,"aspectRatio":1.7777777777777777,"height":1080,"_type":"sanity.imageDimensions"},"isOpaque":true,"blurHash":"MhNU3O~V%2%MRiofWBayofj[V@xuj[Rja}","_type":"sanity.imageMetadata"},"uploadId":"wl0znlYqlMhaMp7N1tPQZuoQpHA5IpkR","assetId":"ee18f4823a3ef2d8baf89a83bc96dc574ba6d501","_updatedAt":"2025-01-28T20:58:26Z","_rev":"Eh8XDLasrIZNyy0Dn5lFzT","_type":"sanity.imageAsset","originalFilename":"CFBThumbnail.1.27.2025.png","url":"https://cdn.sanity.io/images/0vv8moc6/biosimilars/ee18f4823a3ef2d8baf89a83bc96dc574ba6d501-1920x1080.png"}},"link":"/view/undefined"},{"_id":"5594db8b-1f84-4fc0-8318-a3fbdb29fa6c","title":"The Top 5 Biosimilar Articles for the Week of January 20","url":"the-top-5-biosimilar-articles-for-the-week-of-january-20","thumbnail":{"asset":{"uploadId":"HeKlqFRZKbA8IPWFdxsK91s6DK9pgDrn","path":"images/0vv8moc6/biosimilars/adb638b8b5e074f0f12f8e59627c4eedd020b664-1920x1080.png","_updatedAt":"2025-01-22T20:51:18Z","extension":"png","metadata":{"dimensions":{"_type":"sanity.imageDimensions","width":1920,"aspectRatio":1.7777777777777777,"height":1080},"isOpaque":true,"blurHash":"MhNU3P~V%2%MRiofaeayofj[WAxtj[Rjaz","_type":"sanity.imageMetadata","palette":{"lightVibrant":{"background":"#88a8dc","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff","population":0.01},"darkVibrant":{"foreground":"#fff","title":"#fff","population":0.03,"background":"#0b4788","_type":"sanity.imagePaletteSwatch"},"lightMuted":{"population":5.4,"background":"#acb9c8","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff"},"vibrant":{"_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":6.97,"background":"#26568a"},"dominant":{"_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":6.97,"background":"#26568a"},"_type":"sanity.imagePalette","darkMuted":{"foreground":"#fff","title":"#fff","population":1.51,"background":"#2f415c","_type":"sanity.imagePaletteSwatch"},"muted":{"_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":0.7,"background":"#587ea2"}},"hasAlpha":true,"lqip":"data:image/png;base64,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"},"assetId":"adb638b8b5e074f0f12f8e59627c4eedd020b664","_id":"image-adb638b8b5e074f0f12f8e59627c4eedd020b664-1920x1080-png","_rev":"mOOlyacta1BdPBMhZnl5P7","_type":"sanity.imageAsset","sha1hash":"adb638b8b5e074f0f12f8e59627c4eedd020b664","size":997601,"_createdAt":"2025-01-22T20:51:18Z","originalFilename":"CFBThumbnail.1.20.25.png","mimeType":"image/png","url":"https://cdn.sanity.io/images/0vv8moc6/biosimilars/adb638b8b5e074f0f12f8e59627c4eedd020b664-1920x1080.png"}},"link":"/view/undefined"},{"_id":"4cb8bfdf-ee1a-409f-8014-ae37f1832454","title":"The Top 5 Biosimilar Articles for the Week of January 13","url":"the-top-5-biosimilar-articles-for-the-week-of-january-13","thumbnail":{"asset":{"extension":"png","_type":"sanity.imageAsset","sha1hash":"42f86f28b62922cd2c41aac5b8e3d95202d0a99f","size":1006039,"_id":"image-42f86f28b62922cd2c41aac5b8e3d95202d0a99f-1920x1080-png","_updatedAt":"2025-01-14T20:31:24Z","metadata":{"hasAlpha":true,"lqip":"data:image/png;base64,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","dimensions":{"_type":"sanity.imageDimensions","width":1920,"aspectRatio":1.7777777777777777,"height":1080},"isOpaque":true,"blurHash":"MiNU3P~Vxu%MV@ofWBayj[j[V@xufkRjfk","_type":"sanity.imageMetadata","palette":{"_type":"sanity.imagePalette","darkMuted":{"title":"#fff","population":1.45,"background":"#2f405b","_type":"sanity.imagePaletteSwatch","foreground":"#fff"},"muted":{"background":"#587ea2","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":0.72},"lightVibrant":{"_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff","population":0.01,"background":"#88a8dc"},"darkVibrant":{"_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":0.03,"background":"#0b4788"},"lightMuted":{"population":6.15,"background":"#abb9c7","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff"},"vibrant":{"background":"#26558a","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":6.96},"dominant":{"_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":6.96,"background":"#26558a"}}},"uploadId":"sZ4eYCNgfF5m8jnsbGg1MJiIX1nkC9jc","_rev":"c8NhmAx8eMp2WUPG5yAbBW","mimeType":"image/png","assetId":"42f86f28b62922cd2c41aac5b8e3d95202d0a99f","_createdAt":"2025-01-14T20:31:24Z","url":"https://cdn.sanity.io/images/0vv8moc6/biosimilars/42f86f28b62922cd2c41aac5b8e3d95202d0a99f-1920x1080.png","path":"images/0vv8moc6/biosimilars/42f86f28b62922cd2c41aac5b8e3d95202d0a99f-1920x1080.png","originalFilename":"CFBThumbnail.1.13.25.png"}},"link":"/view/undefined"},{"_id":"b51fd39e-1bcf-4b6a-837e-ae0042468769","title":"Streamlining Biosimilar Access: How EHR Automation Transforms Patient Care","url":"streamlining-biosimilar-access-how-ehr-automation-transforms-patient-care","thumbnail":{"asset":{"_updatedAt":"2025-01-10T22:28:24Z","extension":"png","size":5669104,"_id":"image-3e4a63e88ad5b31c674e712be57a560d50cc9ce5-2880x1617-png","_rev":"c7Gvv1S2RIWR2hWNDPEktx","mimeType":"image/png","assetId":"3e4a63e88ad5b31c674e712be57a560d50cc9ce5","originalFilename":"Disalle.png","metadata":{"dimensions":{"_type":"sanity.imageDimensions","width":2880,"aspectRatio":1.7810760667903525,"height":1617},"isOpaque":true,"blurHash":"MGFr#800?w4.Ri^*9FxukDxaW=WVt6aKWB","_type":"sanity.imageMetadata","palette":{"lightMuted":{"background":"#b0b9cd","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff","population":1.01},"vibrant":{"background":"#774c33","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":0.19},"dominant":{"foreground":"#fff","title":"#fff","population":8.6,"background":"#584b3e","_type":"sanity.imagePaletteSwatch"},"_type":"sanity.imagePalette","darkMuted":{"background":"#584b3e","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":8.6},"muted":{"_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":0.01,"background":"#ac6c58"},"lightVibrant":{"population":0.32,"background":"#d2daf5","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#000"},"darkVibrant":{"foreground":"#fff","title":"#fff","population":0.01,"background":"#3a1207","_type":"sanity.imagePaletteSwatch"}},"hasAlpha":true,"lqip":"data:image/png;base64,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"},"_type":"sanity.imageAsset","sha1hash":"3e4a63e88ad5b31c674e712be57a560d50cc9ce5","path":"images/0vv8moc6/biosimilars/3e4a63e88ad5b31c674e712be57a560d50cc9ce5-2880x1617.png","uploadId":"oTIXBosIY6QS8ozytb3BaQnRQD0lu5Mk","url":"https://cdn.sanity.io/images/0vv8moc6/biosimilars/3e4a63e88ad5b31c674e712be57a560d50cc9ce5-2880x1617.png","_createdAt":"2025-01-10T22:28:24Z"}},"link":"/view/undefined"},{"_id":"99498a3d-8988-4096-9cf0-0ac19feb7258","title":"The Top 5 Biosimilar Articles for the Week of January 6","url":"the-top-5-biosimilar-articles-for-the-week-of-january-6","thumbnail":{"asset":{"_rev":"wbSamiuJCs4EjqWb3U1RWM","_updatedAt":"2025-01-08T21:29:21Z","originalFilename":"Screenshot 2025-01-08 at 4.28.17 PM (2).png","extension":"png","_type":"sanity.imageAsset","path":"images/0vv8moc6/biosimilars/5eb52adcc9e0032611f3bed75bf9b7a71e4d3d95-1920x1080.png","_createdAt":"2025-01-08T21:29:21Z","_id":"image-5eb52adcc9e0032611f3bed75bf9b7a71e4d3d95-1920x1080-png","metadata":{"lqip":"data:image/png;base64,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","dimensions":{"aspectRatio":1.7777777777777777,"height":1080,"_type":"sanity.imageDimensions","width":1920},"isOpaque":true,"blurHash":"MhNdm}~Vxu%MRiflaya|j[oeWAxtj[Rja}","_type":"sanity.imageMetadata","palette":{"darkMuted":{"_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":1.65,"background":"#2e425c"},"muted":{"foreground":"#fff","title":"#fff","population":0.74,"background":"#587fa2","_type":"sanity.imagePaletteSwatch"},"lightVibrant":{"_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff","population":0.01,"background":"#8cacdc"},"darkVibrant":{"title":"#fff","population":0.03,"background":"#0b4787","_type":"sanity.imagePaletteSwatch","foreground":"#fff"},"lightMuted":{"foreground":"#000","title":"#fff","population":5.1,"background":"#acb9c8","_type":"sanity.imagePaletteSwatch"},"vibrant":{"population":7,"background":"#26558b","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff"},"dominant":{"population":7,"background":"#26558b","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff"},"_type":"sanity.imagePalette"},"hasAlpha":true},"uploadId":"2BLlyGbPwXyb09OTWJriPEiRyNG8BERX","url":"https://cdn.sanity.io/images/0vv8moc6/biosimilars/5eb52adcc9e0032611f3bed75bf9b7a71e4d3d95-1920x1080.png","assetId":"5eb52adcc9e0032611f3bed75bf9b7a71e4d3d95","mimeType":"image/png","sha1hash":"5eb52adcc9e0032611f3bed75bf9b7a71e4d3d95","size":979983}},"link":"/view/undefined"},{"_id":"ee5b33e2-14d3-4534-b59d-8e21ddfd783e","title":"Reducing Financial Toxicity in GI Cancer Care Through Biosimilars","url":"reducing-financial-toxicity-in-gi-cancer-care-through-biosimilars","thumbnail":{"asset":{"metadata":{"lqip":"data:image/png;base64,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","dimensions":{"aspectRatio":1.6,"height":1800,"_type":"sanity.imageDimensions","width":2880},"isOpaque":true,"blurHash":"V6GuR9.S0001%200oI?^sC%LE.IV#8$yIoD*M{ogS$oM","_type":"sanity.imageMetadata","palette":{"lightMuted":{"background":"#c2c4ac","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff","population":0.13},"vibrant":{"background":"#d4af8f","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff","population":3.42},"dominant":{"background":"#a78d70","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":7.89},"_type":"sanity.imagePalette","darkMuted":{"population":1.35,"background":"#493927","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff"},"muted":{"foreground":"#fff","title":"#fff","population":7.89,"background":"#a78d70","_type":"sanity.imagePaletteSwatch"},"lightVibrant":{"background":"#daba9f","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff","population":0},"darkVibrant":{"background":"#5b462b","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":1.7}},"hasAlpha":true},"_rev":"5K24o7vC94LP4crFKkV7h6","assetId":"a7aa9dfeb54bfe4ba853aaec1b7319864f76ce4d","_type":"sanity.imageAsset","mimeType":"image/png","originalFilename":"Tiago Biachi image.png","extension":"png","uploadId":"o2wegNFK135CWPaJhOXAbFR7jLUzW8RM","sha1hash":"a7aa9dfeb54bfe4ba853aaec1b7319864f76ce4d","url":"https://cdn.sanity.io/images/0vv8moc6/biosimilars/a7aa9dfeb54bfe4ba853aaec1b7319864f76ce4d-2880x1800.png","path":"images/0vv8moc6/biosimilars/a7aa9dfeb54bfe4ba853aaec1b7319864f76ce4d-2880x1800.png","_createdAt":"2025-01-03T21:33:32Z","_updatedAt":"2025-01-03T21:33:32Z","size":4801868,"_id":"image-a7aa9dfeb54bfe4ba853aaec1b7319864f76ce4d-2880x1800-png"}},"link":"/view/undefined"},{"_id":"4228cbe5-be63-4a59-beb9-1432f09d703b","title":"The Top 5 Biosimilar Articles for the Week of December 30","url":"the-top-5-biosimilar-articles-for-the-week-of-december-30","thumbnail":{"asset":{"_id":"image-25005283b8219e218c7961322d21ab162bc53f10-1920x1080-png","extension":"png","uploadId":"Gz2nGstsGOCgZSzBaWpSvtvtdQGQ69hG","originalFilename":"Top5CFBThumbnail.12.30.24.png","_type":"sanity.imageAsset","url":"https://cdn.sanity.io/images/0vv8moc6/biosimilars/25005283b8219e218c7961322d21ab162bc53f10-1920x1080.png","assetId":"25005283b8219e218c7961322d21ab162bc53f10","_updatedAt":"2025-01-02T16:14:06Z","_rev":"AR6qoypNcER7zlbM0moglU","path":"images/0vv8moc6/biosimilars/25005283b8219e218c7961322d21ab162bc53f10-1920x1080.png","size":970368,"_createdAt":"2025-01-02T16:14:06Z","metadata":{"_type":"sanity.imageMetadata","palette":{"lightMuted":{"title":"#fff","population":4.83,"background":"#acb9c7","_type":"sanity.imagePaletteSwatch","foreground":"#000"},"vibrant":{"_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":7.48,"background":"#25558a"},"dominant":{"population":7.48,"background":"#25558a","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff"},"_type":"sanity.imagePalette","darkMuted":{"foreground":"#fff","title":"#fff","population":1.65,"background":"#2f415b","_type":"sanity.imagePaletteSwatch"},"muted":{"_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":0.71,"background":"#587ea2"},"lightVibrant":{"title":"#fff","population":0.01,"background":"#88a8dc","_type":"sanity.imagePaletteSwatch","foreground":"#000"},"darkVibrant":{"population":0.1,"background":"#163176","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff"}},"hasAlpha":true,"lqip":"data:image/png;base64,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","dimensions":{"_type":"sanity.imageDimensions","width":1920,"aspectRatio":1.7777777777777777,"height":1080},"isOpaque":true,"blurHash":"MgNn8m~Vxu-;Rij]aya|j[oeRjxuj[Rjj["},"mimeType":"image/png","sha1hash":"25005283b8219e218c7961322d21ab162bc53f10"}},"link":"/view/undefined"},{"_id":"cca64e05-af1a-4a7d-925e-b76106f5cbff","title":"The Top 5 Biosimilar Articles for the Week of December 16","url":"the-top-5-biosimilar-articles-for-the-week-of-december-16","thumbnail":{"asset":{"assetId":"4003e12726c8587d4dc786cecd46750e801ca5c2","_createdAt":"2024-12-17T21:44:26Z","_id":"image-4003e12726c8587d4dc786cecd46750e801ca5c2-1920x1080-png","_updatedAt":"2024-12-17T21:44:26Z","extension":"png","uploadId":"MmRPz0xz4GhQE19DMjK4obz4GthBaz65","_rev":"5K24o7vC94LP4crFHsdIN6","metadata":{"isOpaque":true,"blurHash":"MiNKep~V%2%MV@flayfQj[j[WAxtj[Rja#","_type":"sanity.imageMetadata","palette":{"vibrant":{"population":0.06,"background":"#3465ad","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff"},"dominant":{"_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff","population":6.62,"background":"#abbac8"},"_type":"sanity.imagePalette","darkMuted":{"title":"#fff","population":1.48,"background":"#2e405b","_type":"sanity.imagePaletteSwatch","foreground":"#fff"},"muted":{"title":"#fff","population":0.8,"background":"#587fa3","_type":"sanity.imagePaletteSwatch","foreground":"#fff"},"lightVibrant":{"background":"#eafcfb","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#000","population":6.31},"darkVibrant":{"foreground":"#fff","title":"#fff","population":0.08,"background":"#084485","_type":"sanity.imagePaletteSwatch"},"lightMuted":{"title":"#fff","population":6.62,"background":"#abbac8","_type":"sanity.imagePaletteSwatch","foreground":"#000"}},"hasAlpha":true,"lqip":"data:image/png;base64,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","dimensions":{"_type":"sanity.imageDimensions","width":1920,"aspectRatio":1.7777777777777777,"height":1080}},"_type":"sanity.imageAsset","sha1hash":"4003e12726c8587d4dc786cecd46750e801ca5c2","path":"images/0vv8moc6/biosimilars/4003e12726c8587d4dc786cecd46750e801ca5c2-1920x1080.png","originalFilename":"Top5CFB.Thumbnail.12.16.24.png","mimeType":"image/png","size":1011877,"url":"https://cdn.sanity.io/images/0vv8moc6/biosimilars/4003e12726c8587d4dc786cecd46750e801ca5c2-1920x1080.png"}},"link":"/view/undefined"},{"_id":"c3cd854a-f7c5-460d-a508-52fa34461b48","title":"Strategies for Improving Biosimilar Access and Utilization","url":"strategies-for-improving-biosimilar-access-and-utilization","thumbnail":{"asset":{"_rev":"opKylK688YYdETOKCJdOjR","_type":"sanity.imageAsset","sha1hash":"e14b8f88d4d2be1b422a9f2ad4561e6c6185d75d","extension":"png","url":"https://cdn.sanity.io/images/0vv8moc6/biosimilars/e14b8f88d4d2be1b422a9f2ad4561e6c6185d75d-2880x1614.png","_id":"image-e14b8f88d4d2be1b422a9f2ad4561e6c6185d75d-2880x1614-png","originalFilename":"Elie Bahou IVBM image.png","mimeType":"image/png","size":4625017,"_updatedAt":"2024-12-05T18:20:57Z","metadata":{"palette":{"_type":"sanity.imagePalette","darkMuted":{"_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":7.75,"background":"#724440"},"muted":{"title":"#fff","population":4.28,"background":"#a0544f","_type":"sanity.imagePaletteSwatch","foreground":"#fff"},"lightVibrant":{"title":"#000","population":0.31,"background":"#b0d3e3","_type":"sanity.imagePaletteSwatch","foreground":"#000"},"darkVibrant":{"_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":0.13,"background":"#62141b"},"lightMuted":{"foreground":"#000","title":"#fff","population":0.19,"background":"#cab0a6","_type":"sanity.imagePaletteSwatch"},"vibrant":{"background":"#6cc8ec","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff","population":0.01},"dominant":{"foreground":"#fff","title":"#fff","population":7.75,"background":"#724440","_type":"sanity.imagePaletteSwatch"}},"hasAlpha":true,"lqip":"data:image/png;base64,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","dimensions":{"_type":"sanity.imageDimensions","width":2880,"aspectRatio":1.7843866171003717,"height":1614},"isOpaque":true,"blurHash":"MPGR*kD%0e%M4T~WD%bv%MI9yDRjaKs:M{","_type":"sanity.imageMetadata"},"uploadId":"FHEyYWAbZnMNMxwzkeNjQjoJuRcGlPfd","path":"images/0vv8moc6/biosimilars/e14b8f88d4d2be1b422a9f2ad4561e6c6185d75d-2880x1614.png","assetId":"e14b8f88d4d2be1b422a9f2ad4561e6c6185d75d","_createdAt":"2024-12-05T18:20:57Z"}},"link":"/view/undefined"},{"_id":"ab850cd2-3119-474f-8a17-901ced8d130b","title":"The Top 5 Biosimilar Articles for the Week of December 9","url":"the-top-5-biosimilar-articles-for-the-week-of-december-9","thumbnail":{"asset":{"_updatedAt":"2024-12-12T19:15:57Z","_type":"sanity.imageAsset","path":"images/0vv8moc6/biosimilars/c9a4d82d9a880c76cb2e91c1ab4f33f4aff36f29-1920x1080.png","_rev":"eTaurzT1bq7O5g5qvGZ8SM","mimeType":"image/png","sha1hash":"c9a4d82d9a880c76cb2e91c1ab4f33f4aff36f29","size":1007195,"assetId":"c9a4d82d9a880c76cb2e91c1ab4f33f4aff36f29","_createdAt":"2024-12-12T19:15:57Z","_id":"image-c9a4d82d9a880c76cb2e91c1ab4f33f4aff36f29-1920x1080-png","originalFilename":"Top5.Thumbnail.12.9.png","extension":"png","metadata":{"blurHash":"MhNU3P~V%2%MRiofWBayofj[V@xuj[Rja}","_type":"sanity.imageMetadata","palette":{"lightMuted":{"population":5.28,"background":"#acb9c8","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff"},"vibrant":{"foreground":"#fff","title":"#fff","population":6.99,"background":"#26568a","_type":"sanity.imagePaletteSwatch"},"dominant":{"_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":6.99,"background":"#26568a"},"_type":"sanity.imagePalette","darkMuted":{"_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":1.52,"background":"#2f415b"},"muted":{"_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":0.71,"background":"#587ea2"},"lightVibrant":{"background":"#8aaedc","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff","population":0.01},"darkVibrant":{"background":"#0b4788","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":0.03}},"hasAlpha":true,"lqip":"data:image/png;base64,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","dimensions":{"height":1080,"_type":"sanity.imageDimensions","width":1920,"aspectRatio":1.7777777777777777},"isOpaque":true},"uploadId":"HCfpcqdQ7mUfKsLzRwzT2Wn9i30TN77s","url":"https://cdn.sanity.io/images/0vv8moc6/biosimilars/c9a4d82d9a880c76cb2e91c1ab4f33f4aff36f29-1920x1080.png"}},"link":"/view/undefined"}],"popUpVideos":[],"features":[{"_createdAt":"2023-10-12T16:27:02Z","sortOrder":1,"_rev":"4flWlnhXPDycHOqtDN0xbc","_type":"feature","feature_url":"/","feature_alt":"Register for IGBA's Global Biosimilars Week LIVE Webinar!","feature_link":"https://globalmeet.webcasts.com/starthere.jsp?ei=1638244\u0026tp_key=c6a2ad3d2d","is_active":true,"_id":"0b61e000-def9-49f1-943e-3663676a1156","_updatedAt":"2023-10-12T16:27:09Z","feature_img":{"asset":{"url":"https://cdn.sanity.io/images/0vv8moc6/biosimilars/77889d8ba2155bfc61aad147e5ba3b38c8b536a4-1600x900.png"}},"feature_title":"Register for IGBA's Global Biosimilars Week LIVE Webinar!","hide_title_body":false},{"feature_alt":"CFB podcast banner","feature_link":"https://www.centerforbiosimilars.com/view/how-streamlining-development-can-save-the-us-biosimilar-industry","feature_title":"How Streamlining Development Can Save the US Biosimilar Industry","_createdAt":"2023-08-21T15:53:40Z","_type":"feature","feature_url":"/","is_active":true,"hide_title_body":false,"_updatedAt":"2023-10-12T16:25:44Z","feature_img":{"asset":{"url":"https://cdn.sanity.io/images/0vv8moc6/biosimilars/15d194c7d44329f7bcbd3642a7fea38108a83900-1024x512.jpg"}},"_rev":"5HObGkyfNibktHt3Sw2pMC","_id":"21ccaac4-9fd4-42e5-a2bc-abb094da555c"},{"_updatedAt":"2023-10-12T16:25:37Z","hide_title_body":false,"feature_img":{"asset":{"url":"https://cdn.sanity.io/images/0vv8moc6/biosimilars/834962dddc3672510ec88480280ce968ebc6b7b9-425x282.jpg"}},"_rev":"5HObGkyfNibktHt3Sw2p6H","feature_alt":"pharmacist counting medications","feature_title":"AAM White Paper Breaks Down Drug Shortage Crisis: Causes and Solutions","_type":"feature","feature_url":"/","feature_link":"https://www.centerforbiosimilars.com/view/aam-white-paper-breaks-down-drug-shortage-crisis-causes-and-solutions","is_active":true,"_createdAt":"2023-08-21T15:59:07Z","_id":"62a1c24a-f98a-4ba1-85d2-c9ba90bc3c1f"},{"feature_title":"Samsung Bioepis Report Proves Lower Biosimilar Prices Correlate With Greater Market Share","_createdAt":"2023-08-21T16:00:53Z","feature_link":"https://www.centerforbiosimilars.com/view/samsung-bioepis-report-proves-lower-biosimilar-prices-correlate-with-greater-market-share","_type":"feature","feature_url":"/","_updatedAt":"2023-10-12T16:25:33Z","is_active":true,"hide_title_body":false,"feature_img":{"asset":{"url":"https://cdn.sanity.io/images/0vv8moc6/biosimilars/50f57d16112a35e8dcb0acd8267e951a0244e360-6000x3000.jpg"}},"_rev":"Mfc1Z4st2g7ktmt3GgCRXR","_id":"6e79106b-660b-4cb7-8708-774e4b124d12","feature_alt":"several filled syringes in different sizes and colors"},{"_type":"feature","_id":"e99421a8-f808-4afd-87fb-3e3a79540bba","_rev":"Mfc1Z4st2g7ktmt3GgCRS9","feature_url":"/","feature_link":"https://www.centerforbiosimilars.com/view/authors-suggest-major-policy-shifts-to-boost-biosimilar-development-accessibility","is_active":true,"feature_img":{"asset":{"url":"https://cdn.sanity.io/images/0vv8moc6/biosimilars/d396d46b74da277f006444b38c10d0954d5fbcc5-983x646.png"}},"feature_alt":"red liquid in a vial","_updatedAt":"2023-10-12T16:25:27Z","feature_title":"Authors Suggest Major Policy Shifts to Boost Biosimilar Development, Accessibility","hide_title_body":false,"_createdAt":"2023-08-21T16:02:07Z"}],"tiData":[{"id":"1165eb6b-e5ea-405c-a68b-f614a03b306e","brandName":"Ajmc","dataType":"ptce","title":"Navigating the Advances in the Treatment of Geographic Atrophy: Updates and Strategies for Managed Care","thumbnail":"https://d36ai2hkxl16us.cloudfront.net/thoughtindustries/image/upload/v1/course-uploads/d2afb412-3c3e-4f73-b3d6-2388078622a3/gvw8bdhuzy42-PTCE_GA_Enduring_AJMC-Supplement_050924v1_800x385.png","description":"2.0 Credits / Ophthalmology/Optometry","releaseDate":"2024-03-29T04:00:00.000Z","expirationDate":"2025-03-30","creditType":"On-Demand","creditAmount":"2","created_at":"2025-03-28T12:06:06.55418+00:00","TI_id":"f510982e-cac2-4c41-8173-8034e4326e0e","slug":"navigating-the-advances-in-the-treatment-of-geographic-atrophy-updates-and-strategies-for-managed-care","delReference":true,"contentTypeLabel":"AJMC Supplement","activity-type":null,"specialty":"[\"Ophthalmology/Optometry\"]","creditCertificate":null,"courseEndDate":"2025-03-30T03:59:59.999+00:00","cventUrl":"","eventData":null,"imageUrl":null},{"id":"d6c81f31-e9ec-4815-833b-818bf5602646","brandName":"Ajmc","dataType":"ptce","title":"AMCP Annual 2025","thumbnail":"https://d36ai2hkxl16us.cloudfront.net/thoughtindustries/image/upload/v1/course-uploads/d2afb412-3c3e-4f73-b3d6-2388078622a3/okzqrmcs4s10-PTCE_AMCP-2025_General-Banners_022425v1_800x385.png","description":"March 31, 2025 - April 3, 2025","releaseDate":"2025-01-03T05:00:00.000Z","expirationDate":"2025-04-04","creditType":"Live","creditAmount":"","created_at":"2025-03-28T12:06:04.687961+00:00","TI_id":"4c68a104-fb8a-4f86-bded-ef444dac1bce","slug":"amcp-annual","delReference":true,"contentTypeLabel":"Live Event","activity-type":null,"specialty":"","creditCertificate":null,"courseEndDate":"2025-04-04T03:59:59.999+00:00","cventUrl":"","eventData":null,"imageUrl":null},{"id":"00a8213b-95a7-4fc6-9391-1307b6b90ab1","brandName":"Ajmc","dataType":"ptce","title":"Novel Therapies and Emerging Strategies for HR+/HER2- Metastatic Breast Cancer and the Impact on Patient Outcomes","thumbnail":"https://d36ai2hkxl16us.cloudfront.net/thoughtindustries/image/upload/v1/course-uploads/d2afb412-3c3e-4f73-b3d6-2388078622a3/s5c623upsbyd-PTCE_AMCP-2024_HR_Enduring_043024v2_800x385.png","description":"1.5 Credits / Oncology, Breast Cancer","releaseDate":"2024-05-03T04:00:00.000Z","expirationDate":"2025-05-04","creditType":"On-Demand","creditAmount":"1.5","created_at":"2025-03-28T12:06:06.154624+00:00","TI_id":"b6a7fee4-52b0-4e39-9b23-4ad568fddc4f","slug":"novel-therapies-and-emerging-strategies-for-hrher2-metastatic-breast-cancer-and-the-impact-on-patient-outcomes-un97","delReference":true,"contentTypeLabel":"On-Demand Virtual Symposium","activity-type":null,"specialty":"[\"Oncology\",\"Breast Cancer\"]","creditCertificate":null,"courseEndDate":"2025-05-04T03:59:59.999+00:00","cventUrl":"","eventData":null,"imageUrl":null},{"id":"5f2f9f0c-ffe1-4536-a7f0-60e033a46312","brandName":"Ajmc","dataType":"ptce","title":"Addressing the Gaps and Clinical Challenges in Chronic Lymphocytic Leukemia: Updates and Strategies for Managed Care","thumbnail":"https://d36ai2hkxl16us.cloudfront.net/thoughtindustries/image/upload/v1/course-uploads/d2afb412-3c3e-4f73-b3d6-2388078622a3/22wqid3lilcb-PTCE_AMCP-2024_CLL_Enduring_043024v2_800x385.png","description":"1.5 Credits / Hematology, Hematologic Cancer, Oncology","releaseDate":"2024-05-03T04:00:00.000Z","expirationDate":"2025-05-04","creditType":"On-Demand","creditAmount":"1.5","created_at":"2025-03-28T12:06:06.292658+00:00","TI_id":"3f5fc85c-88a5-4d21-9e76-047d384b88f2","slug":"addressing-the-gaps-and-clinical-challenges-in-chronic-lymphocytic-leukemia-updates-and-strategies-for-managed-care-dxq5","delReference":true,"contentTypeLabel":"On-Demand Virtual Symposium","activity-type":null,"specialty":"[\"Hematology\",\"Hematologic Cancer\",\"Oncology\"]","creditCertificate":null,"courseEndDate":"2025-05-04T03:59:59.999+00:00","cventUrl":"","eventData":null,"imageUrl":null},{"id":"b3692513-63e3-4143-be46-fedbcb8387a5","brandName":"Ajmc","dataType":"ptce","title":"Keeping Pace With New Developments in Multiple Myeloma: Updates and Strategies to Optimize Bispecific Antibodies and CAR T-Cell Therapy","thumbnail":"https://d36ai2hkxl16us.cloudfront.net/thoughtindustries/image/upload/v1/course-uploads/d2afb412-3c3e-4f73-b3d6-2388078622a3/hvzihm9lmt65-PTCE_AMCP-2024_MM_Enduring_043024v1_800x385.png","description":"1.5 Credits / Oncology, Hematology, Hematologic Cancer","releaseDate":"2024-05-03T04:00:00.000Z","expirationDate":"2025-05-04","creditType":"On-Demand","creditAmount":"1.5","created_at":"2025-03-28T12:06:06.350283+00:00","TI_id":"e2a1de76-f5f4-4393-85a1-e17a243a9853","slug":"keeping-pace-with-new-developments-in-multiple-myeloma-updates-and-strategies-to-optimize-bispecific-antibodies-and-car-t-cell-therapy-tcdv","delReference":true,"contentTypeLabel":"On-Demand Virtual Symposium","activity-type":null,"specialty":"[\"Oncology\",\"Hematology\",\"Hematologic Cancer\"]","creditCertificate":null,"courseEndDate":"2025-05-04T03:59:59.999+00:00","cventUrl":"","eventData":null,"imageUrl":null},{"id":"1de83d65-461b-4a03-bfc2-3c44b1f983c9","brandName":"Ajmc","dataType":"ptce","title":"Application of Recent Data in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: Managed Care Insights and Strategies","thumbnail":"https://d36ai2hkxl16us.cloudfront.net/thoughtindustries/image/upload/v1/course-uploads/d2afb412-3c3e-4f73-b3d6-2388078622a3/9k0f7jlluuzn-PTCE_AMCP-2024_AMD-DME_Enduring_043024v1_800x385.png","description":"1.5 Credits / Ophthalmology, Optometry","releaseDate":"2024-05-03T04:00:00.000Z","expirationDate":"2025-05-04","creditType":"On-Demand","creditAmount":"1.5","created_at":"2025-03-28T12:06:06.395222+00:00","TI_id":"bcd72b26-a99a-45e5-88c5-0e8cf918bae6","slug":"application-of-recent-data-in-neovascular-age-related-macular-degeneration-and-diabetic-macular-edema-managed-care-insights-and-strategies-z4ru","delReference":true,"contentTypeLabel":"On-Demand Virtual Symposium","activity-type":null,"specialty":"[\"Ophthalmology/Optometry\"]","creditCertificate":null,"courseEndDate":"2025-05-04T03:59:59.999+00:00","cventUrl":"","eventData":null,"imageUrl":null},{"id":"fe815760-37e8-45aa-9a66-be0aae5f9319","brandName":"Ajmc","dataType":"ptce","title":"Emerging Concepts and Approaches in the Treatment of Food Allergy: What Managed Care Professionals Need to Know","thumbnail":"https://d36ai2hkxl16us.cloudfront.net/thoughtindustries/image/upload/v1/course-uploads/d2afb412-3c3e-4f73-b3d6-2388078622a3/fzp3g3z7u7z1-PTCE_AMCP-2024_Food-Allergy_Enduring_043024v1_800x385.png","description":"1.5 Credits / Immunology, Allergy","releaseDate":"2024-05-03T04:00:00.000Z","expirationDate":"2025-05-04","creditType":"On-Demand","creditAmount":"1.5","created_at":"2025-03-28T12:06:06.510331+00:00","TI_id":"515baf60-bb64-4aba-a642-c317d0b33437","slug":"emerging-concepts-and-approaches-in-the-treatment-of-food-allergy-what-managed-care-professionals-need-to-know-ky75","delReference":true,"contentTypeLabel":"On-Demand Virtual Symposium","activity-type":null,"specialty":"[\"Immunology\",\"Allergy\"]","creditCertificate":null,"courseEndDate":"2025-05-04T03:59:59.999+00:00","cventUrl":"","eventData":null,"imageUrl":null},{"id":"7cbe0326-0e0d-4b64-8868-95c41183767c","brandName":"Ajmc","dataType":"ptce","title":"Novel Agents as Proactive Approaches to Addressing Food Allergy: The Role of the Pharmacist in Guiding Optimal Treatment","thumbnail":"https://d36ai2hkxl16us.cloudfront.net/thoughtindustries/image/upload/v1/course-uploads/d2afb412-3c3e-4f73-b3d6-2388078622a3/1pzr08zu6qre-PTCE_Asembia-2024_Food-Allergy_Enduring_051024v1_800x385.png","description":"1.5 Credits / Allergy","releaseDate":"2024-05-17T04:00:00.000Z","expirationDate":"2025-05-18","creditType":"On-Demand","creditAmount":"1.5","created_at":"2025-03-28T12:06:06.051903+00:00","TI_id":"f08d5036-ca07-4e84-aa4e-01b1b08f193f","slug":"novel-agents-as-proactive-approaches-to-addressing-food-allergy-the-role-of-the-pharmacist-in-guiding-optimal-treatment-w7re","delReference":true,"contentTypeLabel":"On-Demand Virtual Symposium","activity-type":null,"specialty":"[\"Allergy\"]","creditCertificate":null,"courseEndDate":"2025-05-18T03:59:59.999+00:00","cventUrl":"","eventData":null,"imageUrl":null}]}},"__N_SSG":true},"page":"/","query":{},"buildId":"cCw4k4UN0a-RdhqtGj97I","isFallback":false,"gsp":true,"appGip":true,"scriptLoader":[]}</script></body></html>